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Abstract
The expression of retroviral vectors in cell lines and primary 
cells was investigated, with emphasis on autocrine stimulation of 
haematopoietic cells by GM-CSF. In this study, two distinct 
retroviral vectors were used which allowed a dual approach to the 
investigation of expression of exogenous sequences in haematopoietic 
cells. Retroviral expression of GM-CSF in the growth factor dependent 
FDCP1 cell line resulted in factor independent colony growth, the 
frequency of which was related to the vector used. The 
characterisation of cell lines derived from viral infection of FDCP1 
cells revealed that these cells required the concentration of self 
produced growth factor to attain a critical level before colony 
development occured. As a result of virus infection, FDCP1 cells 
which express the retrovirally encoded GM-CSF have a proliferative 
advantage over the parental cell line.
Finally, a number of variables which might influence the success 
of retroviral infection of primary murine bone marrow cells were 
investigated. Initial results suggest that bone marrow cells can be 
infected with retroviral constructs containing the neomycin gene, the 
efficiency of which may be related to the origin of the vector.
Thus, this study demonstrates the feasability of using retrovirus 
vectors to express exogenous sequences in haematopoietic cells. It 
also provides a system which can be used to evaluate the efficiency 
with which new vectors will express genes in primary haematopoietic 
cells.
Abbreviations
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CFC colony forming cell
CFU colony forming unit
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CSF colony stimulating factor
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GM-CSF granulocyte/macrophage colony stimulating
factor
IL-3 interleukin 3
kb kilobases
LTR long terminal repeat
LTMC long term marrow culture
M-CSF macrophage colony stimulating factor
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Chapter 1.1
MAINTENANCE AND REGULATION OF THE HAEMATOPOIETIC SYSTEM 
Introduction
The amenability of the haematopoietic tissues for the 
development of both culture and assay systems has been a key point in 
studies addressing the mechanisms of differentiation. Thus it has 
been established that during the process of blood cell formation, stem 
cells proliferate and differentiate into large numbers of short lived 
mature cells (Whetton and Dexter 1986). The relationships between 
these cell types are depicted in Figure 1.1. The mechanisms by which 
cells as diverse as erythrocytes, macrophages, granulocytes, 
platelets, megakaryocytes and lymphocytes are derived from a common 
stem cell has been investigated by In vitro and in vivo clonal assays 
(Metcalf 1984). These assays have been used to characterise the group 
of glycoprotein growth factors known collectively as the colony 
stimulating factors (CSFs) which have been shown to be essential in 
vitro for proliferation and differentiation of the haematopoietic 
cells (Sieff 1987, Metcalf 1984).
The Cellular Composition of the Haematopoietic Compartment 
Stem Cells.
The haematopoietic hierarchy can be subdivided into three 
compartments: the stem cell, progenitor cell and mature cell
compartments (Metcalf 1984). Stem cells are defined as a pluripotent 
population capable of producing the entire range of functional mature 
haematopoietic cells (Till and McCulloch 1980). The stem cell 
compartment is maintained by self renewal, a property which 
discriminates this compartment from others (Metcalf 1984). The murine 
haematopoietic stem cell has been characterised and studied using an 
in vivo assay (see below).
Murine In vivo stem cell assay.
In 1961 Till and McCulloch established a method for analysing 
the radiation sensitivity of normal murine bone marrow. This assay 
relied on mice ( whose haematopoietic system had been destroyed by 
irradiation), receiving an intravenous injection of a small number of 
bone marrow cells from a healthy donor mouse. Murine haematopoietic
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Figure 1.1
This figure is reproduced from Metcalf, D. (1984) 
The precursor cells in each haemopoietic lineage. 
Two subsets of self-generating stem cells exist 
(CFU-S-1 and CFU-S-11). These give rise to 
committed progenitor (colony forming) cells 
restricted to one differentiation lineage, or two 
in the case of granulocyte-macrophage progenitor 
cells. All stem and progenitor cells can form 
colonies in semi-solid cultures. CFU-S-1 form 
blast cell colonies, CFU-S-11 (Mix-CFC or 
Multi-CFC) form mixed colonies usually containing 
erythroid cells. All other colony-forming cells 
form colonies of restricted differentiation 
lineage. Some macrophages, mast cells and T- and 
B- lymphocytes retain substantial proliferative 
capacity and also form colonies _in vitro. The 
existence and exact origin of stem cells common to 
T- and B-lymphocytes are unresolved questions.

tissue was thus discovered to contain a population of cells that have 
the capacity to form macroscopic colonies of proliferating 
haematopoietic cells in the spleens of irradiated recipient mice. 
However, the bone marrow contains many different cell types, and so 
the precise cellular origin of the colonies is speculative. Due to 
this uncertainity these cells are termed colony forming units (CFU) or 
colony forming units- spleen (CFU-S). Analysis of colony morphology 
over several days after transplantation showed that on day one the 
colonies consisted mainly of early and late erythroblasts,
undifferentiated cells and small numbers of myelocytes and
metamyelocytes. However by day eleven erythropoiesis and
granulopoiesis were equally well advanced and megakaryocytes were 
also observed. This system has allowed the analysis of self renewal 
and differentiation capacities of the CFU.
Clonal Nature Of The Spleen Colonies
Till and McCulloch (1961) predicted that colonies were clonal 
by showing a linear relationship between the small number of cells 
injected (10^ -10-*) and the small nunbers of colonies observed (7-12 
per 105 cells injected). However a minimum transplant of 10^  cells 
were required before colonies were observed and this was assumed to be 
due in part to the presence of a high proportion of differentiated 
cells in the bone marrow which do not participate in colony formation 
and in part to lodging and development of CFU in regions other than 
the spleen. Clonality was formally proven by using donor bone marrow 
that had been exposed to ionizing radiation (Barnes et al 1968, Becker 
et al 1963), which causes random chromosome abnormalities in cells, 
resulting in each individual cell (including CFUs) possessing unique 
chromosome markers (Barnes £t_al 1968, Becker et al 1963)- The clonal 
progeny from different CFU s could therefore be distinguished on a 
cytogenetic basis (Barnes et_al 1968, Becker et al 1963).
Proliferation. Differentiation and Self Renewal of CFU-S
During the first 10 days spleen colonies show extensive 
proliferation and attain a size of approximately 10° cells (Trentin 
1971). Up to ten days most colonies exhibit only one differentiated 
cell type, but from days 11 to 14 an increasing number of colonies 
consist of two or more different differentiated cell phenotypes
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(Trentin 1971) . Initially it was the high proliferative capacity and 
the multilineage development that made the CFU a candidate for a stem 
cell in this system (Trentin 1971) • Siminovitch et al. (1963), 
studied the self renewal properties of CFU by retransplanting 
individual primary colonies into secondary hosts. If self renewal 
occurs within the developing colony then spleen foci should be 
observed in secondary recipients. In fact colony forming cells are 
found within individual primary colonies but their distribution is 
extremely heterogeneous, with 24 out of 36 individual colonies showing 
no capability to form spleen colonies, while 12 out of 36 show varying 
degrees of self renewal from 1 to 36 colonies per spleen. This 
heterogeneity could be a reflection of an intrinsic property of the 
cell population being assayed. Thus it may be possible that not every 
CFU capable of forming a primary colony is able to self renew or 
alternatively variation could be due to sampling errors between 
spleens. The observation that heterogeneity in numbers of CFU-S per 
spleen between spleens was not so great using pooled colonies, 
suggested that the observed differences may be a property of the 
cells themselves (Siminovitch et al. 1963).
Heterogeneity among spleen colonies with respect to self renewal
Siminovitch et al.(1963) examined a number of parameters in 
order to explain the heterogeneity described above. It was observed 
that when self renewal was tested in colonies of different ages 
ranging from day 10 to 14, the number of CFU s within the
colonies increased with age although heterogeneity was present at all 
time points. Colony size also varied but not enough to explain the 
overall heterogeneity observed, leaving the question open as to the 
cause of this variation.
The bone marrow cells which can form primary colonies 
constitute a mixture of cells with varying degrees of self renewal 
capacity (Siminovitch et al.1963)• If this is a heritable trait of 
the CFU, then serial transplantation should result in predictable self 
renewal patterns. This experiment is difficult to carry out as the 
self renewal capacities of the CFC decrease during repeated passage , 
perhaps due to dilution out of CFC or accessory cells rather than any 
alteration in phenotype of the CFC themselves (Schofield and Dexter 
1985, Spooncer et al 1985, Ross et al 1982). Alternatively it may be
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that not all the spleen colonies arise due to proliferation of a 
multipotential cell. Single lineage colonies which are observed 
especially during early time points of colony formation (Trentin 1971) 
,may not have reached their full developmental capacity or indeed 
passed the point where mixed lineages were obvious, so they may appear 
to be lineage restricted although having arisen from a multipotential 
cell. It is difficult to assess what is a multilineage colony since 
it is unlikely that a few macrophage cells would be noticed in a 
colony that is predominantly erythroid.
The lower self renewal capacity of cells in day 10 colonies 
compared to that in day 14 colonies suggests the presence of a lineage 
restricted, low self renewing progenitor cell population capable of 
forming spleen colonies (Siminovitch et al. 1963). Colony formation 
may be a dynamic event with subpopulations exhibiting different 
characteristics each contributing to repopulation of the spleen.
Finally, heterogeneity among CFC with respect to self renewal, 
might occur during the development of the colony due to alterations in 
the balance between self renewal and differentiation. Colonies 
showing no self renewal capacity may have received a strong stimulus 
to differentiate and the use of irradiated mice may provide localised 
environments within the spleen which are biased towards 
differentiation or self renewal (Siminovitch et al. 1963). This point 
raises the question of the role of the microenviroment in stem cell 
maintenance, self renewal and differentiation (See Chap.1.3).
Models for haematopoietic development based on the CFU assay.
The haematopoietic inductive microenvironment (HIM) model of 
Trentin (1971), proposes the multipotential stem cell interacts with 
the environment to direct the course of development, a theory which 
is based on the spacial distribution and phenotypic heterogeneity of 
foci within the spleen. Trentin (1971) observed that spleen foci 
consisting of predominantly one mature cell phenotype, could on 
transplantation into secondary recipients, generate spleen foci 
consisting of many cell morphologies. He concluded that the initial 
lineage restriction was due to local enviromental influences at the 
site of the focus, and that the re-seeded CFC became influenced by 
their individual localities. Till and McCulloch 1980, Till et al.
1964, favour an alternative interpretation of the data available on
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heterogeneity within spleen colonies. Their model is called the 
stochastic model of stem cell proliferation and suggests that each CFC 
has a random (stochastic) decision either to self renew or 
differentiate. This infers that the control of stem cell development 
is very flexible. However if a population of CFC s are examined as a 
whole then regulation would appear tightly regulated as any individual 
random decision would be obscured. Under normal conditions the number 
of mature cells in the blood remains fairly constant (Burgess and 
Nicola 1983), so if the mature cell compartment was originally derived 
from very few cells, and a stochastic mechanism was responsible for 
developmental decisions, then the number of mature cells would 
fluctuate at random. The only two situations in which a stochastic 
mechanism could work would be if many stem cells contribute to the 
maintainance of haematopoiesis, so negating heterogeneity caused by 
small sample numbers, or, if haematopoiesis was maintained by a few 
stem cells, the circulating cell numbers would be kept constant by a 
feedback mechanism acting after their production. This could be
achieved by mature cell storage in tissues and organs.
Recent work by Leminschka et al.. (1986) has enabled the nunber 
of stem cells actively contributing to the mature cell compartment to 
be assessed. Mice received transplants of bone marrow infected with a 
retroviral vector. The random integration of retroviruses into host 
DNA provides a unique marker system in which cells derived from a 
common precursor can be identified due to the integration site of the 
virus. These results indicate that very few stem cells contribute to 
the mature cell compartment at any one time. Although this is
preliminary data subject to the sensitivity of Southern analysis, it
argues against a stochastic mechanism for the maintainance of 
haematopoiesis.
Summary of CFU-S experiments.
The observed heterogeneity of CFU s is likely to be due to
several causes. The bone marrow used for the initial injection is a 
mixed population of cells and the cell giving rise to the colonies is 
undefined (Till and McCulloch 1961). It is likely that the cell 
population capable of generating spleen colonies is heterogeneous 
itself and not all are stem cells Siminovitch .§£ nl# (1963). If 
sub-populations could be purified sufficiently or cell lines 
generated, then this could be examined in more detail. Attempts have
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been made to do this, but purification manipulations appear to alter 
the cells characteristics (Schofield and Dexter 1985, Spooncer et al 
1985, Ross et al. 1982).
Different regions of the spleen may provide local environments
which regulate differentiation or at least influence the probability
of a stochastic decision (Trentin 1971). Microenvironmental control 
is difficult to examine in vivo and experiments using in vitro culture 
systems have been designed to address the uncertainty around the
control of haematopoiesis. These will be discussed in Chapter 1.3.
All experiments described above were carried out using
irradiated mice as an in vivo culture system for studying 
haematopoietic development, which is clearly not the normal situation. 
It should be re-emphasised that the cells leading to colony formation 
are not necessarily the same as those which maintain normal 
haematopoiesis. These experiments were not specifically designed to 
examine long term reconstitution of the haematopoietic system and
there is a variable degree of animal mortality following irradiation 
which could lead to experimental bias.
In vitro assays for multipotential cells.
The In vivo stem cell assay has been used to determine factors 
influencing haematopoietic differentiation (McCulloch et al. 1964, 
Curry et al. 1967). The assay is however difficult to manipulate and
early time points of colony formation are not readily observable (Till 
and McCulloch 1980). The methodology for achieving clonal growth of 
bone marrow cells _in vitro was originally developed independently by 
Bradley and Metcalf 1966 and Pluznik and Sachs 1965. In vitro colony 
assays have permited the analysis of progenitor and stem cell 
populations which have colony forming capabilities under the
appropriate growth conditions. Colony formation takes place within a 
semi solid matrix such as soft agar or methocellulose when a source of 
colony stimulating factor (CSF) is added (Metcalf 1984).
Mix-CFU in vitro Assay for mixed ervthroid colony growth
Although CFU-S cannot be formally proven as the cell that
maintains haematopoiesis, its proliferative, self renewal and
differentiation properties are indicative of a stem cell. 
Multilineage colony growth was first described by Johnson and Metcalf
6
in 1977. Foetal liver cells were used as a source of haematopoietic 
cells and colony growth was analysed after stimulation by pokeweed
mitogen stimulated spleen cell conditioned media (SCM). Up to 649 
erythroid colonies per 10-* cells were formed depending on the stage 
of foetal liver development, although only about 50% of these
erythroid colonies show mixed lineages. Erythroid development from 
lineage restricted progenitors has been shown to be dependent on the 
presence of erythropoietin (Epo). Any erythropoiesis observed could 
therefore be due to Epo contamination of the SCM or human plasma which 
might stimulate a progenitor cell popoulation rather than a stem cell. 
However, an _in vivo assay for Epo failed to detect contamination, 
which suggested that mixed colony formation was due to direct
stimulation of a multipotential cell.
When Metcalf et al.(1979) examined the self renewal properties 
of 7 day mixed colonies from foetal liver by recloning primary
colonies in agar, secondary colonies were observed at a frequency of 
1 in 10 with a low or variable replating efficiency. These colonies 
were small and were mostly granulocytes and/or macrophages, with only 
8 out of 76 daughter colonies being mixed erythroid. When pools of 
seven day mixed erythroid colonies were injected into irradiated mice 
to assay for CFU-S, low numbers were detected (10 CFU-S/ 10-* cells). 
These early attempts to characterise _in vitro assays for the stem cell 
population were in part successful, as mixed lineages were detected 
and self renewal was observed although only at a low level and with 
some loss of multipotentiality.
Johnson revised this assay in 1980 (Johnson 1980) and made 
several important changes. Originally human plasma was used, which 
resulted in variation between batches in the ability to form and 
maintain mixed colonies from both foetal and adult tissue. When 
foetal calf serum selected for granulocyte/macrophage colony growth 
was used, and the SCM concentrated 10 fold, erythroid colony growth 
could be detected in adult bone marrow at a frequency of 22 to 44 
colonies per 10-* cells, in comparison to less than 10 colonies per 10-* 
cells with human plasma. The cell population detected by this assay 
is termed mix-CFC (Johnson 1980), or alternatively CFU-mix (Harra and 
Noguchi 1982) or CFU-GEMM (Nakahata and Ogawa 1982). Its relationship 
to the CFU-S has been established not only by its colony forming 
characteristics but also by cell cycle and physical characteristics.
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Johnson (1980) showed that 12.5% of adult bone marrow mix-CFU 
were in S-phase as determined by tritiated thymidine or hydroxyurea 
suicide experiments, a value similar to that for CFU-S in cycle 
reported by Vassort et al. 1973. In contrast CFU-GM progenitor 
cells show a reduction of 31% Johnson (1980). The physical 
characteristics of the different cells were also analysed. Johnson 
(1980) and Vassort et al (1973) demonstrated that both CFU-S and 
mix-CFU have similar bouyant densities of 3.6 to 5.3 mm/h, whereas 
CFU-GM progenitors which sediment at 4.6 to 6.1 mm/h. The ability of 
mix-CFU to generatate multilineage colonies and self renew suggests it 
is a stem cell population, which is heterogeneous and has a very 
low incidence of true multipotential cells (Johnson 1980). It should 
be stressed that only 40-50% if the total erythroid colonies are 
multilineage, and on average only one CFU-S is observed in a single
mix-CFU colony (Johnson 1980). It is possible however that the
observed heterogeneity and low incidence may not be entirely due to
the cell population itself, but may in part be due to culture
conditions (Johnson 1980).
Blast Cell Colony Assay
In 1982 Nakahata and Ogawa (Nakahata and Ogawa 1982)
identified a new class of colony forming unit which showed stem cell
characteristics and formed what are described as blast cell colonies.
When bone marrow or spleen cells are incubated for over 10 days in the 
presence of SCM and Epo most of the developing colonies show
differentiation. However, beyond two weeks these colonies begin to
disintegrate. Surviving colonies contain 40-1000 homogeneous cells
with no apparent terminal differentiation (blast cell colonies). All 
colonies yielded mixed colonies consisting of granulocytes, 
erythrocytes, macrophages and megakaryocytes (GEMM colony) after 
replating (Nakahata and Ogawa 1982). The cells from the primary
colony also show high replating efficiencies, and secondary and 
tertiary blast cell colonies producing further blast cell and GEMM
colonies with high efficiency, highlighting the extensive self
renewal capacity of these cells. Self renewal was also examined 
after transfer of the blast cell colonies into irradiated mice. These
experiments revealed as many as 47 CFU-S per stem cell colony. The
numbers of CFU-S and CFU-GEMM within stem cell colonies closely
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correspond to each other and they are therefore perhaps overlapping 
populations. However when identical analysis was performed on GEMM 
colonies, no stem cell colonies were observed on replating, and only 
low numbers of CFU-S were observed within GEMM colonies. The data 
obtained in GEMM colonies is similar to that obtained by Metcalf _et al 
(1979) on the clonies from mix-CFC and the populations they describe 
are probably identical. Nakahata and Ogawa(1982) propose that because 
of lack of differentiation and the large numbers of secondary GEMM 
colonies within stem cell colonies, the stem cell colonies arose from 
a more primitive cell than the GEMM.
The data showing that stem cell colonies occur at a low 
frequency and are heterogeneous in their self renewal and GEMM 
forming capacities (Nakahata and Ogawa 1982), has been used to 
substantiate the stochastic model for stem cell self renewal and 
differentiation (Nakahata et al.1982, Ogawa .et al.1983). What would 
the possible role of the environment in the culture system be? Since 
colony formation will not occur unless a source of stimulator is 
added, (in this case SCM), (Nakahata and Ogawa 1982). The growth 
factor added may be considered to allow cell survival only and not 
influence the decision to self renew or differentiate. The data could 
also be explained by the presence of a heterogeneous population which 
requires SCM to ’’activate” a pre-existing commitment which has 
occurred earlier in the cells history either stochastically or 
induced. Alternatively the SCM and microenvironments within the
factors may act on the heterogeneous population influencing commitment 
and/or subsequent development. The actions of soluble growth factors 
will be discussed in more detail in another section.
Colony Forming Unit Type A (CFU-A) Assay
Recently Pragnell and colleagues (1988), have described a new 
in vitro assay that detects a multipotential cell population, (CFU-A), 
which has similarities to CFU-S. By incubating a low density of normal 
bone marrow cells, with a source of GM-CSF and M-CSF, macroscopic 
mixed lineage colonies develop over 11 days. The multipotential cells 
(CFU-A) which give rise to such colonies have been shown to have 
similar cell cycle characteristics to CFU-S, and also respond to 
specific proliferation regulators of CFU-S. The CFU-A assay is 
attractive in its simplicity to perform
culture more active role in decision making. Soluble
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(normal bone marrow and defined growth factors) and score(macroscopic 
colonies at a high incidence of 150-200 colonies per 10-* cells).
The in vitro multipotential cell assays described, have
established a methodology by which early cell development can be 
studied. There are however doubts as to the exact nature of the cell 
population they detect and both in vivo and in vitro assays show
considerable variability in certain characteristics.
Progenitor Cell Compartment and its relationship to Haematopoietic 
Growth Factors.
The in vitro growth of haematopoietic cells is dependent on a
source of colony stimulating factor (Metcalf 1984). Prior to the
establishment of in vitro assays for multipotential cells, growth
conditions were described that permitted colony growth displaying only 
one, or at most two, mature differentiated cell types (Pluznick and 
Sachs 1965, Bradley and Metcalf 1966). These colonies were assumed to 
be the progeny of early cells which had restricted lineage potential 
and were termed progenitor cells (Metcalf 1984). This characteristic 
was used to distinguish them from multipotential stem cells as assayed 
in vivo (Metcalf 1984). The development of progenitor assays is 
inextricably linked to the investigation of the interaction of colony
stimulating factors with haematopoietic cells (Metcalf 1984). The
class of progenitor under examination is defined by the morphology of 
the resultant colony , which in turn, is dependent on the source and
type of colony stimulating factor (CSF) (Metcalf 1984). The actions
of CSF (or growth factors) will be described shortly.
In order to resolve the relationship between murine in vivo
stem cells and colony forming cells in vitro, cell;, separation studies 
must be performed on the heterogeneous haematopoietic population. If 
a single population of cells with the ability to proliferate in both 
stem and progenitor assays could be purified , then it would be likely 
that the assays characterise the the same cells. If, however, cell 
populations could be separated that showed colony forming ability in
only one or other assay, this would provide good evidence for the 
presence of sub-populations within the haematopoietic compartment and 
relationships and roles in haematopoietic development could be 
investigated.
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Cell Separation Studies
Worton et al. (1969) used cell density and cell size as 
parameters to separate murine bone marrow. Fractions from 
equilibrium density gradient and velocity sedimentation gradients were 
analysed in the CFU-S and the In vitro progenitor colony forming assay 
using conditioned media from mouse L cells as a source of stimulator. 
Two populations of cells were distinguished by cell density and cell 
size, and CFC progenitors had a higher sedimentation velocity 
(4.9mm/h) than the CFU-S (3*9mm/h). Although these populations 
overlapped, the results led Worton et al.(19 69) to conclude that at 
least some of the cells that can form spleen colonies are not detected 
in the _in vitro culture assay and that some of the cells that form 
colonies in vitro are not detected in the spleen assay. The 
overlapping distributions of these suggest that perhaps there is a 
sub-population of cells in the region of overlap which is detected by 
both assays. This overlap may reflect true variation with each 
population or it may be the result of variation in the detection 
efficiency of the two assays used.
Improvements in techniques such as fluorescent activated cell 
sorting has enabled cell populations to be separated much more 
efficiently. Fluorescent activated cell sorting (FACS) separates 
cells according to light scattering properties (Visser and Bol 1981). 
This property, coupled to either lectin or antibody affinity has 
clearly defined the existance of subsets of early haematopoietic 
clonogenic cells ( Visser and Bol 1981).
Nicola and Johnson (1982) separated two fractions of 
clonogenic cells from foetal liver which differed in their lectin 
binding properties and thus were amenable to fluorescent activated 
cell sorting. The two fractions were termed the pre-colony forming 
cell (preCFC) fraction and the CFC fraction. The pre CFC fraction 
contained many CFU-S but very few cells with the ability to form  
colonies In vitro (CFCs). In 1iquid culture this preCFC fraction 
generated many CFC after stimulation for 5-7 days with either pokeweed 
mitogen stimulated spleen cell conditioned media (SCM) or 
postendotoxin serum. In contrast, the CFC fraction contained very few 
CFU-S but a high frequency of CFC cells. Stimulation of this fraction 
in liquid culture for 2 days by colony stimulating factors generated 
large numbers of differentiated progeny and by 4 days few CFC could be
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detected. Thus multipotential cells could be separated from 
progenitor (CFC) cells and under the appropriate conditions 
multipotential cells may generate lineage restricted colony forming 
cells.
It is clear that sub-populations of haematopoietic cells
exist. The observation by Nicola and Johnson (1982) that pre CFC 
(multipotential cells) can generate lineage restricted CFC, offers an 
experimental system within which factors influencing transitions from 
multipotential to lineage restricted cells can be examined. The fact 
that cells are physically separate from these forming spleen colonies 
in irradiated mice, confirms the theory that the haematopoietic
compartment is made up of sub-populations.
Response of Haematopoietic Cells to Colony Stimulating Factors.
In vitro colony growth is totally dependent on a source of 
colony stimulating factor (Metcalf 1984). Colony growth has been used 
to define and purify a family of glycoproteins collectively known as
the colony stimulating factors (Sieff 1987). Stimulatory activity has
been identified in many sources including murine organs and many 
established cell lines, (Burgess et al.1986, Metcalf and Johnson 1978, 
Nicola et al.,1979, Shrader and Clark-Lewis 1982, Pragnell et al.1988, 
Stanley and Heard 1977, Schrader and Crapper 1983, Koury and Pragnell
1982), with the most predominant activity resulting in granulocyte 
and/or macrophage colony growth and termed granulocyte-macrophage 
colony stimulating factor (Metcalf 1985ft. Purification and molecular 
cloning has so far identified four distinct proteins capable of 
sustaining granulocyte/macrophage development, namely G-CSF, M-CSF, 
GM-CSF and IL-3 (Metcalf 1986, Fung et al.1984, Yang et aL 1986, 
Nicola al. 1985, Nagata £t al. 1986, Wong et al.1987, Wong et. al . 
1985, Stanley e£ alJ985, Miyatake £t al 1985). The full range of 
these growth factor activities will now be discussed in relation both 
to one another and other relevant regulation factors, such as 
erythropoietin (Metcalf and Johnson 1979) and H-1 (Mochizuki et al 
1987).
Colonies which differ in their composition of single lineage 
mature cells, may arise from a single growth factor interacting with 
different pre-committed progenitor cells, or alternatively, a group of 
regulatory factors, which themselves differ, could operate on a rather
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more homogenous target cell population, actively influencing the 
developmental decisions of the cell. These two scenarios in which 
haematopoietic growth factors might interact with responsive cells to 
regulate colony formation need not be mutually exclusive and the use 
of pure growth factors and fractionated cell populations has permitted 
experiments designed to address such questions to be attempted.
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Chapter 1.2
Biological Activities of Granulocvte-Macrophage Colony Stimulating 
Factor
Introduction
Early observations by Metcalf (1970) indicated the importance 
of colony stimulating factors (CSFs) in haematopoietic colony 
development. For example Metcalf (1970) demonstrated that single cell 
suspensions of bone marrow cells immobilised in soft agar were capable 
of limited proliferation (up to 16 cells) but died unless CSF from 
human urine was added. Supplementation by growth factor tends to 
sustain cellular proliferation with approximately 10% of the initiated 
clusters of cells progressing to colonies, (clusters are defined as 
groups of less than 50 cells, whereas colonies comprise of more than 
50 cells). The colony morphology follows a predictable pattern and 
during the first two days colonies are granulocytic but by day seven, 
macrophage colonies predominate. The number and rate at which new 
colonies appear increases with the concentration of CSF suggesting 
that CSF is at least a trigger for colony formation. The delayed
addition of CSF to the cultures revealed a 50% loss of viability after-
only one day and so CSF is also necessary for survival. Colony 
growth decreases and ceases by day seven but this is not due to growth 
factor depletion or instability. Experiments in which prior 
incubation of CSF and re-use of agar previously used to support colony 
growth were performed which led the author (Metcalf 1970) to rule out
these possibilities. Although new colony growth will occur after the
addition of fresh cells to agar that has already sustained colony 
growth, the CSF does show some depletion, which suggested to 
Metcalf(1970) that perhaps the CSF was actively metabolised.
Analysis of CSF-progenitor cell interactions
The ability to recognise mature granulocytes and macrophages 
within colonies allowed for the purification of the proteins 
responsible for this activity (Burgess et al 1986). The lung cells 
from mice previously treated with endotoxin (MLCM) are a good source 
of granulocyte, macrophage stimulating activity (Burgess et al 1986, 
Burgess .gfc .al,1977). One of the proteins isolated from MLCM is called 
granulocyte-macrophage colony stimulating factor (GM-CSF) (Burgess et
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al 1986), The protein was initially purified 3500 fold from MLCM and 
used to stimulate colony growth from murine marrow (Burgess et al 
1977)* At high concentrations (greater than 20 jig/ml), Burgess et al 
(1977) observed 3 colony types consisting of granulocytes, macrophages 
and mixed granulocyte/macrophages. The proportions of
each colony type were slightly different from that after stimulation 
of bone marrow cells by unfractionated MLCM. MLCM stimulates almost 
equal proportions of all three cell types whereas the pure GM-CSF 
showed a slight bias towards macrophage colonies. The colony 
proportions altered more obviously after the concentration of GM-CSF 
was decreased. This led to the frequency of granulocyte colonies 
decreasing until at lew concentrations (less than 70pg/ml) only 
macrophage colonies developed (Burgess et al 1977).
It can be concluded from this series of experiments (Burgess 
et al 1977) that GM-CSF is able to interact with cells in the 
progenitor compartment that are either bipotential 
granulocyte-macrophage colony forming cells (GM-CFC s) or unipotential 
granulocyte CFC s (G-CFC s). The observation that a single pure growth 
factor stimulated three different colony types (Burgess et al 1977) 
was held to substantiate previous data on the heterogeneity of the 
progenitor compartment (Metcalf and MacDonald 1975).
Heterogeneity of the progenitor compartment
Two years previously Metcalf and MacDonald (1975) had used 
velocity sedimentation to analyse the heterogeneity among bone marrow 
colony forming cells. They found that the larger, more rapidly 
sedimenting cells required less stimulation by MLCM in order to 
produce colonies than the more slowly sedimenting smaller cells. In 
fact when colony morphology was examined, macrophage colonies formed 
only from the rapidly sedimenting fractions whereas the proportion 
of granulocyte colonies rose in cultures of more slowly sedimenting 
cells. Initially two distinct sub-populations appear to have been 
separated and these respond to different levels of 1C CM. Most 
colonies which were granulocytic in composition change with the 
appearance of a secondary population of macrophage cells until the 
whole colony consists of macrophages. Therefore although the 
sedimentation technique separates cells which differ in their response 
to CSF concentration , this may represent a compartment of cells which
15
differ in their rate of transformation during colony growth from 
granulocyte to macrophage, rather than qualitative difference in their 
capacity for differentiation. Macrophage colonies are formed at low
CSF concentration and it is the large colony forming cells (CFC s)
which respond to low levels of CSF, and so this may explain why such 
colonies develop. There may then be a prexisting heterogeneity in the 
bone marrow within which various CSF s might preferentially stimulate 
selected subpopulations. This data sugests that two such populations 
which respond to MLCM may exist: a progenitor restricted to the
macrophage pathway is activated at low CSF concentration and a 
bipotential GM-CSF progenitor which, at high concentrations of CSF, 
will develop into granulocytes and macrophages.
The Influence of GM-CSF on Colony Composition
Metcalf (1980) studied the ability of GM-CSF to influence 
colony composition by analysis of paired daughter cells derived from a 
single cell, initiated in a high concentration of GM-CSF. Semi-pure 
GM-CSF was titred so that 2,500 units stimulated colonies that were 
58% granulocyte and 50 units stimulated colonies that were 76%, 
macrophage. Bone marrow cells were incubated in the presence if 2,500 
units of GM-CSF for 16 to 24 hours, after which the daughter pairs 
from dividing cells were removed, separated and transferred to new
culture dishes. Subsequent development proceeded in either 50 units 
or 2,500 units of GM-CSF. Eight out of forty one pairs of daughter 
cells treated this way generated granulocyte colonies when transferred 
into high GM-CSF concentration and macrophage containing colonies when 
moved into low concentrations of GM-CSF. A further six out of forty
one pairs gave granulocyte-macrophage mixed colonies on transfer into 
high GM-CSF concentrations. In comparison 39 out of 48 pairs
produced colonies that were identical in composition when both 
daughter cells were transferred into high levels of GM-CSF (Metcalf 
1980). As previously discussed^low levels of GM-CSF predominantly
stimulate macrophage colonies and high concentrations of GM-CSF 
results in granulocyte or mixed granulocytes/macrophage colonies
(Metcalf and MacDonald 1975). The data on transfer of paired daughter 
cells from high GM-CSF concentration suggests that at the time of
transfer these cells are still able to respond to the new environment
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since in seme cases, daughter cells transferred into low GM-CSF 
conditions develop into macrophage colonies (Metcalf 1980)- These 
results imply that for GM-CSF to influence the morphology of colony 
formation it may have to remain constant for a period of longer than 
the initial 16 to 24 hours (Metcalf 1980). Thfisedata (Metcalf 1980) 
does seem to indicate that the progeny of progenitor cells are 
responsive to environmental changes and so represent a point at which 
developmental regulation can occur.
Analysis of Commitment to Single Lineages bv Haematopoietic Growth 
Factors
Interaction of GM-CSF and Macrophage CSF (M-CSF)
M-CSF is a 70, 000 molecular weight glycoprotein which 
preferentially stimulates macrophage colony formation (Stanley et al
1983). This growth factor has been examined together with GM-CSF in 
order to compare the populations of cells stimulated and the manner in 
which they exert their differentiation properties. Using pure GM-CSF 
and partially purified M-CSF, Metcalf and Burgess (1982) used a 
similar approach to that described for the analysis of the influence 
of GM-CSF on colony composition. Cultures were initiated using either 
M-CSF or GM-CSF and daughter and grand-daughter cells were either 
separated after 24 hours or colonies removed after 2 - 3 days and
re-cloned in either M-CSF or GM-CSF. Colony morphology was observed 
and noted over the subsequent incubation period. Colonies maintained 
in GM-CSF were composed of approximately equal frequencies of
granulocyte, macrophage and mixed granulocyte/macrophage colonies, 
whereas control colonies maintained in M-CSF were 90% macrophage. If 
M-CSF was used as an initial stimulus for 2 - 3  days, transfer to 
either GM-CSF or M-CSF resulted in the colonies being 90% macrophage. 
GM-CSF-initiated colonies gave approximately 50% granulocyte and
granulocyte/macrophage colonies when transferred to either stimulus. 
These experiments indicate that some commitment is occurring during 
the 2 - 3  day initial incubation (Metcalf and Burgess 1982).
When these types of experiments were carried out after an 
initial incubation of only 24 hours (Metcalf and Burgess 1982), cells 
which had undergone only 1 or 2 cell divisions did not show such clear 
induction of commitment.During the re-cloning of paired daughter cells
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granddaughter cells and colonies, not all survived transfer into 
different growth conditions (Metcalf and Burgess 1982). Twelve
K
percent of the cells initiated in M-CSF failed to respond to Qa-CSF and 
so were considered to be monoresponsive to M-CSF. The freqency of 
monoresponsive cells to GM-CSF is approximately 32% by a similar 
calculation (Metcalf and Burgess 1982). This indicates that at least 
two-thirds of the granulocyte-macrophage proge nitor cells in the 
adult marrow are bi-responsive to GM-CSF or M-CSF (Metcalf and Burgess
1982). Th£sedata is difficult to interpret as failure to transfer may 
be due to conditioning of a previously biresponsive cell by the 
initial stimulus to become monoresponsive and so this frequency of 
biresponse is probably an underestimate (Metcalf and Burgess 1982).
Lazar et al (1985) have examined the regulation by growth 
factors of granulocyte/macrophage production using a genetic approach. 
They observed that two inbred mouse strains C57BL/6J and LP/J differed 
in their response to CSF. When SCM was used as a source of GM-CSF 
(Lazar et al 1985) the dose response curves for bone marrcw colony 
forming cells (CFC) for both strains showed a similar plateau value. 
However the LP/J marrow had a higher response at low levels of SCM. 
This response was not seen when mouse L-cell conditioned medium was 
used as a source of M-CSF (Lazar et al 1985) both strains of mice had 
identical dose response curves. Lazar and his colleagues (1985) 
interpreted these results to mean that the two CSF’s act independently 
on bone marrow progenitors.
Subsequently, however, Lazar et al (1985) discounted the 
possibility that two factors used (GM-CSF and M-CSF) were acting on 
independent populations of progenitors. Concentrations of both 
factors that gave maximal colony formation were mixed. If both 
factors were acting on separate populations, the numbers of colonies 
should be additive (or higher) than the numbers generated by the 
individual factors. However mixing L-cell conditioned media with SCM 
showed no significant increase in colony numbers over those observed 
for the single factors, and so it seems likely that both CSF s act on 
a single population of progenitors which differs in its response to 
M-CSF and GM-CSF in LP/J mice.The conclusion that a single 
biresponsive population of progenitors is the main target for both 
GM-CSF and M-CSF agrees with the previously discussed work (Metcalf 
and Burgess 1982).
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The increased sensitivity of progenitor cells from the LP/J 
strain of mice to lower levels of GM-CSF in comparison to C57BL/6J 
mice, without any obvious differences in total numbers of colony 
forming cells present in the marrow, could be explained on the basis 
that the C57BL/6J mice have progenitor cells with receptors which 
display an altered affinity for GM-CSF, resulting in fewer colonies 
being produced at low CSF concentrations (Lazar et al 1985). At high 
concentrations, differences between strains would perhaps be minimal 
since all receptors would be saturated regardless of affinity (Lazar 
et al 1985). It is of interest that the preliminary comparisons of 
circulating blood cells levels did not reveal any significant strain 
deficiency, which could mean that the CFC response to growth factors 
is not significant in determining the final numbers of circulating 
cells. It is possible that the levels of CSFs may be regulated by 
strain differences , for example LP/J mice may have decreased levels 
of GM-CSF in comparison to C57BL/6J.
Proliferative Efects of GM-CSF and Granulocyte-CSF (G-CSF)
The discussion has so far been limited to the activities of 
GM-CSF and M-CSF. Two factors which appear to act on an overlapping 
population of progenitor cells In vitro. A third growth factor, 
G-CSF, is associated with the ability to stimulate granulocyte colony 
growth from bone marrow cells (Metcalf and Nicola 1983) and can induce 
differentiation of both murine (Metcalf and Nicola 1982) and human 
leukaemic cells (Vellenga et al. 1987)-
Metcalf and Nicola (1983) used G-CSF purified from MLCM to 
examine its proliferative effects on normal mouse haematopoietic 
cells. This preparation stimulated small numbers of granulocyte 
colonies. If the plates were examined after two or three days many 
proliferating cells which, by day seven had died, were found to be 
present. It was suggested that G-CSF may sustain the early 
proliferative divisions of cells destined to differentiate down 
lineages other than the granulocytic, and without the appropriate 
lineage specific stimulus these cells die. In order to study this, 
replating experiments were carried out in which cells initiated for 
two days in either G-CSF or GM-CSF were transfered to new growth 
conditions. Thus when proliferating cells, initiated in G-CSF for two 
days, were transferred to similar G-CSF growth conditions, only 9% of
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the cells survived to produce granulocytic colonies. However, on 
transfer to dishes containing GM-CSF, 40% of the cells survived. 
Reciprocal transfer experiments, using GM-CSF initiated cells, 
resulted in approximately 90% of the proliferating cells surviving 
transfer . These observations suggest that G-CSF can initiate, but 
not sustain, the proliferation of many granulocyte-macrophage colony 
forming cells (GM-CSF1s) and is capable of stimulating only a 
subpopulation of progenitors to form colonies. The effect of G-CSF on 
multipotential mix-CFC's and BFU-E erythroid progenitors was also 
examined by overlaying the G-CSF initiated foetal liver cells with 
either SCM or erythropoietin. SCM will stimulate erythroid or mixed 
erythroid colony formation, whereas erythropoietin will not (Metcalf 
and Nicola 1983)- If G-CSF is used as an initial stimulus and 
erythropoietin is added two days later, no erythroid development is 
observed. In contrast the delayed addition of SCM resulted in
reasonable numbers of erythroid containing colonies as well as 
eosinophil colonies. It was therefore suggested that G-CSF either 
stimulates the initial proliferation of multipotential cells, or it 
permits their survival but not proliferation (Metcalf and Nicola
1983). To discriminate between these two possibilities individual 
cells were mapped on culture plates and their fate followed during the 
course of the experiment. The results obtained indicated that most of
the mixed and erythroid colonies that developed following addition of
SCM arose from single cells that had survived but not proliferated 
under the influence of G-CSF (Metcalf and Nicola 1983)-
In order to define the population of cells that are stimulated 
to form granulocyte colonies in response to G-CSF, and to relate this 
to the progenitor populations already known to respond to GM-CSF and 
M-CSF, colony numbers were counted, either after stimulation of bone 
marrow by G-CSF alone, or in combination with M-CSF and GM-CSF 
(Metcalf and Nicola 1983)• The combination of G-CSF with either of 
the other two factors resulted in the formation of more colonies than 
would have been predicted by the addition of colony nunbers resulting 
from stimulation by either factor alone, sugesting that G-CSF may 
interact with a sub-population of bone marrow progenitors distinct 
from either GM-CSF or M-CSF (Metcalf and Nicola 1983).
GM-CSF was previously shown to be capable of stimulating 
limited proliferation of multipotential precursor cells but unable to
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generate mature erythroid of mixed erythroid colonies (Metcalf and 
Johnson 1979, Metcalf et al 1980). The above data adds G-CSF to a 
list of factors that have the capacity to allow survival and 
proliferation of a wider range of cells that was initially suspected 
from the predominant colony type they generated In vitro.
Proliferative and Differentiation Effects of GM-CSF
The GM-CSF cDNA has recently been cloned (Gough et al., 1984). 
The cDMA has been expressed in both eukaryotic (Metcalf et al,. 1986b) 
and prokaryotic systems (Metcalf et al. 1986a, DeLarnarter et al. 1985, 
Robinson .gt al, 1987) thus allowing large quantities of recombinant 
protein to be purified and its activity compared to native GM-CSF 
(Metcalf e£ al, 1986a). The use of prokaryotic expression systems for 
growth factor production has an advantage over eukaryotic tissue 
culture systems since there is less likely to be contaminating
cellular protein or serum proteins which may act on haematopoietic 
cells. Proteins produced by bacteria do not however undergo 
post-translational modification and so cannot be assumed to have the 
same activity as native GM-CSF (Metcalf et al 1986a). Metcalf et al 
(1986a) have directly compared pure native GM-CSF, with E.coli
produced recombinant GM-CSF (rGM-CSF). Both forms shew almost 
identical activities and stimulate granulocyte and/or macrophage 
colony formation from both adult and foetal haematopoietic tissue. At 
high concentrations (greater than 80 pg/ml) both forms stimulate 
eosinophil colonies, and, at very high concentration (greater than 640 
pg/ml) megakaryocyte colonies. The observation that GM-CSF 
stimulates megakaryocytes could be due to contaminating factors in the 
high concentrations of GM-CSF used, however, Robinson et al (1987) 
have also noted megakaryocyte colony formation after simulation by 
rGM-CSF produced by E.coli at a concentration of around 9 ng/rrh.
This is a 10-fold lower concentration than that used by Metcalf and
his colleagues (1986a). These two independent reports suggest that 
megakaryocyte colony stimulating activity may also be a function of 
GM-CSF.
In addition,at high concentration both native and rGM-CSF 
showed a weak erythroid response on adult bone marrow (Metcalf et jd 
1986a). This was not observed for foetal liver progenitors. However, 
as expected, both forms could support the initial proliferation of
21
erythroid and multipotential cells.
Summary
The availability of in vitro colony assays have enabled the 
CSF responsive cells to be identified and analysed. CFC’s can be 
identified by the fact that they divide a short period of time after 
growth factor stimulation and are recognisable as doublets (Metcalf 
1980). Single cell transfer of paired daughter cells has established 
that a single cell can give rise to a colony consisting of both 
granulocytes and macrophages (Metcalf 1980, Metcalf and Burgess 1982). 
This cell is termed the granulocyte-macropage colony forming cell 
(Metcalf and Burgess 1982). This system has been utilised to determine 
the effect of sequential exposure to different growth factors 
(Metcalf and Burgess 1982), and has contributed greatly to our present 
understanding of the various cell populations in the bone marrow and 
the range of factors they interact with.
Both GM-CSF and M-CSF appear to act on a largely overlapping 
population of progenitors but they differ in effect on the final 
colony composition ( Metcalf and Burgess 1982 , Lazar et al 1985). 
The use of rGM-CSF has highlighted its ability to stimulate 
eosinophil and megakaryocyte colony formation (Metcalf et al 1986a, 
Robinson et al 1987). Thus the interaction between GM-CSF and its 
target cell population is complex. GM-CSF acts in a concentration 
dependent manner on GM-CFC’s (Metcalf 1980) and can stimulate 
proliferation of what is likely to be an even earlier cell than the 
GM-CFC which has the potential to generate erythroid or mixed 
erythroid colonies (Metcalf et al 1980, Metcalf .et al 1986a). 
Stimulation by a particular growth factor such as GM-CSF or M-CSF not 
only permits survival and proliferation but can also in some way 
commit the developing cells within a clony to become lineage 
restricted (Metcalf and Burgess 1982). Subsequent stimulation of 
committed cells by another growth factor cannot alter the type of 
differentiation pathway the cells have entered (Metcalf and Burgess 
1982).
A third factor, G-CSF, shares with GM-CSF the capacity to 
stimulate a wider range of progenitor cells than its name implies 
(Metcalf and Nicola 1983). On its own it is unable to sustain fully 
differentiated colony growth other than granulocytic colonies 
(Metcalf and Nicola 1983). Granulocytic growth appears to result from
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stimulation by G-CSF of a sub-population of GM-CFC’s distinct from 
that stimulated by GM-CSF or M-CSF alone (Metcalf and Nicola 1983).
Colony stimulating factors have a wide variety of activities. 
Not only do they provide a permissive milieu for progenitor cell 
survival and proliferation in a partially lineage indifferent manner, 
but they can direct cells along particular differentiation pathways. 
In fact, once cells are committed to a particular differentiation 
pathway, CSF s may again act in a rather lineage indifferent manner to 
promote colony formation. The above discussion is an obvious 
simplification of the ongoing processes due to differences in specific 
activities exhibited by different factors and the inherent 
heterogeneity of the haematopoietic compartment.
Interleukin 3 (IL-3)
Introduction
GM-CSF is capable of stimulating the early cell divisions of a 
multipotential cell that on subsequent stimulation by an appropriate 
factor can form a mixed erythroid colony in vitro (Metcalf et al
1980). By itself GM-CSF shows only a weak and perhaps artifactual
ability to generate erythroid or mixed erythroid colonies (Metcalf et
al 1986a). The in vitro multipotential stem cell assay requires
stimulation of the mix-CFC by lectin stimulated spleen cell 
conditioned media to generate erythroid colonies (Johnson 1980). This 
activity is also detected in the conditioned media from the murine 
WEHI 3B myelomonocytic cell line (Bazill et al 1983). The injection 
of cells derived from mix-CFC colonies can lead to the formation of 
spleen colonies suggesting that at least some of the mix-CFC 
correspond to multipotential stem cells (Johnson 1980), and it is 
these cells that may be targets for the CSF in SCM or WEHI 3B 
conditioned media, (Iscove et al., 1982). The conditioned media from 
SCM exhibits four biological activities as assessed by colony growth. 
These are granulocyte/macrophage, eosinophil, megakaryocyte and
erythroid colony stimulating activities (Clark-Lewis .et al 1984).
These activities may be a result of a variety of different factors 
acting on haematopoietic precursor cells or alternatively, one
molecule may be active on an early multipotential cell and its
progeny. This activity has been variously referred to as burst 
promoting activity (BPA), multi-CSF, interleukin 3 (IL-3), mast cell
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growth factor (MCGF), P-cell stimulating factor and haematopoietic 
growth factor (Ihle et al. 1983).
Purification of The Molecule Responsible For BPA
Protein purification of SCM indicated that some of the 
eosinophil and granulocyte/macrophage activity could be attributed to 
separate factors but most of the eosinophil and granulocyte/macrophage 
activity was associated with erythroid and megakaryocyte colony 
stimulation (Cutler et al. 1985). These activities have 
subsequently been purified to homogeneity from SCM (Cutler et 
al.,1985) and WEHI conditioned media (Ihle et al., 1982), with
retention at all stages of the multilineage activity. The cDNA coding 
for IL-3 has been cloned from both the WEHI 3B (Fung et jl, 1984) and 
normal T cells (Yokota et al. 1984) and it seems that IL-3 production 
is closely associated with T cells (Schrader and Clark-Lewis 1982, 
Young gt al. 1987). These cells may therefore be important in 
haematopoietic regulation. Proliferation and molecular cloning has 
enabled the range of actions ascribed to IL-3 to be examined in detail 
and these will be discussed below.
Biological Activities of IL-3 
Stem Cell Interactions
Interest in IL-3 was stimulated when it was observed that 
IL-3 was the only CSF that supported the proliferation and 
differentiation of such a diverse number of mature cell types which 
sugested it might interact with a multipotential stem cell (Hapel et 
al 1985). Current experimental evidence to substantiate a direct 
interaction with a stem cell is poor. However, the availability of 
pure recombinant IL-3 (rIL-3) (Sieff gt al. 1987) should enable 
further experiments to be carried out. Schrader and Clark-Lewis 
(1982) described an in vitro liquid culture system in which factors 
that modulate stem cell survival can be monitored by incubation with 
bone marrow for seven days. Stem cell numbers were subsequently 
measured by standard in vivo spleen cell focus forming assay (Till and 
McCulloch 1961). The conditioned media from SCM and a T-cell hybrid 
produced an activity distinct from GM-CSF or IL-2, which was found to 
promote survival of CFU-S in liquid culture. A source of GM-CSF used 
as a control did not stimulate CFU-S survival. It is likely
24
considering the source, molecular weight and biological activities of 
this factor that it is identical to IL-3 ( Schrader and Clark-Lewis 
1982).
Nicola and Johnson (1982) used FACS to separate haematopoietic 
cells into preCFC and CFC fractions, (as described previously). The 
pre CFC fraction contained the majority of CFU-S and very few CFCs, 
and the initial CFC fraction contained very few CFU-S but had many 
progenitor CFCs. Stimulation of this fraction by SCM resulted in 
mature differentiated cells being produced with the loss of CFCs. The 
production of lineage restricted progenitors from the CFU-S containing 
fraction was found to be dependent on SCM and therefore the SCM was 
considered to elicit a differentiation effect on the stem cells 
present in the preCFC fraction allowing them to produce progenitor 
cells (Nicola and Johnson 1982). Using a source of GM-CSF (MLCM), no 
such effect was observed. Therefore a factor or factors present in 
SCM but not MLCM could interact with members of the stem cell 
compartment. Pure IL-3 from SCM added to this assay system resulted 
in a similar pattern of differentiation as impure SCM (Cutler et ai. 
1985).
The _in vitro blast cell colony assay (Nakahata and Ogawa 
1982) has been used to assess the role of IL-3 in multipotential cell 
proliferation and differentiation. As described in a previous section 
the blast cell colony assay detects multipotential cells present at 
low frequency in haematopoietic tissues by their response to SCM 
(Nakahata and Ogawa 1982). It is possible to substitute IL-3 for SCM 
in the assay ( Suda et al. 1985). Koike et al. (1986b) demonstrated 
that blast cell colonies were sensitive to low levels of IL-3, whereas 
the multilineage and progenitor colonies of differentiated cells were 
dependent on high levels of IL-3. If the addition of low levels of 
IL-3 was delayed until seven days after the commencement of 
incubation, blast cell colonies proliferate as if stimulated from day 
one. Although a reduction of colonies derived from more mature 
progenitors was observed, the number of blast cell colonies was the 
same as in control cultures. Koike and colleagues (1986b) concluded 
from these results that IL-3 provides a permissive environment for the 
proliferation of an early population of stem cells , but is not 
required for their survival if they are non-cycling. This conclusion 
assumes that stem cells enter the cell cycle at random and then
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require IL-3, The blast cell colonies observed after delayed addition 
of IL-3 are apparently derived from multipotential cells that have 
remained out of cycle until IL-3 was supplied. The lack of any 
detectable drop in blast cell colony numbers between control and
delayed addition plates implies that very few stern ceils are cycling 
and any that are cycling prior to IL-3 addition would be lost but not 
observed due to experimental variance. The observation that mature 
colonies require higher concentrations of IL-3 to survive than blast 
cell colonies implies a declining sensitivity to IL-3 as stem cell:; 
develop into mature cells. How growth factors interact physical!y 
with cells and hew specific differentiation messages are transmitted 
will be discussed in Chapter 1.4, However declining sensitivity may
be due to changes in receptor nunber or affinity for IL-3 ss the cell
differentiates- or , an alternative possibility could be that early 
progenitor cells transduce the signal elicited by IL-3 mor*--
efficiently (Koike £t al 1986b),
Differentiation Patterns of Cells Responding to lb-3 
IL-3L aM__ .Era thro so ie s i s
Most la vitro systems used to study colony growth require 
various concentrations of sera which may contain erythropoietin or 
other growth factors which could act synergisticaXXy with# or mask, 
the effect of any added growth factor, Suda et al. (1986) used a
serum free system to study the combination of pure IL-3 and 
erythropoietin (Epo) on an enriched source of haematopoietic
progenitors. In the absence of Epo# IL-3 alone could produce 
multilineage colonies of which 3 out of 29 contained a low percentage 
of erythroid cells, Mo colonies were formed by Epo alone# but the 
combination of IL-3 plus Epo produced colonies of wn .’or. 31 out of 33 
contained erythroid cells. Single cell transfer e/pcr. merits showec 
that IL-3 was able to maintain the growth of mu# t: potent: al cells sno 
support the terminal differentiation of neutrophils, macrophage®, 
eosinophils and megakaryocytes without additional growth factors.
Terminal differentiation of erythroid cells were not observed as added 
Epo is necessary for maximal erythroid differentiation#
The detection of erythroid or mixed erythroid colonies Is in 
part dependent on the source of haematopoietic tissue# The authors 
cited above' use the spleens from adult mice treated with the
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cytotoxic drug 5-fluorouracil (5FU), which has been demonstrated to 
cause a transient enrichment for early precursor cells (Bradley and 
Hodgson 1979). Foetal liver is another source of enriched early 
precursor cells (Metcalf and Johnson 1979) and it has been reported 
that erythroid colonies could be detected in the absence of detectable 
Epo (Suda et al.,1985;1986,Johnson and Metcalf 1977, Hapel et al 1985, 
Metcalf et al 1987a). It cannot be ruled out that in these cases 
IL-3 stimulates the release of Epo from cells present within the agar 
matrix resulting in erythropoiesis (Zucali et al 1987, Mangan et al 
1982, Sieber and Sharkis 1982). Alternatively even though some
experiments were carried out ” serum free", the growth factor 
preparation may be contaminated by other CSFs or bacterial endotoxin.
With respect to the ability of IL-3 to stimulate erythroid 
development, the data is confusing (Suda et al. 1985;1986 ,Johnson and 
Metcalf 1977, Hapel et al 1985, Metcalf et al 1987a, Sieff et al., 
1980). IL-3 could conceivably be capable of supporting terminal 
differentiation of erythroid cells, but this may be only a
sub-population of the cells which can generate erythroid colonies 
under other stimulatory influences. The proportion of pre-erythroid 
cells that are responsive to IL-3 on its own may be very small and 
vary between tissues of the adult and foetal mouse. The observed 
erythropoiesis could also be a result of an indirect action of IL-3 on 
a varying populations of cells that respond to IL-3 by producing Epo, 
or purely artifactual due to contaminating material. At present it 
seems reasonably clear that Epo is necessary for optimal erythroid or 
mixed erythroid colony growth in conjuction with IL-3 or GM-CSF (Sieff 
et al., 1985, 1986).
IL-2 TARGET CELL POPULATION
Although IL-3 has been demonstrated to generate colonies of
diverse mature cell types which suggests it can act on a
multipotential cell (Clarke-Lewis et al 1984), M-CSF was considered to 
act predominantly on a unipotential or bipotential progenitor cell 
that has been derived form a multipotential cell (Metcalf and Burgess 
1982). Koike et al. (1986a) have tried to determine a link between 
cell populations on which various factors act. M-CSF generated more 
macrophage containing colonies from normal bone marrcw than IL-3. 
When a population of bone marrow cells enriched for primitive cells
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was subjected to stimulation, IL-3 produced more macrophage colonies. 
Thus it was interpreted by Koike et al. (1986a) that both IL-3 and
M-CSF could support macrophage colony growth, but IL-3 acted on a more 
primitive cells than M-CSF. In order to define whether the two 
populations were separate or overlapping, IL-3 and M-CSF were mixed 
and macrophage containing colonies counted. The number of colonies 
after stimulation by both factors together was close to or in excess 
of the sum of the number of colonies supported by M-CSF or IL-3 alone, 
which suggests either that the target cell populations are different, 
or alternatively, there is a population of cells that require both 
factors for their proliferation. In addition to the increase in 
colony numbers, it was noted that the combined growth factors resulted 
in larger colonies than generated by the separate factors, and so even 
if the two factors act on distinct populations their activities may 
overlap. The delayed addition of M-CSF to IL-3 initiated cultures 
indicated that factors can act sequentially on developing colonies to 
increase the final colony size.
Bartelmez et al (1985) analysed liquid cultures enriched for 
primitive or mature cells for their responses to IL-3 and M-CSF . 
Addition of IL-3 to the culture of primitive cells resulted in an 
increase in the total number of M-CSF binding cells , whereas addition 
of M-CSF did not. In cultures of more mature cells, M-CSF generated 
approximately 17 times more M-CSF binding cells than IL-3. Taken 
together this data indicates that IL-3 can act on a more primitive 
cell than M-CSF to generate macrophage colonies. There are probably 
two distinct populations that respond to either IL-3 or M-CSF, but 
IL-3 may generate the more mature progenitors that M-CSF can 
stimulate. This would explain why IL-3 initiated colonies respond to 
M-CSF to generate larger colonies than either factor alone ( Koike et 
al 1986a). In contrast,as previously discussed, the populations of 
cells that GM-CSF and M-CSF stimulate show almost a complete overlap 
(Metcalf and Burgess 1982) and so comparison of target cell 
populations may represent a distinguishing point between IL-3 and 
GM-CSF.
Sieff and his colleagues (1987) carried out a direct 
comparison between the ability of IL-3 and GM-CSF to sustain the 
proliferation of BFU-E erythroid progenitor cells in the presence of 
Epo. Using recombinant gibbon IL-3, human GM-CSF and human marrow or
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foetal liver cells, the authors showed that IL-3 generated 25% more 
BFU-E erythroid colonies than GM-CSF. The addition of both IL-3 and 
GM-CSF to bone marrow cells together did not result in stimulation of 
more BFU-E than IL-3 alone. It was therefore suggested that there 
are two populations of BFU-E one of which is responsive to IL-3 alone 
and another population which responds to both IL-3 and GM-CSF. The 
relationship between IL-3 and G-CSF was examined in the same study 
(Sieff e£ al 1987). G-CSF showed no capacity to produce erythroid 
colonies and the addition of both IL-3 and G-CSF together did not 
result in any increase in BFU-E colonies above those stimulated by 
IL-3 alone (Sieff et al 1987). In comparison to this both factors 
together generated more granulocyte colonies than either IL-3 or G-CSF 
alone (Sieff et al 1987), suggesting there may either be distinct 
sub-populations of cells that respond to G-CSF or IL-3 or a 
population that requires both. The granulocyte colonies which develop 
after dual stimulation are larger than those which are stimulated by 
single factors which implies that at least some colonies respond to 
both IL-3 and G-CSF during their development. The comparison between 
GM-CSF and G-CSF previously discussed (Metcalf and Nicola 1983) noted 
that GM-CSF probably acts on a distinct population from G-CSF, or both 
act together on a single population. In this respect GM-CSF and IL-3 
have a similar relationship to the progenitor cell population specific 
for granulocyte colonies.
SUMMARY
IL-3 is a growth factor that has a broad range of 
proliferative effects on primitive haematopoeitic cells (Metcalf et al 
1987). It can directly stimulate granulocyte, macrophage, eosinophil 
and megakaryocyte colony formation (Metcalf et al 1987). In addition 
it can stimulate multipotential precursors of mixed erythroid colonies 
(Suda et al 1986) . Both G-CSF (Metcalf and Nicola 1983) and GM-CSF 
(Metcalf et al 1980) promote the survival and proliferation of a 
nunber of immature cells, a function not initially apparent from the 
colonies they produce. GM-CSF is most closely related to IL-3 when 
the wide range of colonies it stimulates is considered (Metcalf et al 
1986a). However, they can be distinguished quite clearly after 
comparison between the target cell populations these factors interact 
with on their own or in conduction with other factors . Although both 
IL-3 and GM-CSF stimulate early multipotential cells, IL-3 probably
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influences a slightly more primitive cell (Nicola and Jonson, 1982). 
It is difficult to make direct comparisons between IL-3 and GM-CSF as 
the information for the most part must be completed from different 
sources. With the improvement of techniques and the availability of 
pure growth factors, systematic studies should now be possible to 
elaborate on the relationships between different CSFs.
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Chapter 1.3
Introduction To Long Term Marrow Culture (LMTC)
LTMC (Dexter et al 1977a,b) are established by forming an 
adherent layer of stromal cells in vitro. This layer has been shown to 
comprise of a mixture of different bone marrow derived endothelial 
cells, adipocytes and macrophage cells (Dexter et al 1977a,b, Allen 
and Dexter 1934). The adherent layer is established when bone marrow 
cells are inoculated into tisssue culture flasks and incubated in 
the presence of carefully selected serum (Dexter .gt al 1977a,b). 
During the first three week establishment period the numbers of 
non-adherent cells, CFU-S and progenitor cells decline and after
three weeks the culture is re-plenished with fresh bone marrow
(Dexter et al 1977a,b). These cultures will now support the long 
term proliferation and differentiation of stem cells, including CFU-S, 
for several months (Dexter et al 1977a,b). During this period the 
ratio of stem celIs:CFU-GM:mature cells is approximately the same as 
found in vivo (Boettiger et al 1984).
Multipotential CFU-S are found both in the adherent stromal 
layer and the non-adherent cells (Dexter et al 1977a). On feeding, 
half the culture medium is removed thus depleting the system of 
non-adherent stem cells (Dexter gt al 1977a). Subsequently the 
numbers of non-adherent CFU-S rise again, an increase which is
mirrored by an increase in the proportion of cycling CFU-S stem cells 
(Dexter gt al 1977a,b, Dexter gt al 1980b). One day after feeding, 40% 
of the CFU-S are in cycle but by day seven this has dropped to 10% 
(Dexter etal 1977b). The self renewal of adherent stem cells thus 
replaces stem cells lost by release into the culture medium (Dexter 
et al 1980b). The increasing number of non-adherent cells could 
participate in a feedback mechanism switching off proliferation of 
stem cells (Dexter gt al 1977b).
Role of the environment in haematopoesis
An absolute requirement for an adherent stromal in LTMC 
(Dexter et al1977a,b), suggests that specific cellular interactions 
are necessary for culture development (Allen and Dexter 1984). Some 
of the most compelling evidence supporting the role of the environment 
in haematopoeisis comes from the study of genetically determined 
haematopoietic defects (Dexter and Moore 1977, Tavassoli gt al 1973,
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Bernstein 1970). Macrocytic anaemia is observed in two strains of 
mice carrying different mutations, (w/wv and sl/sl^ mice)
(Bernstein 1970). The anaemia observed in w/wv mice is caused by an 
intrinsic defect in the stem cell population and bone marrow from 
these mice is therefore unable to rescue irradiated recipient mice 
(Dexter et al 1980b, Bernstein 1970). In contrast, the abnormal 
haematopoeisis observed in sl/sl^ mice is due to a defective 
microenvironment (Dexter et al 1980b, Bernstein 1970). Bone marrow 
cells from sl/sl^ mice will form spleen colonies in irradiated mice 
but the anaemia in these recipients cannot be cured by injection of 
normal bone marrow stem cells (Dexter et al 1980b, Bernstein 1970, 
Trentin 1971). The anaemia observed in w/wv mice (normal
environment, defective CFU-S) can be corrected by injection of stem 
cells from sl/sl^ mice (defective environment, normal CFU-S)
(Bernstein et al 1968). However the anaemia in sl/sl^ mice can only 
be alleviated by transplanting w/wv haematopoietic environment tissue 
i.e. spleen tissue (Bernstein 1970, Tavassoli et al 1973. These in 
vivo effects can be reproduced in vitro using LTMC (Dexter and Moore 
1977). These observations therefore underline the importance of the 
stromal microenviroment for the maintenance of normal haematopoiesis.
In an attempt to define more rigorously the complex 
interactions between stem cells and the microenvironment, Dexter and 
his colleagues have used FACS purified stem cells (Spooncer et al 
1985) and multipotential cell lines (Wyke et al 1986) to repopulate 
feeder layers consisting of mouse fibroblast 3T3 cells. Addition of 
FACS purified stem cells to monolayers of 3T3 cells results in their 
proliferation and differentiation as if the cells had been seeded on 
to normal stromal cells (Roberts et al 1987). Although the FACS 
purified cells used in these experiments contained between 50% and 
100% CFU-S, the survival and differentiation on 3T3 cells could be a 
result of "contaminating” bone marrow cells (Roberts et al 1987). 
The availability of cell lines which retain the characteristics of 
multipotential stem cells has made the investigation of cell to cell 
interactions simpler (Wyke et al 1986). These lines, termed FDCP-mix, 
have been established from LTMC after infection with v-src retrovirus 
preparations, and can differentiate into mixed lineage colonies (Wyke 
et al 1986). FDCP-mix cells are dependent on the presence of IL-3 for 
their survival and proliferation in vitro (Wvke et al 1986). However,
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they can be maintained on established bone marrow stromal layers 
without the addition of IL-3 (Roberts et al 1987). The 3T3 culture 
system described above also supported the normal development of 
FDCP-mix cells in the absence of IL-3 but could not support another 
IL-3 dependent cell line, FDCP-2 (Dexter et al, 1Q8Qg^ Roberts et al. 
1987). Since both of these cell lines require IL-3 for their growth 
in vitro, it seems likely that IL-3 is not the active factor
maintaining FDCP-mix cells in the 3T3 system (Roberts .et al, 1987).
It is possible however that the FDCP-2 cell line cannot utilise any 
IL-3 in the form in which it is presented by the 3T3 cells (Roberts 
_al,1987). In fact, the conditioned media from 3T3 cells was found 
to be unable to support FDCP-mix or FACS CFU-S cells (Roberts et al, 
1987). These results suggest that if any critical growth factor is 
released, then it is present in very small amounts. It is most likely 
therefore, that cell to cell interaction is an essential aspect of 
stem cell maintenance (Roberts et al 1987). This simplified system 
again highlights the absolute requirement for cell to cell contact 
and membrane intergrity for stem cell survival and differentiation. 
It is even possible that metabolic activity may not be an absolute
requirement in the short term. If growth factors are involved in this 
system they may be membrane bound, and so be available to stem cells 
even after gluteraldehyde fixing of the feeder layer (Roberts et al 
1987).
Stromal Cell Production of CSF Activity
There is some evidence that cells which reside in the marrow ,
but which are not colony forming cells (Hultner el al.1982, Chan and
Metcalf 1972 , and bone marrow stromal cell lines (Naparstek e t al 
1986, Tsai et al 1986) can release haematopoietic growth factors, 
which would seem to contradict the results obtained for LTMC outlined
above. Although it can be argued that cell lines have undergone many
changes during their establishment and that any growth factor release 
is an abnormal. However, it is also possible that in normal bone
marrow or in LTMC the growth factors are either membrane bound, or 
released in very lew levels that cannot be detected using the current 
assays. The cell to cell contact in LTMC may therefore optimise the 
transfer of growth factors and allow specific homeostatic activities 
to occur that maintain the regulated balanced development. Recently
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Gordon and her colleagues (1987) demonstrated that although CSF 
activity could not be detected from the conditioned media of LTMC 
stromal cells layers, dialysed salt extract from these cells contained 
detectable CSF activity. These salt treated stromal layers were then 
tested for their ability to bind exogenous GM-CSF. These experements 
showed that that not only did stromal material bind exogenous GM-CSF, 
but that bone marrow stromal extracellular matrix also had this 
capacity (Gordon et al 1987). Thus the compartmentalisation of growth 
factors within the stromal layer and subsequent interaction with 
target cells via cell to cell contact can be envisaged. This data 
goes sane way to reconciling the apparent discrepancies in the roles 
attributed by haematopoietic growth factors in different _in vitro 
culture systems.
The possibility that membrane bound forms of haematopoietic 
growth factors exist, and can interact with target cell populations
over short distances can now be tested. The cDNA for human
macrophage-CSF (M-CSF) has been introduced into 3T3 fibroblasts
resulting in the release of detectable levels of CSF activity in the
growth medium (Rettenmier et al 1987). Using an antibody to M-CSF , 
the kinetics of protein synthesis were analysed and M-CSF was found 
in the culture medium after a lag period during which the protein was 
only detected in an intracellular form (Rettenmier .et. al 1987). 
Indeed, the secreted protein was found to be smaller in size than the 
intracellular protein , thus these results sugest that the release of 
mature protein into the culture median may require proteolysis 
(Rettenmier et .al 1987). It is of notable interest that trypsin 
treatment of M-CSF expressing 3T3 cells increased the detectable 
amount of M-CSF in the culture medium (Rettenmier et jal 1987). The 
membrane bound form of M-CSF could thus be envisaged as exerting its 
effect only at points of cell to cell contact (Rettenmier e£ al 1987). 
The demonstration that such a membrane bound form of M-CSF exists in 
this case supports this hypothesis.
The Role of Diffusable Regulators in LTMC
Clonal growth of haematopoietic cells in vitro (Metcalf 1984) 
and the short term survival of CFU-S (Schrader and Clark-Lewis 1982) 
has been shown to be dependent on a source of colony stimulating 
factor (CSF). It therefore follows that LTMC may produce their own CSF 
in order to maintain the culture. However both conditioned media from
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feeder layers or "populated" cultures fail to support colony growth 
(Dexter et al.1977o(. It is possible that the levels of CSF are too 
low to be detected, or that any CSF released is metabolised very 
quickly. Therefore in an attempt to optimise conditions Dexter and 
his colleagues (1977^ added CSF in the form of mouse embryo or heart 
conditioned media to the LTMC. Feeding the cultures with exogenous 
conditioned media caused a dramatic decrease in CFU-S and progenitors 
after only one week, followed by their virtual disappearance after
three weeks in culture (Dexter et al.19770. These results suggest
that perhaps the balance between self renewal and differentiation 
observed in the culture is affected by the levels of CSF added 
resulting in a shift in the balance towards differentiation . More 
recently, the addition of pure GM-CSF or L-cell conditioned media to 
cultures did not result in any such decline in stem cell self renewal, 
nor did the addition of antisera raised against L-cell growth factor 
disturb the cultures in any detectable way (Dexter et al 1980k. These 
results imply that cultures are sensitive to some sources of CSF. 
Other sources, such as GM-CSF, have no detectable effect and as a
result the GM-CFC progenitor cells may be under very tight control in
this system (Dexter et al.1980$. It is possible that any effect that 
occurs may be masked by dynamic changes in cell numbers due to 
homeostatic regulation in response to GM-CSF activity. However these 
experiments do not give any positive evidence for the role of CSF in 
the maintainance of LTMC.
Early observations by Lord et al. (1976) demonstrated the 
presence of inhibitor of stem cell proliferation in normal bone 
marrow, which was also detected in LTMC (Dexter et al 1980B- Dexter et 
al.(1980k observed that after feeding LTMC, the proportion of cycling 
CFU-S increased from 10% to 35% is associated with two activities 
detected after Amicon filtration of LTMC conditioned media. Amicon 
filtration separated two activities, a stimulator of stem cell 
proliferation in fraction III, and an inhibitor of stem cell 
proliferation in fraction IV (Dexter et al 1980B. The stimulatory 
activity in fraction III observed from the first day after feeding 
conditioned media was found to be active at 50pg/ml and could increase 
the steady state (10%) of CFU-S in cycle to greater than 35% (Dexter 
et al. 1980k. In comparison seven day conditioned media also 
stimulated stem cell proliferation but only at a level of 100 pg/ml.
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Similarly fraction IV from day one post-feeding showed an inhibitory 
effect at 200 Ug/ml, whereas the corresponding factor from day seven 
media was more active in its inhibition at a lower concentration 
(Dexter et al 1980b. The relative activities of these factors, with 
stimulator being more effective in day one media and inhibitor of stem 
cell proloferation more active in day seven media, corresponds to the 
percentage of CFU-S in cell cycle during this period (Dexter jet al
1980ft. These experements showed that the proportion of stem cells in
S-phase is high immediately after feeding (day one) and then drops to 
10% by day seven, suggesting that modulation of the stem cell 
inhibitor and stimulator levels is required in order to maintain
haematopoeisis in LTMC (Dexter et al 1980B- The removal of stem 
cells during feeding leads to the production of stimulator, an effect 
which is still observed when fresh media containing cells previously 
removed, were returned to the cultures (Dexter et al 1980B. It is
therefore unlikely that the cells themselves provide the stimulus. The 
authors suggest that perhaps a disruption in cell to cell interactions 
caused either by simple mechanical agitation, differentiation, 
migration,or death might be the signal for inhibitor/stimulator 
production (Dexter e£ al 198(3).
It is possible to extend this hypothesis to the regulation of
normal haematopoiesis in the bone marrow where the proliferation of
stem cells also can be influenced by inhibitor and stimulator levels .
Inhibitor/stimulator levels may thus fluctuate in a regulated manner 
in order to achieve the correct nunber of stem cells required to
maintain haematopoiesis. The same effect could also be achieved if 
the level of say inhibitor remained constant and a corresponding 
alteration in the level of stimulator occured in response to stem cell 
demands. An alternative hypothesis sugests that different regions of 
the bone marrow produce these proteins and cells move from niche to 
niche during development they become exposed to different 
microenvironments, and different developmental stimuli.
Summary of the role of growth factors and microenvironment in 
haematopoeitic development.
Conclusions as to how haematopoietic development may be 
controlled differ depending on the experimental system used. LTMC 
experiments appeared to suggest that CSF s are not required in
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haematopoietic development (Dexter et al 1977a,b), whereas in vitro
assays with semi-solid media are CSF dependent (Metcalf 1984). The 
characterisation of stimulators and inhibitors of stem cell
proliferation in LTMC (Dexter et al 1930) and bone marrow cells (Lord
et al 1976, Lord and Wright 1980), as well as CSF activity from
stromal cells (Tsai et al 1986) has begun to resolve many
inconsistencies between the two systems. For example the bone marrow 
stroma was previously considered to be a physical niche within which 
stem cells develop (Till et al 1964) but is now considered as an 
environment in which biochemical interactions can take place (Allen 
and Dexter 1984). Molecules which modulate stem cells or stem cell 
progeny may be distributed in compartments or concentrations
throughout the stroma, as may the clonogenic population itself. It
is quite conceivable that the levels of these regulatory molecules are 
not static but are modulated in response to the demands on the system 
(Lord and Wright 1980, Dexter et al 1980). During normal steady state 
haematopoiesis it is arguable whether much control is necessary if the 
rate of production of new mature cells is equal to that of cell death.
Whether the identified glycoprotein CSFs are responsible for 
the maintainance of normal haematopoiesis _in vivo is also debatable.
Certainly GM-CSF activity has been detected in the serum and tissues 
of mice (Burgess et al 1986,Metcalf and Johnson 1978, Nicola et al 
1979) but IL-3 has only been detected after stimulation of T-cell 
populations in vitro (Schrader and Clark-Lewis 1982 Young et al 1987)- 
The presence of these activities could be connected with the role of 
some CSF's in mature granulocyte and macrophage activation (Lopez jet 
al 1983, Grabstein et al 1986).
Continuous infusion or repeated injection of GM-CSF (Metcalf 
et al 1987b) and IL-3 (Metcalf et al 1987<*> Kindler et al 1986) into 
mice shows that exogenous CSF can elicit a response _in vivo but these 
experiments are difficult to interpret. It is debatable whether 
endogenous CSF would ever be maintained _in vivo at a continuous level 
similar to that achieved by exogenous administration. Whether 
intraperitoneal or intravenous injection of CSF ever reaches the 
’’normal” sites for haematopoiesis is not clear. It is important to 
remember that the cells which can respond to CSF experimentally are 
not necessarily the same as the ones which do respond _in vivo during 
normal haematopoiesis, a caveat which applies to many of the
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experiments described so far.
Although growth factors can be functionally distinguished by 
criteria such as target populations and the predominant colony 
morphology, they do appear to overlap in their functions (Chap.1.2). 
It is possible that in vivo their full developmental activities are 
never exploited except under very rare circumstances. Therefore each 
factor may in effect be considerably more restricted in activity. 
IL-3, for example, may be an "emergency" factor which can stimulate 
primitive cells to differentiate along several lineages. Thus, if
there was a sudden loss of mature cells, IL-3 could initiate 
pan-lineage stimulation which could then become directed by 
interactions with lineage restricted factors such as M-CSF. It could
however have a restricted role in maintaining a particular class of
stem cell survival or proliferation, without commiting the cells to
any differentiation pathway.
The possibility exists that a cell at any given point in the 
differentiation pathway may have a different growth factor requirement 
either for survival, cell cycle status or differentiation commitment, 
and this may vary from stage to stage. The declining sensitivity of 
IL-3 to stem cells during differentiation may be an example of this 
(Koike et al 1986$. The differing requirements of distinct progenitor 
subtypes to achieve maximal colony stimulation (Sieff et al., 1987)
may therefore relect the "sternness" of the progenitor cell being 
assayed. As cells progress down the differentiation pathway they may 
require growth factors which previously had little effect, but which 
can now either instruct the cell to develop down a particular pathway 
or act as a trigger to release a previously determined programme of 
differentiation events. At any given progenitor stage, a cell could 
show differing sensitivities to alternative growth factors and so not 
only would the presence or absence of a factor be important but the 
balance of various factors factors may be vital to the cell during its 
developmental course.
If all primitive cells were responsive to growth factors, 
very strict compartmentalisation would have to be enforced in the 
marrow, which permit restricted and orderly cell/growth factor 
interaction. It is apparent that not all cells respond to any given 
factor, and that several factors act on separate populations with 
various degrees of overlap (Chap. 1.2). This means that even though
38
CSF may be present, a cell may not be able to respond to it. The 
specific interaction necessary could be envisaged to occur by cells 
displaying the appropriate surface receptors for the growth factors, 
these may be maturity or lineage restricted. These are discussed 
below.
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Chapter 1.4,
Growth Factor/Receptor Interactions
The production of mature granulocytes and macrophages in vitro 
has so far been shown to be dependent on four molecularly distinct 
CSFs (Chap.1.2). These have overlapping biological activities, and 
clonal analysis experements have shown that the same progentor cell is 
stimulated by more than one CSF (Chap.1.2). This implies either that 
a progenitor cell may have receptors for more than one CSF, or that 
several growth factors act through the same receptor. However, as 
discussed in chapter1.2, this latter possibility is unlikely. The 
relationships between the different CSF receptors in terms of their 
cell lineage and stage specific expression has been examined using 
radioiodinated derivatives of G-CSF, M-CSF, GM-CSF and IL-3. The 
binding of the CSFs to their receptors has been analysed, and the 
results have led to a possible explanation as to how the overlapping 
biological actions of the CSFs are achieved.
Cellular Distributions of Receptors
Cross linking experiments using iodinated M-CSF has identified 
the M-CSF receptor as a protein of molecular weight l65kD homologous 
to the viral oncogene v-fms (Sherr .et ^1 1985). Bone marrow
macrophages have been shown to express around 5x101* M-CSF receptors 
at 2°C (Guilbert and Stanley 1986). This temperature causes 
irreversible binding without permitting any metabolic processess such 
as membrane turnover to influence the nunber of receptors and allows 
the total number of M-CSF receptors to be established (Guilbert and 
Stanley 1986). On shifting the cells from 2° C to 37° C there is a 
rapid disappearance of surface ^^I-M-CSF (with a half life of a few 
minutes) which is due, in the main, to internalisation (Guilbert and 
Stanley 1986). A minor component is dissociated from the cell surface 
(Guilbert and Stanley 1986). Receptor replacement takes 1-3 hours but 
the relative contribution by receptor recycling and &e novo synthesis 
is uncertain (Guilbert and Stanley 1986). Byrne et al (1981), 
Bartelmez et al (1985) have shown that binding of M-CSF is restricted 
to mononuclear phagocytic cells and their precursors. Of particular 
interest is the observation that with bone marrow preparation, 
enriched for primitive cells, there is very little binding of 
125i_m_csf when compared to a population which contained many
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progenitor type cells which bound M-CSF (Bartelmez e t al 1985). The 
increased binding capacity of the more mature cells has been 
attributed to the fact they express high numbers of M-CSF receptors 
per cell (Bartelmez e t al 1985) and they therefore concluded that the 
numbers of M-CSF receptors per cell increased with cell maturation 
(Bartelmez et. al 1985). Using iodinated G-CSF, Nicola and Metcalf 
(1985) have demonstrated by autoradiography and morphological 
examination, that there was an increase in receptor numbers per cell, 
on more mature cells in experiments when all cells of the neutrophil 
granulocyte lineage were labelled. Crosslinking of G-CSF to its 
receptor has revealed a protein of molecular weight 150kD which is 
present at an average of 80-160 molecules per bone marrow cell (Nicola 
and Metcalf 1985).
The binding distribution of ^-*I-IL3 reflects its multilineage 
activity, since essentially all neutrophils, granulocytes, eosinophil 
granulocytes and macrophages are labelled (Nicola and Metcalf 1986). 
The labeled population express approximately 117-130 receptors per 
cell (Nicola and Metcalf 1986). In contrast to both M-CSF and G-CSF 
binding there was an observed decrease in labelling with the 
increasing maturity of the cells (Nicola and Metcalf 1986), There 
was however a small heterogeneous population of cells which exhibited 
high labelling (Nicola and Metcalf 1986). This pattern could explain 
the observed functional heterogeneity displayed by IL-3 (Chap.1,2) and 
also the declining sensitivity of cells to IL-3 as they mature (Koike 
et al.1986). Park et al(1986a) noted that crosslinking of IL-3 to 
the IL-3 dependent myeloid cell line FDC-P2 detected two putative 
receptor molecules of molecular weight 72.5kB and 113kD respectively, 
both of which show the same affinities for IL-3. These molecules 
could either represent two distinct receptors or the higher molecular 
weight protein could be a complex of the 72.5kD receptor bound to a 
40.5kD protein which may be part of the IL-3 receptor complex (Park et 
all986a). Although both bands are observed on crosslinking to intact 
cells, only the 72.5kB receptor protein is crosslinked when purified 
cell membranes are used (Park al 1986a). If the cytoplasmic 
protein (40.5kD) does interact with an integral membrane protein 
(72.5kD) then this could be dislodged during preparation of the plasma 
membranes (Park et al 1986a). It could of course be crosslinked 
fortuitously and may be unrelated to the receptor for IL-3 (Park
41
1986a).
The major action of GM-CSF is stimulation of the production 
of mature granulocytes and macrophages (Metcalf 1984), and this 
biological pattern is mirrored by by the physical labelling of cells 
within the myelomonocytic lineage by ^I-GM-CSF (Walker and Burgess 
1985). Radiolabelled GM-CSF not only binds to primary bone marrow 
cells (Walker and Burgess 1985) but to many myeloid cell lines as well 
as two T-cell lines (Park et al 1986b - Walker and Burgess (1985) have 
observed that there appear to be two classes of GM-CSF receptor,a low 
and a high affinity receptor, present on both bone marrow cells and 
mature peritoneal exudate neutrophils. Although the low affinity 
receptor is present in equal numbers per cell in both bone marrow and 
peritoneal neutrophils, the bone marrow has a greater number of high 
affinity receptors than the peritoneal cells (Walker and Burgess 
1985). Walker and Burgess(1985) propose that the different classes of 
receptor may reflect different actions GM-CSF may exert on mature and 
imature cells. The presence of only low affinity binding sites on 
mature peritoneal neutrophils led to the proposal that the high 
affinity receptors may be present on the GM-CFC progenitor ceils and 
early myeloid cells which would be replaced by the lew affinity 
receptors as the cells differentiate (Walker and Burgess 1985). The 
numbers of low affinity receptors per cell is in the range of 30-400 
whereas the high affinity receptor could be present up to 1000 
molecules per cell (Walker and Burgess 1985). Walker and Burgess 
(1987) also followed ^I-GM-CSFs interaction with its receptor on 
WEHI 3B cells. They demonstrated that bound GM-CSF is rapidly 
internalised (half life Train) and processed within the lysozomal 
compartment. The reappearance of GM-CSF receptors on the membrane 
can in part be attributed to receptor recycling since blocking de 
novo protein synthesis with cycloheximide does not prevent receptor 
reappearance, but the majority results from synthesis of new 
receptors.
Park and her colleagues (1986b) have also studied GM-CSF 
binding to murine bone marrow cells, as well as a number of myeloid 
and T-cell lines. They detected a crosslinked receptor protein of 
molecular weight 130kD in contrast to the bone marrow receptor of 
molecular weight 51kD reported by Walter and Burgess (1985). Park et 
al (1986b) suggest that the 51kD protein described by Walker and
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Burgess 1986) is a proteolytic product which corresponds in size to 
the smallest crosslinked fragments. Park £t al (1986b) also 
crosslinked GM-CSF to bone marrow cell receptors, and this resulted in 
two proteins corresponding to receptor sizes of 179kD and 69kD. One 
other myeloid cell line tested also had the smaller peptide and a 
larger l88kD protein. If the 179kD protein product observed in 
bone-marrow is the true GM-CSF receptor and the 51kD peptide is the 
final product of proteolysis (this is disputed by Walker and Burgess 
1985) then bone marrow may have a specific protease that modifies the 
179kD receptor to a smaller 69kD biproduct. These results (Park et 
al 1986b) suggest that the 130kD receptor observed in 5 continuous 
cell lines, including WEHI 3B, could perhaps be an altered gene 
product, similar to the observed differences between the v-frris
(Coussens et al 1986) and v-erb B (Schlessinger 1986) oncogenes and 
their cellular counterparts which act as receptors for M-CSF and EGF 
respectively. The variety of different molecular sizes that are 
associated with ^^I-GM-CSF crosslinking may be related to the 
multiple biological actions of GM-CSF (Metcalf 1984, Chap. 1.2.) The
concentration dependent commitment by GM-CFCs in response to GM-CSF
(Metcalf 1980) and its activity on fully differentiated cells (Lopez 
et al 1983, Grabstein et al 1986) may be mediated through independent 
receptors (Walker and Burgess 1985), although at present this is pure 
speculation.
The data on identification and cellular distribution of CSF 
receptors is complex. Binding of the iodinated growth factor reveals 
the distribution of protein able to interact with CSF. When using
myeloid cell lines it must be remembered that establishment of the 
clone in culture may have resulted in an alteration in the product of 
interest. It is however difficult to resolve a complex issue 
involving many receptors with such a heterogenous population as the 
bone marrow cells, without the aid of cell lines. It is worth noting 
that the levels of iodinated CSF necessary to observe maximal receptor 
occupancy have been as high as three orders of magnitude greater than 
that necessary to produce biological effects (Park .gt al 1986b). This 
suggests that only a few of the maximum available receptors are 
required to stimulate colony formation and it is therefore the 
interactions occurring at these sites that would be most interesting. 
The availability of more receptors than required to produce maximal
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stimulation may be necessary if growth factor is produced in very
small amounts within a 3-dimensional environment. The random 
distribution of receptors around the cell surface could increase the 
probability 4f interaction under limiting growth factor release 
conditions. Alternatively the excess receptors may provide a cascade 
system in which growth factors interact with a cell surface receptor 
stimulating a down regulation of receptors from the cell surface so 
mimicking receptor occupancy and so amplifying the initial stimulus. 
The dynamic interactions between CSF receptors will now be discussed.
Modulation of CSF Receptors
Walker and colleagues (1985) observed that the four growth 
factors M-CSF, G-CSF, GM-CSF and IL-3 did not compete for the same 
receptor when assays on murine bone marrow were carried out at 0°C. 
Therefore each individual CSF interacts with a unique receptor. 
However, preincubation with of one CSF at either 21°C or 37°C, could 
consequently modify the binding properties of other CSFs to their 
isologous receptor in a predictable manner (Walker e£ al. 1985). The 
down regulation of an unoccupied receptor by the binding of a distinct 
CSF to its isologous receptor is termed CSF receptor trans-modulation 
(Walker si al. 1985).
Walker et al,(1985) observed that at high concentrations, IL-3 
down regulate its own receptors as well as the receptors for GM-CSF 
and M-CSF very efficiently, but will only reduce receptor binding to 
G-CSF by about 50%. GM-CSF binding down modulates its own receptor 
and the unoccupied receptors for M-CSF and G-CSF although in a similar 
manner to IL-3 there are still approximately 25% of the G-CSF
receptors available for isologous CSF binding (Walker et al 1985). 
Pre-incubation of bone marrow with G-CSF down modulates the G-CSF 
receptor and approximately 50%o of the M-CSF receptors and M-CSF down 
modulates its own receptors and approximately 60% of the GM-CSF 
receptors (Walker et al 1985). The degree to which down modulation 
occurs is dependent on the concentration of the CSF used during
the pre-incubation with bone marrow before iodinated factor is added 
(Walker et al 1985). The pattern observed at high concentration of 
GM-CSF or IL-3 reveals a population of G-CSF receptors that are
refractory to down modulation (Walker si si 1985). These may either 
be distributed among all the receptor bearing cells or perhaps
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represent a sub-population of cells (Walker et al 1985). It is 
possible that cells may express the receptor for G-CSF but not IL-3 or 
GM-CSF and so would not interact with IL-3 or GM-CSF. Clonal analysis 
of cells that respond to these three factors has already been 
discussed in chapter1.2, and it was concluded that G-CSF could act on 
separate populations of cells to that of IL-3 (Sieff et al 1987) or 
GM-CSF (Metcalf and Nicola 1983). The presence of G-CSF binding 
sites that do not down modulate is perhaps due to the existence of 
different subsets of G-CSF receptors or a population of cells that 
have IL-3 and GM-CSF receptors but these are not linked to the G-CSF 
receptors (Walker e£ al.1985)
Receptor transmodulation could occur by either internalisation 
of the receptor or by causing a receptor to alter its affinity to its 
ligand. There are examples of both types of event in the literature. 
Transmodulation of the EGF receptor has been observed in 3T3 
fibroblast cells treated with PDGF (Bowen-Pope jet al 1983) . The
observed response of 3T3 cells treated with PDGF is a result of an
altered affinity for EGF at the EGF receptor without a change in
receptor numbers (Bowen-Pope e£ al., 1983). The M-CSF receptor on 
murine peritoneal macrophages can be transmodulated by the phorbol 
ester TPA due to receptor internalisation (Chen et al 1983). TPA can 
also elicit a down regulation of EGF receptors in HeLa or A431 
epithelial cells by causing an alteration in receptor affinity 
(Bowen-Pope et al.. 1983, Shovub et al 1986). Thus the same effector, 
TPA, can generate a similar response (receptor down regulation) in 
different ways depending on the receptor. Walker al (1985) deduce 
from the binding curves of the various iodinated haematopoietic growth
factors to bone marrow cells that transmodulation is occurring via
receptor internalisation rather that an altered affinity.
Biological Significance of Receptor Transmodulation
The observed pattern of receptor down regulation is similar to 
the growth promoting activities of the individual factors (Walker et 
al 1985)* For example IL-3 can stimulate cells to produce 
granulocyte/macrophage colonies as well as stimulate the early 
proliferative division of primitive cells and erythroid precursors 
(Metcalf et al 198^ Sieff et al 1986). IL-3 elicits the most wide 
ranging down regulation effects by transmodulating the G-CSF, GM-CSF 
and M-CSF receptors (Walker ^1 1985), although this type of
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correlation is most obvious for GM-CSF. In vitro. GM-CSF shows a
concentration dependent effect on colony development from GM-CFC 
progenitors (Metcalf 1980). At low concentrations, mainly macrophage 
colonies develop, but with increasing concentration of GM-CSF, 
granulocyte colonies appear (Metcalf 1980). GM-CSF also shows a
concentration effect on the down regulation of M-CSF and G-CSF 
receptors (Walker et al*1985). At low concentrations of GM-CSF, M-CSF 
receptors are down regulated, whereas, at increased concentrations 
G-CSF receptors begin to be down regulated (Walker et al • 1985). If 
the down regulation of an unoccupied receptor mimics the response of 
an occupied receptor, then macrophage colony growth at low levels of 
GM-CSF could be explained by the binding of GM-CSF to its own receptor 
causing transmodulation of the unoccup ied M-CSF receptor resulting in 
macrophage colony growth (Walker et al 1985 , Nicola 1987). This
argument could be applied to IL-3 which causes the down regulation of 
M-CSF, G-CSF and GM-CSF receptors (Walker et al 1985). In vitro, in 
the absence of other factors colony growth stimulated by 11-3 occurs 
when the unoccupied receptors are down regulated (Walker et al 1985, 
Nicola 1987) . The data described above would explain why G-CSF and 
M-CSF are lineage restricted in their effects. According to this
theory, in the absence of lineage specific factors such as G-CSF or 
M-CSF, IL-3 and GM-CSF would primarily be mitogenic signals
stimulating cell proliferation, with differentiation directed by the 
down regulation of the more lineage resrtricted receptors (Nicola 
1987) .
The above model implies that at some point during the
proliferation of primitive cells in response to IL-3 or GM-CSF they 
must express lineage restricted receptors . Bartelmez et al (1985) 
demonstrated that bone marrow enriched for early progenitors did not
respond to stimulation by M-CSF even though a small number bound 
125i_m_csf. This enriched population of primitive cells could be 
stimulated by IL-3 to produce cells which showed an increase in the 
percentage of **^I-M-CSF binding cells. This was shown by 
autoradiography to be due to an increase in the number of M-CSF 
binding cells and in receptor density per cell, prior to these cells 
becoming fully differentiated (Bartelmez et al 1985). The receptor 
for M-CSF appears to be present on primitive cells before it is 
capable of responding to M-CSF. The appearance of M-CSF receptors on
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the surface of the proliferating cell population would then be 
available for either transmodulation by IL-3, or isologous receptor 
down regulation by M-CSF, to produce mature cells.
Despite the obvious difficulties in interpreting the short 
term effects on a heterogeneous population, the model for 
transmodulation does explain the observed colony development after 
CSF stimulation although it may simplify a complex set of interaction 
occurring in any developing colony. Analysis of this sort on purified 
cell populations and autoradiographic studies should ease the problems 
of interpretation as should the use of cell lines.
The Theory of Receptor Transmodulation and its Implication in the 
Disturbance of Normal Haematopoiesis.
If GM-CSF and IL-3 are primarily mitogenic signals that act as 
differentiating agents only in the absence of lineage specific factors 
(Nicola 1987), then it should be possible to disrupt the 
transmodulation pathway such that the lineage specific receptors are 
not down regulated, and cells will proliferate in response to IL-3 or 
GM-CSF but not differentiate. This is exactly what is observed with 
the factor dependent haematopoietic cell lines (Dexter et al 1980a). 
Most factor dependent myeloid cell lines require IL-3 for survival 
(Dexter et al 1980a). If these cells have a disruption in their 
receptor transmodulation pathway, then it is not surprising that they 
continue to survive and proliferate in response to the mitogenic 
stimulus of IL-3, although are unable to mediate transmodulation of 
lineage specific receptors for differentiation (Nicola 1987). The 32D 
myeloid cell line is dependent on IL-3 for its survival In vitro 
(Metcalf 1985a), but will however differentiate if G-CSF is added to 
the culture (Rovera et al1987). This observation implies that some of 
the factor dependent cell lines, although blocked at a certain point 
in differentiation and perhaps defective in transmodulation, could 
differentiate if exposed to the appropriate growth factor. Receptor 
transmodulation has only been examined in one cell line (Walker and 
Burgess 1985). The WEHI-3BD+ myeloid cell line is not dependent on 
exogenous growth factor for its survival (Metcalf and Nicola 1982) but 
it does retain receptors for GM-CSF (Walker and Burgess 1985). It 
does not, however, shew receptor transmodulation of the GM-CSF 
receptor in response to exposure to IL-3 (Walker and Burgess 1985).
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This may be due to the cell lines origin in vivo. It could be 
derived from a cell which would not normally display tranmodulation in 
vivo, or alternatively it could be an artifact relating to
immortalisation. It could also however, represent a required event
in the establishment of the cell line, relieving dependance on CSF. 
The WEHI 3BD+ line will differentiate in response to G-CSF (Metcalf 
and Nicola 1982) and so it will be of interest to see if this receptor 
is affected by exposure to IL-3 or GM-CSF and a direct comparison 
could be made to the WEHI 3BD” subline which cannot be induced by 
G-CSF and has no receptors for G-CSF (Metcalf and Nicola 1982, Nicola 
and Metcalf 1985).
Lotem and Sachs (1986) have also investigated the 
mechanisms by which growth factors interact with haematopoietic cells 
to induce proliferation and differentiation. They have isolated
myeloid leukaemic cell lines which proliferate in the absence of 
exogenous growth factor but will not differentiate unless stimulated 
by a factor termed MGI-2 which is found in endotoxin serum and the 
conditioned medium from Krebs ascites cells (Sachs 1982). MGI-2 has 
no CSF activity itself but it is produced by normal cells (Sachs 1982, 
Lotem et al 1980). Lotem and Sachs (1982) propose that during normal 
differentiation the cell will proliferate in response to CSF and 
produce the differentiation factor MGI-2 which contributes to the 
maturation of the colony. These cell lines, in conjunction with CSF 
and MGI-2 activity, have been used to determine the links between
proliferation and differentiation and how it may become uncoupled in 
malignancy (Lotem and Sachs 1977). A factor independent cell line 
clone 11 was observed not to require exogenous CSF to proliferate ( 
Lotem and Sachs 1982). However , if the differentiation inducing 
protein MGI-2 was added to the cells, proliferation ceased irrmediately 
( Lotem and Sachs 1982). This effect was not due to differentiation 
as the majority of the cells were still relatively undifferentiated. 
If, however, exogenous CSF was added to the cultures the cells 
continued to proliferate and finally differentiated due to the 
presence of MGI-2 ( Lotem and Sachs 1982). It was assumed then that 
the cells triggered to differentiate by MGI-2 become dependent on 
exogenous growth factor for their survival and proliferation ( Lotem 
and Sachs 1982).
Subsequently, Lotem and Sachs (1986) demonstrated by a
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receptor binding assay that the addition of MGI-2 increases the 
receptor numbers for GM-CSF on clone-11 from 140 per cell to 4,800 per 
cell, of which most are occupied by GM-CSF as demonstrated by elution 
of bound growth factor at low pH prior to the cells receiving any 
exogenous growth factor. Receptor bound growth factor could explain 
why these cells remain viable after induction with MGt-2. If the 
level of autocrine stimulation is not great enough to stimulate 
proliferation then exogenous factor would have to be added ( Lotem and 
Sachs 1982). The differentiation activity of MSL-2 may be due to its 
ability to induce cell surface receptors ( Lotem and Sachs 1986). 
Once the CSF receptors are expressed on the cell surface then they 
would be subject to normal differentiating effects of growth factors. 
If receptor transmodulation does occur, then it too could take place 
once the appropriate receptor had been expressed. It is unclear 
whether the autocrine stimulation of the up-regulated receptors would 
occur in vivo in response to MGI-2 stimulus. If MGT-2 up-regulated 
CSF receptors in cells it would make them competent to external 
stimuli. Bartelmez and Stanley (1985) have described a protein H—1, 
which has no intrinsic CSF activity. It can however act 
synergistically with M-CSF on primitive murine bone marrow cells to 
allow these cells to respond to M-CSF and proliferate ( Bartelmez and 
Stanley 1985). Normally these primitive cells would not respond to 
M-CSF, so H-1 in the presence of M-CSF, may be increasing the number 
of M-CSF receptor bearing cells ( Bartelmez and Stanley 1985). The 
synergistic effect observed between H-1 and M-CSF has also been 
reported for H-1 and IL-3 ( Bartelmez et al 1985). In both cases, 
H-1 permits the CSF to act on a developmentaly earlier cell than the 
CSF could act on alone ( Bartelmez and Stanley 1985 , Bartelmez et al
1985). It is possible that primitive cells cannot respond to CSFs 
unless they have a receptor for H-1, or H-1 and the CSF. Only after 
H-1 has bound to its receptor might the rest of the CSF receptors 
become activated or up-regulated. The protein MG1-2 described by 
Lotem and Sachs (1986) may have a similar function to H-1 ( Bartelmez 
and Stanley 1985)- A protein of this type could perhaps represent a 
trigger which primes primitive cells to respond to CSFs. The block to 
differentiation observed in the cell lines used by Lotem and Sachs 
may represent a failure of these cells to express CSF receptors in an 
appropriate way, so the differentiating effects of lineage specific
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CSFs and receptor transmodulation may not be possible. It is 
particularly interesting that these cells do not require added growth 
factor before induction to differentiate, but do seem to require It 
subsequently. This may be a reflection of the return to ’’normality" 
of the cell line once the differentation block has been overcome and 
for this reason the cause of the differentiation block may shed some 
light on the process by which growth factors stimulate proliferation 
and differentiation.
The use of iodinated growth factors to study CSF/receptor 
interactions has enabled the apparent numbers and cellular 
distrubutions of several CSFs to be examined (Nicola 1987). These 
experiments have highlighted a possible mechanism for the regulation 
of haematopoietic proliferation and differentiation by the 
transmodulation of CSF receptors by IL-3, GM-CSF, G-CSF or M-CSF 
(Walker et al 1985). If transmodulation is to be examined in 
primitive cells, then the use of unfractionated bone marrow cells as 
a model will present difficulties because of the relatively small 
percentage of primitive cells present (Metcalf 1984), and the 
differences in concentration of CSFs required to give biological 
stimulation in comparison to the binding assay (Park et al 1986b). 
There are many haematopoietic cell lines with a variety of 
characteristics which would be amenable to receptor binding studies 
(Metcalf 1985a, Dexter al 1980a, Wyke et al 1986). The use of
these cells may give some indication of the biological relevance of 
the dynamic changes observed in receptor nunbers in normal bone marrow 
(Walker el al 1985).
Chapter 1.5.
Possible Mechanisms bv Which Growth Factors Elicit Their Effects in 
Haematopoietic Cells.
Protein Phosphorylation in Biochemical Pathway Control
Growth factors interact with receptor molecules situated on 
the cell surface, but how does receptor occupancy lead to cellular 
survival and proliferation? It seems that the cell surface
interaction has to be transmitted to the cytoplasmic face of the
plasma membrane before it can trigger the appropriate cellular 
responses via a secondary messenger system (Cohen 1985). One 
mechanism by which a growth factor can elicit a cellular response is 
via secondary messengers such as diacylglycerol (DAG), and inositol 
triphosphate (IP3) (Cohen 1985 , Bell 1986). The proposed chain of 
events leading to the generation of DAG and IP3 are outlined in 
Fig1.2. The activated receptor may interact with a closely 
associated G protein which is allosterically altered when it binds to 
GTP (Gilman 1984), which may be part of the activation process of the
G protein. The G protein is thought to function by activating
phospholipase C which in turn produces the secondary messages IP3 and
DAG by the hydrolysis of PIP2 (Gilman 1984, Bell 1986)
The secondary messengers refered to above are then thought to
act in the case of IP3 by increasing intracellular levels of Ca2+ 
or, in the case of DAG by activating protein kinase C (PK-C) (Gilman
1984, Nishizuka 1984) . The increased intracellular Ca2+ can be
complexed to the Ca2+ binding protein calmodulin which then
regulates Ca-calmodulin dependent enzymes such as some protein kinases 
(Cohen 1985). The reversible phosphorylation of proteins has been 
demonstrated to modulate enzyme activity in a number of pathways
leading to activation or inactivation of the enzyme (Cohen 1985). In
this way rapid changes in phosphorylation states can regulate
biochemical pathways.
DAG is the other product of PIP2 hydrolysis and is thought to
be a second messenger because of its ability to activate protein
kinase C (PK-C) (Bell 1986, Nishizuka 1984). PK-C is a Ca2+
dependent protein kinase which in its active form is translocated from 
the cytoplasm to the cell membrane (Nishizuka 1984). PK-C shows a 
broad range of substrate specificities, and due to the biochemical 
relevance of protein phosphorylation, it may play an important role in
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Figure 1.2
A scheme illustrating the possible cascade of 
events following binding of an agonist (growth 
factor) to its receptor. PI, phosphoinositol;
PIP2, phosphoinositol biphosphate; IP3, isositol 
triphosphate; DG, diacylglycerol.
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the regulation of receptor mediated responses to growth factors (Cohen 
1985, Nishizuka 1984).
How does Growth Factor Receptor Occupancy lead to Cellular Survival 
and Proliferation.
Whetton et al.(1986^ have used myeloid cell lines dependent on 
IL-3 for survival and proliferation in order to ascertain the 
mechanics by which IL-3 elicits a response. If IL-3 is removed from 
the IL-3 dependent FPDC-P2 myeloid cell line, the intracellular pools 
of ATP become depleted and cells die after 12h (Whetton et al.19861. 
The addition of IL-3 to FDCP-2 and IL-3 dependent FDCP-MIX1 cell lines 
results in increased glucose transport across the membrane which 
promotes ATP production (Whetton et al.1986tl. The production of ATP 
via glucose transport explains how IL-3 sustains and allows the 
proliferation of IL-3 dependent cells (Whetton et al.1986dU The 
mechanism by which this is regulated in biochemical pathways has been 
investigated at the level of secondary messengers.
If IL-3 acts through secondary messengers DAG and IP3 to 
stimulate PK-C and Ca^+ mobilisation respectively, then the effects 
of secondary messengers can be examined both by stimulating PK-C and 
increasing intracellular Ca^+ levels (Whetton et al.1Q86A. The 
phorbol ester TPA activates PK-C, and the calcium ionophore A23187 
will increase Ca^+ levels in cells (Nishizuka 1984). Therefore if 
IL-3 acts through PK-C and Ca^+ levels then TPA and A23187 should be 
able to substitute, at least in part, for IL-3 function (Whetton et 
al.1Q86oL Using the FDCP-MIX1 multipotential IL-3 dependent cell line 
(Wyke et al 1986), it has been shown that optimal concentrations of 
TPA and A23187 can relieve the requirement of IL-3 for cell survival 
and proliferation (Whetton et al.1986^ . A 48h pre-incubation with 
these components in the absence of IL-3 does not affect the ability of 
cell lines to form multipotential colonies in semi-solid medium upon 
appropriate growth factor stimulation (Whetton et al.1986d(. Therefore 
the viability and proliferative effects of IL-3 arc mimicked by TPA 
plus the calcium ionophore A23187 (Whetton et al.1986ol. Witters .et 
al(1985) have shown that PK-C is capable of phosphorylating the 
glucose transport protein in erythrocytes. As previously discussed, 
protein phosphorylation can alter protein activity (Cohen 1985) and so 
glucose uptake via a transport protein may be susceptible to this type
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of modulation. The effect of IL-3 on activation of PK-C may explain 
how glucose levels are regulated by IL-3 in haematopoietic cells.
Concomitent with PK-C activation, is the translocation of PK-C 
from the cytosol to the cell membrane (Nishizuka 1984). The 
association of PK-C with the inner surface of the membrane has been 
observed in several factor dependent haematopoietic cell lines. 
Stimulation of the IL-2 dependent CT6 line by IL-2 (Farrar and 
Anderson 1985), and the FDCP1 IL-3 dependent cell line by IL-3 (Farrar 
et al 1985), or IL-3 stimulation of the FDCP-MIX1 cell line (Whetton 
et al.1Q86cL results in the membrane association of PK-C . It has 
also been demonstrated that the translocation event observed in CT6 
and FDCP1 cells can be achieved in the absence of growth factors by a 
phorbol ester (Farrar and Anderson 1985, Farrar .et §11985). The 
activation of PK-C in these cases may change the phosphorylation of 
key regulatory molecules involved in cell survival, proliferation and 
differentiation. Evans et al (1987, 1986) have identified a 68kD 
protein which is phosphorylated in several factor dependent cell lines 
upon stimulation by the growth factors or a synthetic diacylglyceride, 
OAG, which will activate PK-C. Stimulation of the cell lines FDCP1 by 
IL-3, NEF60-8 by G-CSF or IL-3, and CT6 cells by IL-2 resulted in
phosphorylation of a common 68kD protein (p68) (as determined by 
peptide mapping) (Evans et al 1987). The NSF6O-8 cell line 
proliferated in response to GM-CSF as well as IL-3 or G-CSF, but 
GM-CSF did not cause the phosphorylation of the common 68kD protein 
(Evans et al 19 87) - All four of the cell lines show the 
phosphorylation of the p68 in response to activation of PK-C by OAG 
(Evans e£. al 1987).
The translocation of PK-C from the cytosol to the membrane in 
two cell lines, including FDCP1, in response to growth factors or a 
phorbai ester (Farrar and Anderson 1985, Farrar et §11985), and the 
phosphorylation of a common protein in several individual cell lines 
in response to growth factor or activation of PK-C (Evans et §1 1987), 
suggests that growth factors may possibly act through PK-C mediated 
phosphorylation. For example p68, may be a common regulator protein 
involved in anion exchange (.Evans et §1 1987) The identification of 
a common route of action for several factors is of interest in 
defining basic regulation of cell survival and proliferation, but does 
not explain the differential effects observed upon stimulation of bone
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marrow by the various growth factors. In this respect the apparent 
inability of GM-CSF to stimulate the p68 protein in NSF60-8 cells, 
even though it stimulates proliferation, is of interest (Evans et al 
1987). These results suggest that GM-CSF may act through the 
phosphorylation of different proteins to IL-3 or G-CSF or indeed 
through a separate secondary messenger pathway (Evans g t al 1987).
It is not known how PK-C is activated in haematopoietic cells 
in response to growth factors. Certainly a synthetic DAG can activate 
PK-C, and cause it to phosphorylate the same 68kD protein as binding 
of the natural ligand (Evans et al 1987, 1986), but this does not mean 
that the DAG required to activate PK-C is derived from PIP2 hydrolysis 
nor does it mean the PK-C is necessarily activated by DAG in
haematopoietic cells. Whetton et al (1986b). stimulated bone marrow
derived macrophages with IL-3 or M-CSF and determined the levels of 
PIP2 hydrolysis. Treatment of the cells with IL-3 or M-CSF did not 
alter the levels of PIP2 or IP3 suggesting that proliferation of 
macrophages in response to these factors is not associated with DAG 
derived from PIP2 hydrolysis ( Whetton et al 1986b). However , there 
is also some evidence to suggest that DAG can be generated by
hydrolysis of phosphatidylcholine (Besterman et al 1986). It is
therefore possible that activation of PK-C may be achieved by DAG 
generation from several pathways each of which could be activated 
independently .
The phosphorylation of protein by PK-C is an attractive method 
for controlling the biochemical pathways required for the survival, 
proliferation and differentiation of haematopoietic cells (Whetton et 
al 19864. Kinases can phosphorylate many proteins thus amplifying the 
initial stimulus and bringing about the activation and inactivation of 
a diverse number of proteins (Cohen 1985). The role of DAG and IP3 
as secondary messengers generated in haematopoietic cells after 
binding of growth factor has not been clarified. However PK-C has 
been implicated in post-receptor binding events due to its 
sub-cellular distribution and its ability to substitute for IL-3 when 
activated by a phorbfil ester on a multipotential haematopoietic cell 
line (Farrar and Anderson 1985, Farrar .gt al 1985, Whetton et. al 
19864.
Most of the previous studies have concentrated on the role of 
PK-C in cellular survival and proliferation but have not addressed the
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problem of how growth factors cause, or permit, differentiation. As 
previously discussed, phorbol esters can substitute for growth factors
presumably via the activation of PK-C ( Whetton et al 1986qU It has
been demontrated that jLn vitro colony growth of bone marrow
progeinitor cells can be stimualted by the phorbol ester TPA in the
absence of exogenous CSF (Stuart and Hamilton 1980). The resulting 
colonies are mainly macrophage (Stuart and Hamilton 1980). In this 
instance TPA could be acting in three ways - it could interact 
directly with the clonogenic progenitor cell and its progeny, or TPA 
may cause the haematopoietic cells to release their own growth factors 
or finally, TPA might sensitise the cells to respond to sub-optimal 
levels of CSF present in the cultures (Stuart and Hamilton 1980).
Chen and colleagues (1983) have analysed the binding 
properties of I^^-M-CSF to murine macrophages in response to 
pre-treatment of the cells with TPA. They have shown that TPA down 
modulates the M-CSF receptor by receptor internalisation rather than 
an altered affinity for the receptor and its ligand (Chen et al
1983). In contrast, TPA treatment of 3T3 cells and a variety of other
lines alters their binding of EGF to its receptor by decreasing the
receptor affinity for EGF (Shoyab et al 1979). However, TPA causes a 
down regulation of EGF receptor in HeLa cells by receptor
internalisation (Lee and Weinstein 1978), similar to M-CSF regulation
(Chen et al_ 198D.. The M-CSF receptor internalisation observed in 
macrophage cells after TPA treatment (Chen et al 1983) could be a 
result of receptor transmodulation (Nicola 1987) as discussed in 
Chapter1.4. The ability of TPA to stimulate in vitro colonies in the 
absence of added growth factor (Stuart and Hamilton 1980) could be 
attributed to internalisation of the vacant M-CSF receptors resulting 
in colony differentiation as well as proliferation. It would be of 
interest to see if TPA down regulates any of the other receptors for 
CSF but this has not been reported thus far.
The down regulation of M-CSF receptors in response to TPA 
(Chen et al 1983) leads to the interesting question of how this might 
be achieved. When EGF binds to its receptor, (which has a tyrosine 
kinase activity), the receptor becomes autophosphorylated at a 
tyrosine residue (Carpenter and Cohen 1979). EGF receptor down 
modulation due to decreased affinity for its ligand can be achieved by 
TPA or PDGF stimulation (Shoyab et al 1979 , Bowen-Pope et al 1983).
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These changes in receptor affinity may be caused by PK-C mediated 
phosphorylation of serine and threonine residues on the EGF receptor 
molecule (Crochet et al 1984, Schlessinger 1986).
In the case of M-CSF receptor internalisation after TPA 
treatment (Chen et al 1983), PK-C or a similar molecule may act on the 
receptor (perhaps to phosphorylate it) causing its internalisation, 
which would in this instance cause a mitogenic and/or differentiation 
event. The receptor for M-CSF is the cellular homologue of the viral 
oncogene v-fms (Sherr et al 1985). The fms gene has tyrosine kinase 
activity (Sherr et al 1985, Sacca et al 1986) and since its normal 
cellular function has now been identified as the receptor for M-CSF 
(Sherr et al 1985), it should be possible to study the manner in which 
growth factor stimulation is linked to cytosolic proteins and
phosphorylation events. Caution must always be placed on interpreting 
results using TPA since PK-C is normally activated by a very short 
lived enzyme DAG (Nishizuka 1984). TPA remains active in the cell for 
longer periods of time and so its stimulating effect on PK-C may not 
be a true reflection of PK-C normal function. In addition, there may 
be other controlling events taking place in the cell due to receptor 
binding that are not mediated via protein phosphorylation. For 
example, the methylation of cellular proteins has also been
demonstrated to alter their acitivities (Pike and Snyderman 1982, 
Hirata and Axelrod 1980) and so may play a role in determining
post-stimulatory effects.
The theories and experimental data concerning the events which 
occur after the binding of a growth factor to its receptor are still 
rather preliminary. Secondary messengers have not been studied in any 
great detail in the haematopoietic system, although as an experimental 
model it would be ideal since growth factor dependent cell lines are 
available (Dexter et al 1980a, Metcalf 1985a, Wvke et al 1986). In 
conduction with bone marrow assay systems (Pragnell et al 1988) these 
experiments should enable growth factors to be linked to cellular 
proliferation and differentiation at the biochemical level.
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Chapter 1.6.
The role of Growth Factors in Abnormal Haematopoiesis
There is very little direct evidence to implicate CSFs and 
their receptors in abnormal haematopoiesis. However due to their in 
vitro activities (Chap 1.2) it is possible that they may play some 
important role in the development of myeloid diseases.
Oncogenes such as mvc and abl have been implicated in 
haematopoietic disorders due to their proximity to translocation break 
points present in cases of Burkitt's lymphoma (Ar-Rushidi et all983) 
and chronic myeloid leukaemia (Shtivelman et al 1985). In addition it 
has been suggested that deletions in chromosome arm 5q, on which the 
loci for human FMS and GM-CSF are localised, observed in a small 
percentage of haematopoietic disorders, might be involved in the 
development of the disease (Le Beau et al 1986, Nienhuis et all985).
Possible mechanisms of growth factor involvement in abnormal 
haematopoiesis
The human disorders of acute myeloid leukaemia (AML), and 
chronic myeloid leukaemia (CML), result from the clonal expansion of 
an abnormal multipotential cell (McCulloch 1979). Eaves et al (1986) 
have shown that a high percentage of progenitor cells from CML 
patients remain in cycle when placed in normal LTMC feeder layers. In 
comparison, normal progenitors go in and out of cycle upon culture 
feeding. This suggests that continuous cycling gives on the CML 
progenitors a proliferative advantage since they do not respond to 
normal regulatory signals ( Eaves et al 1986). It is possible that 
either the CML progenitors do not display receptors for inhibitory 
molecules or cannot interact with the stromal layer in the correct 
fashion for regulation to take effect ( Eaves e£ 1986).
Alternatively, these cells may be hyper-responsive to low levels of 
growth factor or produce, and respond to levels their own growth 
factors in an autocrine fashion ( Eaves g t al 1986).
Autocrine stimulation of haematopoietic cells.
Friend Murine LeukaemiaVirus (Fr-MLV) infection of LTMC..
Mice infected with replication competent Fr-MLV, produce 
after a long latency period, a myeloid leukaemic disease (Shibuya and 
Mak 1982), In order to investigate the steps involved in the 
progression of the disease, the effect of virus infection of LTMC were
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analysed (Heard et al 1984). The response of non-adherent clonogenic 
cells to CSF (mainly GM-CSF) in semi-solid media assays was testd at 
various time intervals after initial infection (Heard et al 1984). 
During the first 10 weeks post infection, colony forming cells (CFC) 
were present in the non-adherant fraction at a frequency similar to 
that in non-infected cultures (Heard et al 1984). Interestingly, 
infected cultures from 12 to 24 weeks displayed an increase in colony 
numbers formed in response to CSF and the morphology of the colonies
changed until by week 24 they consisted of mostly immature cells
(Heard et al 1984). These colonies of immature cells could be
re-plated and re-cloned in the presence of GM-CSF and gave rise to
factor dependent cell lines (Heard e£ al 1984). The clonogenic cells 
present during this period of post-infection events are clearly still 
dependent on CSF for colony development but exhibit an abnormal 
response to stimulation and proliferate rather than differentiate 
(Heard et al 1984). Cell lines can thus be selected for autonomous 
growth in the absence of exogenous growth factor, after approximately 
36 weeks from the initial infection at high frequency ( 8 out of 20) 
(Heard et al 1984). The cloning efficiency was greatest in these
growth factor independent (FI) cell lines when plated at high cell
density suggesting that these lines may be FI due to autocrine 
stimulation (Heard et al 1984). Similar results were obtained by 
Heard et al (1983) when mice were infected with Fr-MLV and the 
resulting myeloblast cell lines were shown to be autocrine stimulated.
The gradual change in response to CSF by the clonogenic cells 
(Heard .et al 1984) in this system provides a mechanism by which cells 
still remain responsive to CSF and proliferate although some event 
(e.g lack of receptor transmodulation) may cause the cell to become 
unable to use this signal to differentiate and so become blocked. 
Because these cells have a bias towards proliferation there is an
outgrowth of these cells which is similar to that observed in some 
myeloproliferative diseases (McCulloch 1979).
Gisselbrecht et al 1987 have analysed 68 murine myeloblastic 
cell lines and tumour DNAs for integration of the Fr-MuLV at a 
chromosomal site termed fim-2. This was originally defined as a site 
of integration for F-MuLV (Sola et al 1986). They found that 14(20%) 
of the samples analysed had proviral integration at the fim-2 site , 7 
of which were from In vivo F-MLV induced leukaemias and 7 were from
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cell lines derived from _in vitro infection of LTMC (Gisselbrecht et al 
1987). It was shown by sequence analysis that the fim-2 locus spans 
the 5’ end of the cfms gene which codes for the M-CSF receptor 
(Gisselbrecht et al 1987). Viral integration at this locus resulted 
in increased levels of normal size cfms message RNA (Gisselbrecht et 
al 1987). It is possible(but not yet demostrated) that the cfms 
positive tumours might stimulate their own proliferation by releasing 
M-CSF (Gisselbrecht et al 1987). These results suggest that the 
initial abnormal response to exogenous CSF observed in Fr-MLV infected 
LTMC (Heard et al 1984) may be due to disruption of receptor 
expression followed by secretion of growth factor. The ability of a 
haematopoietic cell to respond to proteins secreted by itself would 
finally relieve its dependence on any other regulatory molecules and 
result in uncontrolled proliferation.
The viral fms gene differs from its normal cfms counterpart 
in that it has constitutive tyrosine kinase activity (Sacca et. al 
1986). The normal membrane bound cfms tyrosine kinase activity is 
activated upon binding of M-CSF (Sherr et al 1985), thus tyrosine 
kinase activity is a function of the activated receptor and probably 
mediates the growth factor response. The introduction of vfms into 
the IL-3/GM-CSF dependent cell line FDCP1 (Wheeler § t al 1987) and the 
M-CSF depednent cell line BAC-1 (Wheeler et al 1986) converts them to 
factor independent growth through a non-autocrine method, probably by 
promiscuous tyrosine kinase activity (Sherr 1987). Both parental 
lines are non tumorigenic in nude mice prior to induced vfms 
expression, and induced tumorigenicity is concomitent with growth 
factor independence (Wheeler et al 1986, 1987) . Thus in this case, 
cells with a mutation in a receptor gene such that it no longer
requires ligand binding to produce a mitogenic response (Sacca et _al
1986) require only one mutagenic event to achieve autonomous growth. 
Cells which proliferate due to autocrine stimulation require two 
events, the production of the growth factor and the production of
receptor. It is possible that one of these may already exist as a
normal product of the cell, but in the case of leukaemic cells in 
which Fr-MLV virus is integrated at the cfms locus (Gisselbrecht et al
1987), the long latency of the disease could be explained by a 
requirement for at least two events in leukaemogenesis, the first 
being integration of the virus at the cfms locus, and the second
59
being the production of growth factor.
It is still unclear however why factors normally involved in 
differentiation, such as M-CSF (Chap.1.2), do not do so and cause 
instead proliferation without differentiation. The introduction of 
the human cfms cDNA into mouse 3T3 cells clearly shows that these 
cells respond to M-CSF stimulation (Roussel et al 1987) and so in this 
instance M-CSF acts purely as a mitogen for an inappropriately 
expressed receptor. In haematopoietic cells a further disruption to 
the cells internal signal transduction system can be envisaged in 
order to explain the lack of differentiation observed upon growth 
factor stimulation.
Abnormal response to CSF bv human leukaemic cells
A model can be proposed in which several events could take 
place resulting in a myeloid leukaemia. One of these events could be 
the uncoupling of proliferation and differentiation so that the 
haematopoietic cells no longer differentiate efficiently (Sachs 1982). 
Another related, or distinct, event could be autocrine secretion of a 
growth factor which the cells would normally require to be "delivered" 
to them (Sporn and Roberts 1985). Autocrine stimulation alone would 
probably not be sufficient for cell transformation but could give a 
clone of cells a selective advantage (Wong et „_al 1987). This 
population of cells could then be more susceptible to further 
alterations in its genome and so finally give rise to the leukaemia 
(Wong et al 1987).
Metcalf .et al (1974) examined the response of human 
granulocytic leukaemia cells to monkey lung CSF. Using 150 samples 
of peripheral blood leukocytes or bone marrow cells, samples from CML 
patients were found to be slightly less responsive to CSF over all the 
concentrations of CSF used in comparison to normal cells. Samples 
from AML patients were slightly more responsive than normal at low CSF 
concentrations and AML patients in remission showed a normal response. 
A response like that observed with AML cells could be due to several 
reasons:-
(i) The cells release some of their own CSF: At low levels of
addition exogenous CSF which would be suboptimal for normal colony 
growth these cells could proliferate if the deficit in CSF was 
augmented by their own production.
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(ii) The clonogenic cells in the AML population are more sensitive to 
growth factors and so respond by proliferating with lower levels of 
CSF than normal cells: Hypersensitivity could be achieved by an 
altered affinity of the receptor for its ligand or an altered 
sensitivity of the secondary messenger system to ligand binding. In 
this context, it has been shown that retroviral expression of the 
normal cmvc gene within the IL-3 dependent FDCP-1 cell line alters its 
sensitivity to IL-3 (Cory et al 1987). FDCP-1 cells expressing the 
retroviral cmvc form colonies at lower CSF concentration than control 
cells (Cory et al 1987). The reason for this is not kncwn but it 
could reflect changes in the post-receptor signalling pathway.
(iii) The AML clonogenic cells may be part of an expansion of a 
pre-existing sub-population of progenitor cells which normally exhibit 
this high sensitivity to CSF. The expansion of this sub-population 
could be causally related to its CSF sensitiviy (Metcalf et al 1974).
Proliferation of AML cells in the absence of added CSF
Investigators interested in the control of leukaemic cell 
growth have tried to define which of the presently known growth 
factors can support AML colony growth _in vitro (Griffin and Lowenberg
1986). Both rGM-CSF and rG-CSF can stimulate colony growth (Vellenga 
et al 1987). Where samples responded to both factors, the colonies 
were often larger but the total number of colonies formed was always 
less than the additive compared with numbers formed by the individual 
factors alone (Vellenga et. al 1987)- This data implies that G-CSF and 
GM-CSF can work on overlapping AML clonogenic populations (Vellenga et 
al 1987). The failure of AML cells to form colonies in semi-solid 
medium is likely to be due to inadequate growth conditions in. vitro 
(Griffin et al 1986). Bone marrow samples taken from AML patients 
could have an undefined number of normal progenitor cells present and 
if these are intrinsic differences between leukaemic progenitor cells 
and normal cells then the proportion of contaminating normal 
progenitor cells may contribute to the variation seen between samples. 
In order to obtain relatively pure populations of such progenitor 
cells many investigators have used peripheral blood as a source of 
clonogenic cells (Griffin et al 1986). The peripheral blood normally 
contains very few clonogenic cells but they can be detected in 
peripheral blood from patients with leukaemia (Griffin et al 1986).
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The growth of haematopoietic colonies in the absence of added 
CSF has been demonstrated to occur (Moore and Williams 1972).
However, the cells responsible supporting this colony formation can be 
separated from the colony forming cells by fractionation and have been
shown to be macrophage and T-cells (Moore and Williams 1972). After
removal of these cells colony formation by the normal marrcw no longer 
occurred (Moore and Williams 1972). Thus it was noticed in J.
Griffins laboratory that on several occasions AML cells depleted of T 
cells or both T cells and macrophages show autonomous colony growth in 
a population of AML cells tested (Griffin et al 1986, Vellenga et al 
1987, Young and Griffin 1986, Young et al 1987).
The possible reasons for the autonomous growth of AML cells in 
vitro was examined in two papers, Young et al (1987), Young and 
Griffin (1986). Young and Griffin (1986) describe three patients 
whose progenitor cells show autonomous growth. Conditioned media 
from these samples could in cases one and two stimulate normal bone 
marrow progenitors to form granulocyte/macrophage colonies. The cells 
from case three released no detectable CSF activity. The addition of 
antisera against GM-CSF to the AML colony assays reduced the 
autonomous colony numbers formed for cases one and two but not three. 
It seems likely therefore that the autonomous growth of the cells in 
cases one and two is due to autocrine stimulation by GM-CSF. Northern 
blot analysis demonstrated GM-CSF transcripts for cases one and two 
but not three which supports the proposed autostimulatory role for 
GM-CSF in these cases.
Young and Griffin (1986) also demonstrate that the addition 
of rGM-CSF to the cells from cases two and three increased both the 
colony number and size, whereas colony size increased in case one. 
This implies that the cells from case two are not maximally stimulated 
by the autocrine route, nor are cells from case three by whatever 
route colony growth is achieved. Case one generated 1090 colonies per 
10^  AML cells in the absence of added CSF whereas case two produces 
81 colonies per 10^  AML cells. Case one AML cells secrete 10 - 100 
fold more CSF into the growth medium than case two and so this higher 
level of growth factor release may cause the maximal stimulation in 
the absence of exogenous stimulation. It is of interest that the 
differing amounts of GM-CSF released into the media does not correlate 
with the GM-CSF mRNA levels, and so processing of the GM-CSF protein
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may differ in the two cases.
Following the observation that GM-CSF is an effective growth 
stimulator for AML cells (Griffin et al 1986, Vellenga et al 1987), 
and that a proportion of AML cells can produce and respond to their 
own GM-CSF in an autocrine manner ( Young and Griffin 1986), Young et 
al (1987) investigated the expression of GM-CSF in 22 cases of AML. 
Of the 22 cases, 11 had GM-CSF transcripts detectable by Northern blot 
analysis and of these 11 cases, cells from 6 of them secrete CSF 
activity. If antiserum to GM-CSF was added, partial or complete 
inhibition of colony growth by conditioned media was observed in 5 out 
of 5 cases tested, all of which showed high levels of both CSF 
activity and GM-CSF transcripts. Autonomous colony formation in 
vitro was also observed in 9 out of 22 of the cases, and 5 of these 
secreted detectable amounts of CSF. Three out of the 9 cases showing 
autonomus growth have GM-CSF mRNA transcripts. In contrast no GM-CSF 
transcripts were observed in 4 CMLs nor 11 ’common’ (pre B cell) acute 
lymphoblastic leukaemias studied. Normal marrow mononuclear cells 
and normal monocytes treatment with or without gamma-interferon or 
phorbol ester did not show GM-CSF transcripts. GM-CSF mRNA expression 
was not observed in resting T cells but could be detected after 
phorbol ester treatment (Young et all987). In order to rule out the 
possibility of contamination of AML by T-cells which could be the 
cause of the observed stimulation and GM-CSF mRNA, Young et al(1987) 
reprobed their blots with the a chain for the T cell receptor. This 
gave a negative result for the AML mRNAs (Young et all987).
The results described above suggest that GM-CSF expression may 
have some role to play in the abnormal proliferation of AML cells. It
is possible that GM-CSF expression is a normal feature of the
progenitor cell component and failure to detect GM-CSF transcripts in 
normal bone marrow cells (Young et all987) may be due to sensitivity 
as the progenitor cells are relativley rare in normal bone marrow 
(Metcalf 1984). It seems more likely that GM-CSF is abnormally 
expressed in some AMLs and that this may contribute the the abnormal
proliferation of the cells (Young et all987). Of the eleven AML
cases which express GM-CSF mRNA, only 6 secrete detectable levels of 
CSF (Young et al1987), which may be a reflection of the amount of CSF 
released and the sensitivity of the detection system ( 
incorporation into purified myeloblasts)(Young et all987). In addition
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it is possible that concentration of the conditioned media (Laker et 
al 1987), or low pH elution of receptor bound growth factor (Lotem and 
Sachs 1986) might detect CSF activity in the other cases. It must be 
noted that a low level of CSF expression may not give the cells any 
observable proliferative advantage (autonomous growth) _in vitro but 
the situation _in vivo may be different.
Not all of the cases studied which showed autonomous colony
growth have detectable levels of GM-CSF mRNA or detectable levels of
CSF activity (Young etal 1987). This serves to highlight the 
complexity of this type of analysis. It is possible that either 
GM-CSF or another factor is responsible for the autonomous colony 
growth but is undetectable. Alternatively other mutations may have 
caused a "short circuit" in the growth factor requirements of the
cell (Rapp et al 1985).
The retroviral expression of v-mvc (Rapp et al 1985) or v-abl 
(Cook et al 1985) in the factor dependent cell line FDCP-1 relieves it 
of its strict requirement for IL-3 or GM-CSF in a non-autocrine 
manner, presumably by acting as a constitutive p@st receptor 
signalling event. A situation like this may have occurred in the AML 
cells that show autonomous growth but no CSF mRNA or CSF activity. A 
mutation at a receptor growth factor locus would also cause a by 
-pass in the normal requirement for ligand binding, for example v-frns 
expression in FDCP-1 (Wheeler et al 1987) cells or M-CSF dependent 
cell line (Wheeler et al 1986). Although the apparent expression of 
GM-CSF in AML cells may be involved in a proportion of AML cases it is 
unlikely to be the only event required to cause the disease.
CSF genes may become activated by physical rearrangement of
the gene’s normal controlling elements, perhaps mediated by a 
mutagenic event. For example the WEHI3B myelocytic cell line 
constitutively produces 11-3 due to insertion of an intercisternal-A 
virus type particle, 5' to the 11-3 coding region (Ymer et al 1985)- 
Another mode of activation would be indirectly though disturbances in 
cellular pathways that would normally be controlled by growth factors. 
Chicken myoblasts and macrophages can be transformed by avian 
retrovirus carrying the v-mvb or v-mvc genes (Adkins et a! 1984). 
These cells are still require a source of chicken myelomonocytic 
growth factor (CMGF), for their survival and proliferation (Adkins et 
al 1984) . However, upon superinfection of the transformed lines by
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retroviruses containing src related genes, cell lines can be derived 
which show autocrine stimulation by release of CMGF (Adkins et al
1984). The basis for the result of expression of src related genes in 
these cells is unknown, but these genes have tyrosine kinase activity 
(Bishop 1985) and may mimic protein phosphorylation normally catalysed 
by an occupied growth factor receptor (Sherr 1987). If this was the 
case, and transmembrane signalling had been short circuited, then a 
non-autocrine mechanism for growth factor independence would seem most 
likely. However, in this instance (Adkins et al 1984) src gene 
expression may mimic receptor occupancy for one factor which them 
induces the release of a second factor, for example CM1F. Such an 
induction has been observed in endothelial cells stimulated by 
interleukin 1 which results in the release of human multilineage 
colony stimulating factor (Zucali et al 1987).
Recently Sakai et al (1987) examined 5 cases of AML for the 
involvement of IL-1 in tumour cell growth. Using uptake as an 
indication of cell proliferation, the cells from one case, HN, showed 
a high spontaneous proliferation rate. The AML cells from HN 
responded to both IL-1a and 11-18 by increased thymidine uptake. 
However only addition of anti-Il-18 antiserum and not anti Il-1a 
inhibited the proliferation of these cells. 11-1 activity was tested 
for and detected in the conditioned media from HN cells by the mouse 
thymocyte comitogenic proliferation assay, which was again inhibited 
by antisera to 11-18 but not Il-1a (Sakai et al 1987) . A molecular 
probe to 11-18 was used to detect 11-18 specific mRNA in Northern 
analysis of AN AML cells so confirming its expression. These results 
indicate that autocrine secretion of 11-1 was involved in the 
proliferation of these myeloid leukaemic cells. 11-1 has been shown 
to stimulate the release of GM-CSF from endothelial cells and so it 
may be having a similar effect in this situation. Sakai et al (1987) 
also added exogenous GM-CSF to HN cells without observing any increase 
in proliferation. These results mean that if 11-1 stimulation of HN 
cells is mediated through autocrine release of a growth factor it is 
probably not GM-CSF (Sakai et al 1987). CSF activity in the 
conditioned media of HN cells was not analysed, and so growth factor 
involvement in this system cannot be ruled out.
A direct approach which assumes that growth factors are part 
of the multi-step process of leukemogenesis involves the
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re-introduction of growth factor genes into haematopoietic cells.
Several groups have re-introduced growth factor sequences into either
factor dependent cells lines or bone marrow with interesting results. 
Lang et al(1985) converted the factor dependent FDCP1 cell to factor 
independent growth by expression of the murine GM-CSF cDNA as has 
Ostertag et al (1987). These papers will be discussed in more detail 
later. Wong et al (1987) infected foetal liver cells as well as the 
factor dependent cells lines FDCP1 and 32D with an IL-3 containing 
retrovirus. The retrovirus contained the dominant selectable marker
neo which allowed them to identify G418 resistant factor
independent (FI) foetal liver cells of mixed haemaopoieitic lineages 
in methocel at a frequency of 35%. These colonies were picked and 
grown into FI cell lines. 10 of 12 mixed erythroid colonies and 7 
out of 7 mast colonies gave cell lines whereas no colonies were 
derived from GFU-GM and BFU-E colonies (0/4). The examination of 3 
cells lines derived from mixed erythroid colonies showed them to be of 
mast cell phenotype. The conditioned media from these FI lines could 
stimulate the proliferation of FDCP-1 cells and so were releasing 
detectable levels of growth factor. Interestingly these cells were 
not tumorogenic in nude mice when 10 x 10^  cells were injected. In 
comparison, the established cell lines FDCP1 and cl-32D became 
factor independent and tumorogenic when infected with the 11-3 
retrovirus (Wong et al 1987). It is reasonable to conclude that the 
cell lines have undergone some genetic changes already which 
predispose them to tumour formation upon factor independence. 
However, factor independence on its cwn is insufficient to convert 
normal cells to the malignant state (Wong et al 1987).
It would be interesting to analyse the factor independent mast 
cell lines derived from foetal liver culture (Wong et al 1987) for 
spontaneously oceuring or induced mutations which would cause them to 
become tumourigenic. The reconstitution of haematopoiesis in lethally 
irradiated mice by bone marrow infected with a CSF retrovirus should 
provide an in  vivo answer to whether these cells have a proliferative 
advantage or not, and what further mutations are requred to generate a 
leukaemia. Once candidate genes have been identified these too
could then be introduced into bone marrow cells or cell lines alone or 
in conjunction with growth factor sequences.
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Summary
Autocrine stimulation of haematopoietic cells by colony 
stimulating factors is an attractive model whereby cells are released 
from normal growth restraints, thus creating a proliferative advantage. 
Myeloid leukaemias, like other cancers, are probably the result of 
several mutagenic events (Cerruti 1988). If a cell with uncontrolled 
proliferative capacity is the target for another mutation, for example 
in a biochemical pathway crucial for differentiation, then this 
mutated stem cells could become predominant in the population due to 
its proliferative advantage.
The demonstration by Young et al (1987) that a high proportion 
of AML cases(11 out of 22) have GM-CSF transcripts suggests a role for 
GM-CSF autocrine stimulation in the development of AML. In order to 
establish whether growth factors are involved in abnormal
haematopoiesis, further detailed studies such as that carried out by 
Young et al (1987) will have to be done. There are difficulties with 
working with such samples as the aeteology of the disease cannot
easily be characterised in terms of its molecular pathways and growth
factor involvement. The use of an In vivo or jn vitro murine system
as described by Heard et al (1984) using infection of marrow by FrMLV, 
or radiation induced leukaemias (Hayata 1983, Azumi and Sachs 1977), 
are however important in describing the steps invoved in the 
generation of leukaemia.
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Chapter 1.7.
RETROVIRUS VECTORS 
Introduction
The activities of growth factors on normal haematopoietic 
cells and their possible roles in myeloid leukaemia have been 
discussed in Chapters 1.1 to 1.6 . The molecular cloning of many of 
the CSF cDNAs and genomic sequences has allowed pure recombinant CSF 
to be produced and tested for various biological activities 
(Chap.1.2). The availability of pure growth factors is an important 
step forward in trying to understand the target cell populations and 
receptor interactions involved in CSF controlled haematopoiesis 
(Chap1.4). Another approach that can be used to study gene function 
is to re-introduce a gene into cells under the control of either its 
own promoter or a heterologous promoter sequence. This approach is of 
particular interest in view of the data on autocrine stimulation of 
haematopoieitic cells (Chap.1.6). Such cells can then be examined 
for proliferative advantage and lack of response to normal growth 
signals in comparison to exogenously stimulated cells.
It is possible to transfer genetic information into eukaryotic 
cells by several methods, the three most commonly considered being 
transfection by calcium phosphate co-precipitation (Graham and Van Der 
Ebb 1973) , electroporation (Toneguzzo and Keating 1986) and infection 
by retrovirus (Bernstein et al 1985). The chosen method must allow a 
high frequency of transfer into the clonogenic population, which, in 
the case of bone marrow progenitor or stem cells is less than 0.1% of 
the total bone marrow population (Metcalf 1984). Stable transfection 
by calcium phosphate co-precipitation is an inefficient method of DNA
ii fstransfer since one in 10-10 fibroblast cells retain and express 
the integrated transfected sequences (Peterson and McBride 1980 , 
Debenham et al 1984).
Car et al (1983) and Cline et al. (1980) used transfection to 
transfer dihydrofolate( DHFR )sequences into haematopoietic cells and 
thus conferring DHFR mediated resistance to methotrexate (MTX). Both 
groups used genomic DNA from a cell line known to be resistant to MTX 
as their starting point for DNA transfection into mouse cells which 
carried a distinct chromosomal marker which allowed bone marrow 
repopulation to be followed _in vivo. Cells exposed to DNA from MTX 
resistant cells were mixed 50:50 with normal bone marrow and then
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injected back into recipient mice. Multipotential cells which 
contained and expressed DHFR were selected In vivo by injection of MTX 
into the mice for several months. Karyotypic analysis of bone marrow 
after long term _in vivo selection demonstrated that approximately 70% 
of the bone marrow was made up of donor cells that had been exposed 
to genomic DNA from MTX resistant cells (Cline et al 1980). From this
type of analysis both groups concluded that DHFR sequences had been
transferred to bone marrow stem cells by transfection. Neither paper 
however shows any molecular data that demonstrates copy number or 
expression of the transfered sequences, and it is possible that the 
transfected cells undergo amplification of their own DHFR sequences
during such a long In vivo selection period. The authors do not 
however favour this explanation as bone marrow cells tranfected with 
"wild type" DNA had no selective advantage during MTX administration. 
Car et al (1983) also exposed fresh bone marrow to DNA from MTX
resistant cells and plated them immediately on to semi-solid media to 
reveal the efficiency of gene transfer. However no MTX resistant 
colonies were found after screening 8x 10^  bone marrow cells, and so 
if transfer of genomic DHFR sequences is occurring it must be at a 
very low efficiencey.
In contrast, Toneguzzo and Keating (1986) have demonstrated 
the stable transfer of both the bacterial neo and gpt genes by
electroporation into haematopoietic progenitor cells without in vivo 
selection. Recovery of human bone marrow after electroporation gave 
an almost 100% recovery of CFU-GM progenitors which were 
indistinguishable from control colonies. This therefore is ideal as a 
method of transfer which does not interfere with viability or 
development. The plasmid pSV7 neoept can be used to select for G418 
resistance or mycophenolic acid (MPA) resistance, after 
electroporation of bone marrow cells ( Toneguzzo and Keating 1986). 
Resistant colonies grew under selection at a frequency of 0.8 to 2.7% 
( Toneguzzo and Keating 1986). Gene transfer was further demonstrated 
by RNA dot blot analysis of pooled MPA resistant colonies. The 
observation that colonies grown in the presence of MPA were 
predominantly macrophage wheras G418 resistant colonies were 
indistinguishable from normal granulocyte/macrophage colonies is of 
interest.
Although these authors demonstrated a low frequency of gene
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transfer into haematopoietic cells ( Toneguzzo and Keating 1986), 
efficient transfer has only been possible using retroviral vectors 
(Gilboa 1986).
Retroviral Vectors
The most common method for the transfer of genetic information 
into eukaryotic cells is calcium phosphate co-precipitation.Stable 
integration of exogenous DNA into the cellular genome by calcium 
phosphate co-precipitation (Graham and Van Der Ebb 1973) has several 
drawbacks:-
i) It is inefficient with only a small proportion of cells 
transformed under optimal conditions (Debenham et al 1984).
ii) Very few established cell lines can be transformed with a high 
efficiency (Mulligan 1983).
iii) Often the transformed lines contain multiple copies of the
newly introduced sequences (up to several hundred) per cell (Mulligan 
1983, Wigler et al 1979).
It is therefore difficult to assess how many of these are active and 
non-mutated (Lebkowski et al 1984).
iv) The precise mechanism by which cells take up and retain the
DNA is unknown (Lebkowski et al 1984).
In comparison, the increasing understanding of the retroviral 
life cycle has made retrovirus ideal candidates for gene transfer 
vectors.A number of advantages are outlined below
i) Infectious virus integrates into the host genome with high 
efficiency (Mulligan 1983).
ii) Virus integration results in a predictable proviral structure
(e.g. cell-LTR-gene-LTR-cell) (Mulligan 1983» Gilboa 1986).
iii) Low copy numbers (often only one) of proviral sequences occur 
per cell (Mulligan 1983).
iv) Gene transfer into a wide variety of cell types is possible 
(Stocking et al 1^ 86, Cone and Mulligan 1984, Kwok el al 1986)
Retroviral Life Cycle and Genome Structure
A schematic representation of the retrovirus life cycle is 
shown in Fig.1.3. After absorption of the virus to the cell membrane, 
the viral RNA genome enters the cell, where the viral RNA genome is 
reverse transcribed into a double stranded circular DNA molecule which
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Figure 1,3
This figure is reproduced from Price (1987). 
The retroviral life cycle. This figure is a 
schematic diagram of the life cycle of a typical 
wild-type retrovirus. The retroviral particle is 
adsorbed on to the cell plasma membrane by the 
binding of its envelope surface glycoproteins to a 
specific surface receptor. Following fusion, the 
retroviral genomic RNA passes into the cytoplasm, 
and is reverse transcribed into DNA, gains entry 
into the nucleus and as a proviral particle 
integrates randomly into the host cell chromosomal 
DNA. The integrated provirus acts as a typical 
chromosomal DNA in that it is inherited by both 
daughter cells whenever the cell divides. The 
provirus is also transcribed and the retroviral 
genes are translated, using the cell’s normal 
machinery. The assembly of a new retroviral 
particle completes the life cycle. The genomic 
retroviral RNA transcript comes together with the 
retroviral gene products and buds off to form a new 
free retroviral particle.
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integrates into the host genome in a precise manner (Weiss et al
1985). The integrated virus, termed to provirus can be transcribed 
and packaged by viral and cellular proteins to become an infectious 
viral particle which is shed from the cell (Weiss et al 1985).
The proviral genome consists of three genes, gag, pol and env, 
bounded by two identical stretches of sequence termed the long 
terminal repeats (LTRs) (Weiss et al 1985). The gag gene encodes a 
virion structural protein, the pol gene is responsible for the reverse 
transcriptase activity and the env gene encodes an envelope 
glycoprotein involved with virus absorption and penetration (Weiss e£ 
al 1985). Expression of these proteins is essential for the 
replicative life cycle of the virus and it is the promoter and 
enhancer regions found within the LTR which control their expression. 
The LTRs are always generated upon genome integration and are required 
for the integration event to take place (Weiss et al 1985). A 
provirus lacking any gag, pol or env sequences cannot complete a 
replicative cycle on its own but it can utilise these gene products if 
supplied in trans by a helper virus (Mulligan 1983). By definition a 
helper virus must be replication competent. Co-infection of a cell 
with both a helper virus and a replication deficient virus will allow 
the replication deficient virus to complete its life cycle with the 
aid of the products supplied in trans by the helper virus (Mulligan 
1983).
The provirus generates two polyadenylated messenger RNAs 
(mRNAs) (Mulligan 1983). A full length proviral transcript initiated 
on the 5’ LTR and terminating on the 3' LTR contains a complete copy 
of the viral genome whereas a spliced message derived from this, 
essentially encodes env sequences (Mulligan 1983). It is only the 
full length genome transcript which is efficiently packaged into 
infectious viral particles (Mulligan 1983). Packaging of viral RNA 
into virus particles is in the main directed by sequences at the 5* 
end of the genome, termed the region (Mulligan 1983 f Mann et al
1983).
Retrovirus Vector Systems
The features of the retrovirus life cycle described above make 
retroviruses a suitable candidate for a gene transfer system 
(Mulligan 1983) which can be split into two parts; vector design and
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packaging cell lines. Vectors can be generated by removing varying 
amounts of viral .gag, pol or env information and replacing it with the 
gene of interest (Cepko et al 1984, Weiss et al 1985). This gene will 
then be transferred into the target cell as if it were a viral 
sequence (Mulligan 1983). The vector must retain the sequence 
found adjacent to the 5' LTR in order to be packaged into infectious 
virus when the proteins required for replication are supplied _in trans 
(Mann et al 1983). Vector design will be discussed in more detail in 
a following section.
Packaging Cell Lines
A second part of the vector system is the packaging cell line 
(Mann e£ al 1983). These are all fibroblast (3T3) cell lines which 
harbour retrovirus deleted of a cis region required for viral 
encapsulation but which express all the viral proteins required for 
viral replication (Mann et al 1983? Mulligan 1983).
Introduction of retroviral vectors into such packaging cell 
lines will result in the vector being encapsulated and released into 
the culture medium (Mann et al 1983). This virus can then be used to 
infect target cell populations (Cepko et al 1984). The use of helper 
free virus avoids the possibility of virus spread and any biological 
effects of the helper virus, a situation which may also arise due to 
endogenous virus in murine systems (Weiss et al 1985). The spread of 
helper virus may also render infected cells refractory to subsequent 
super-infection by retroviral vectors (Weiss et al 1985).
The two most commonly used packaging cell lines are the 2 
(Mann et al 1983) and PA137 lines(Miller and Buttimore 1986) . The
V2 line was constructed by Mann et al. (1983) by transfecting a
deletion mutant of MoMuLV into 3T3 fibroblasts. This virus had a 350 
nucleotide deletion between the putative 5’ splice donor site and the 
AUG that initiates the coding sequence. The reverse transcription 
assay is a sensitive method for the detection of virus expression
(Mann et al 1983). ^ 2  cells shew reverse transcriptase activity
whereas viral particles fromS^2 cells do not. It can therefore be 
concluded that the defective helper virus mutated in the sequence 
cannot be efficiently packaged. In order to test whether the Y2 line 
could package replication defective virus (which still retained^
sequences), a plasmid containing a MSV derivative was transfected into
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it. The MSV construct used contained the gpt dominant selectable 
marker, and thus if infectious virus was released from the Y2 cells 
then infection of 3T3 fibroblast cells should result in XGPRT 
resistant colonies. Resistant colonies were observed at a frequency 
of approximately 5 x 10^  gpt+ cfu per millilitre of virus suspension.
Retrovirus particles enter cells via a interaction between the 
virally encoded env protein and cellular receptors(Weiss et al 1985) . 
The MoMLV helper virus within Y2 cells expresses ecotropic viral 
envelope protein which recognises a receptor only present on mouse and 
closely related rodent cells (Weiss et al 1985). Therefore ^ 2 cells 
can only be used to infect a limited number of species. There are 
however related viruses which, as a consequence of differences in 
their env genes, can infect a wider variety of species ( Weiss et al.,
1985) including human cells. The two most common packaging cell lines 
with expanded host range infectivity are calledt&m (amphotropic) (Cone 
and Mulligan 1984) and PA137 cells (Miller and Buttimore 1986). These 
cell lines were constructed in a similar way to the Y 2 line (Mann et 
al 1983), by transfection of packaging defective virus into 3T3 cells 
and selecting clones which did not release helper virus. Transfection 
of viral vector into packaging cell lines caused a minority of clones 
to release helper virus (Miller and Buttimore 1986). This is
presumably due to a recombination event between the "endogenous"
packaging defective replication competent virus and the packaging 
competent vector (Miller and Buttimore 1986). In order to reduce 
the possibility of such an event occurring, Miller and Buttimore 
(1986) constructed the PA137 cell line by introducing a packaging 
defective virus into the 3T3 cells which also carried a nunber of
other deletions and replaced the right hand LTR with the SV40
polyadenylation signal . The resultant plasmid has all the necessary 
information for expression of viral gene products but had 
significantly less homology to sequences with which the viral vector 
could recombine with to generate packagable replication competent 
virus (Miller and Buttimore 1986).
Vector Design
There are three basic vector designs. Each vector may carry a 
selectable marker gene which enables infected cells to be identified 
and cloned (Bernstein et al 1985). The first of these vectors is
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termed a double expression vector (Gilboa 1986) as described by Cepko 
et al (1984) . As described previously, viral genes are normally 
expressed from two RNA species, a full length viral genomic transcript 
and a spliced subgenomic product (Mulligan 1983). Double expression
vectors retain the identified sequences for the splice donor and
acceptor sites but replace the viral genes with two foreign genes
(Gilbo 1986). Thus one gene is expressed from the full length mRNA,
while the other is expressed from the sub-genomic message (Gilbo
1986). It is of course possible to express both genes form the full 
length transcript (Peabody and Berg 1986) but efficient expression of 
the second gene requires translation of the spliced message (Peabody 
and Berg 1986). The pZip neo vector designed by Cepko et al (1984) is 
of this type and before any foreign sequences are cloned into it, 
there is a one to one ratio of genomic to sub-genomic message. 
However, ligation of either c-mvc (Cory et al., 19S7) or murine GM-CSF 
(Lang et al 1985) into the vector resulted in a decrease of up to 50% 
of the sub-genomic message in infected cell. It is thus possible that 
some sequences may inhibit splicing, and so reduce the efficiency of 
expression of the 3' gene. It is now quite clear that sequences other 
than those of the splice donor and acceptor sites are required for 
accumulation of spliced message (Miller and Temin, 1986; Hwang et al.,
1986) and the absence of these from double expression vectors could 
contribute to the poor expression of spliced mRNA in sane constructs 
(Cory et al., 1977 Lang et al 1985). Gene expression in double
expression vectors is controlled by the viral LTR and therefore 
expression is limited to cells in which this LTR is active (Stocking 
et al 1986). The variation in expression between different promoters 
will be discussed shortly.
A second basic type of vector expresses one gene from the 
viral LTR and a second gene form an internal promoter and thus does 
not rely on splicing to achieve efficient expression of both genes 
(Gilboa 1986). An example of this type of vector is pV200neo 
(Episkopou et al 1984). This vector has an internal TK promoter from 
Herpes simplex virus, in this instance linked to the bacterial neo. 
gene which confers resistance to the antibiotic G418 in eukaryotic 
cells (Jimenez and Davis 1980). The foreign DNA is expressed from the 
viral LTR (Gilboa 1986). Such vectors allow a choice in the promoters 
used to express the transduced gene and therefore more control can be
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excercised over gene expression (Episkopou et jal 1984). 
Unfortunately however some promoter sequences may be inhibitory to the 
virus life cycle and so become deleted in order for the virus to 
complete replication and infection (Bernstein et al 1985). Emmerman 
and Temin (1984q<;1986) have also noted that selection for expression 
of one gene within dual promoter vectors may reduce expression of the 
second transcriptional unit. This will be discussed in more detail 
later.
Self inactivating (SIN) vectors are the third basic form of 
vector (Gilboa 1986). The viral LTRs contain transcriptional enhancer 
elements which can influence gene activity (Weiss et al 1985). For 
example the integration of a retrovirus adjacent to a cellular
oncogene can disturb its normal expression pattern (Neel et al 1981), 
therefore if retroviruses are to be used in somatic cell therapy in 
humans the activation of cellular oncogenes by retroviral enhancer 
elements must be avoided. In order to study the control sequences of 
genes, putative control segments can be introduced into recipient
cells and their activity monitored (Cone et al 1987). If such 
sequences are sub-cloned into the vector in the same orientation as
the LTRs, then the full length mRNA from the LTR may cause any
observed gene activity rather than the putative control sequences 
under study. One solution is to orientate the sequences under study 
in the opposite direction to the viral LTRs (Episkopou et al 1984). 
This approach has been used successfully to study tissue specific gene 
expression (Episkopou et al 1984) and an inducible promoter (Miller et 
al 1984). However, viral enhancer elements could still influence some 
internal promoters irrespective of insert orientation (Yee et al 
1987).
The availability of SIN vectors is an important advance in 
retrovectorology since they were designed in an attempt to circumvent 
the problems associated with viral enhancers (Gilboa 1987). SIN 
vectors contain a small deletion in the 3f LRT encompassing either the 
viral enhancer sequences (Cone et al 1987) or the enhancer/promoter 
region (Yee et al 1987). These viral transcriptional control elements 
are situated in the U3 region of the virus (Weiss et al 1985). During 
viral replication the 31 U3 region becomes duplicated such that the 
resulting provirus has two U3 regions at either end of the provirus as 
part of the LTRs (Weiss et al 1985). Any deletion made in the 3' U3
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region will therefore be duplicated after replication and integration 
in the 5’ LTR (Weiss et al 1985, Gilboa 1986). Such provirus are 
transcriptionally silent due to the lack of appropriate control 
elements (Gilboa 1986, Weiss et al 1985).
The original plasmid vector to be transfected into the 
packaging cell line only contains a deletion in the 3* U3 region as 
full length transcripts originating from the 5* LTR are required to 
generate infectious virus (Gilboa 1986, Weiss et al 1985). One SIN 
vector, SVXenh-, is deleted of enhancer sequences (Cone et al 1987). 
It is therefore possible that sequences inserted into this vector 
might activate the promoter sequences (Cone et al 1987, Yee et al 
1987). The pRMH SIN vector (Yee et al 1987) has a deletion which 
spans both the promoter and enhancer region and is therefore a better 
candidate for a true self inactivating vector.
Problems Associated with Retroviral Vectors
Vectors containing sequences which mav interfere with normal virus 
replication.
In order for infectious virus particles to be generated, the
virus must transcribe a mRNA which extends from the left hand LTR to
the right hand LTR. Any sequences inserted into the vector which
interferes with this, will result in inefficient or non-existant virus 
particle formation.
Emerman and Temin (1984 B) constructed retrovirus vectors
based on the avian spleen necrosis virus (SNV) which included the
herpes simplex virus thymidine kinase (tk) gene, complete with its 
heterologous promoter. Between the tk selectable marker gene and the 
left hand LTR, a mouse aglobin gene with(promoter*) or 
without(promoter-) its heterologous promoter sequences was inserted. 
These constructs were transfected into tk- chicken fibroblast cells 
together with helper virus and tk+ cells selected for. Following 
infection of fibroblast cells with virus supernatant, unintegrated 
virus was isolated after 3 days and its structure determined by
Southern blot analysis. Eleven virus producer clones which shed the 
aglobin promoter+ construct, released virus of varying sizes of which 
eight released virus containing deletions in comparison to expected
viral size. In comparison the seven a globin promoter- producer
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clones shed virus of the expected size.
Two a globin promoter+ clones which shed deleted virus 
were analysed in more detail and the deletions were mapped. The two 
deletions were found to be of different sizes but in both cases the 
entire coding region of the a globin gene was deleted. One deleted 
virus, (ME107) was cloned and sequenced revealing the loss of both the 
globin structural gene and the transcriptional control sequences. The 
deleted ME107 virus was compared to the parental globin promoter + 
virus in terms of conversion of the tk- fibroblasts to tk+. These 
results demonstrated that the deleted virus had a higher tk+ 
transforming abiblity (10 fold higher after normalisation for virus 
production).
The experiments described above imply that certain sequences 
may be incompatible with viral replication under certain selective 
conditions. Emerman and Temin reported "data not shown" to the effect 
that globin promoter+ vectors which are not selected for tk+ 
expression do not undergo rearrangements. It is therefore possible 
that efficient expression of the tk gene in the presence of the 
globin promoter requires deletions in the globin gene.
The polyadenylation signals of HSV and SV40 have also been 
associated with vector instability (Joyner and Bernstein, 1983). The 
insertion of such sequences within retroviral constructs may cause 
premature polyadenylation of the putative full length viral genomic 
mRNA. The prematurely terminated mRNA may be unable to complete the 
retrovirus life cycle and so virus titre would be low. Joyner and 
Bernstein used vector constructs which contained either the HSVtk gene
or the bacterial neomycin gene (neo). The neo gene was flanked by
SV40 promoter and polyadenylation signals while the HSVtk gene 
retained its endogenous control signals. Sogner and Bernstein found 
that the generation of infectious virus that could confer either the 
tk+ phenotype or neo resistance was associated with deletions in the 
polyadenylation sequences of the selectable markers. Thus the 
presence of these sequences required for post transcriptional
modification appears to be incompatible with infective virus.
Spleen necrosis virus (SNV) vectors have been constructed 
containing the chicken cellular tk gene complete with its own promoter 
and polyadenylation sequences (Brandyopadhyay and Temein, 1984).
Virus production and expression has been shown to differ depending on
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the orientation of the tk gene with respect to the viral LTRs. When 
the tk gene was in the same orientation (parallel) as the LTRs, virus 
production was very poor, which was attributed to deletions in the tk 
gene. In contrast, when the tk gene was in the opposite orientation 
(antiparallel) to the viral LTRs, viral production was inefficient 
although the transforming activity was greater than tk in the parallel 
orientation. The virus generated from the antiparallel construct did 
not have any gross rearrangements. The lower level of virus release 
observed in the antiparallel construct in comparison to the parallel 
construct could perhaps be due to transcriptional interference. 
Depending on the relative strengths of the SNV LTR promoter and the tk 
promoter the converging transcripts may interfere with the production 
of full length transcripts and thus reduce virus production. 
Antiparallel constructs modified by Bal31 deletion of the tk promoter 
region resulted in increased virus titres at the expense of tk 
transforming activity. However Miller et al. (1984) have constructed 
retrovirus vectors with a rat growth hormone minigene in both 
transcriptional orientations, both of which give virus producing 
clones of equivalent titre. It is difficult to generalise as to what 
sequences will cause vector instability and each vector may have to be 
considered as unique until its behaviour in terms of virus production 
and gene expression have been tested.
Epigenetic Suppression of Gene Activity in Retrovirus Vectors
The occurence and problem of gross deletions in retroviral
vectors has been discussed in the above section. Distinct from this 
type of mutation is epigenetic supression. This does not involve 
mutation at nucleotide level but is related perhaps to changes in 
chromatin structure or methylation states of genes.
Emerman and Temin (198^ have generated SNV based vectors
which contain two selectable markers under control of two promoters. 
One promoter is always the SNV LTR, the other the tk promoter from HSV 
(Emerman and Temin 1984). The selectable markers are tk activity (HAT 
media) and resistance to G418 (neor) (Emerman and Temin
1984^ . Infected fibroblasts were selected for either tk+ phenotype or 
f\€ter, and individual clones were then re-plated under selection for
the "untested" gene. Colony formation was compared to unselected
cells or cells selcted for neor were replated in HAT (requires
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expression of tk gene). Of 12 neor clones treated in this way, 7 
failed to re-pi ate in HAT media, while the other 5 had a range of 
efficiencies from 1-9%. Similarly clones initially selected for tk+ 
expression failed to re-plate efficiently when transferred to G418. 
However two clones were identified which did re-plate well in G418. 
The apparent inability of cells selected to express one gene within 
the vector to express the second gene was also obvious when growing 
colonies were marked in the tissue culture plate and subjected to a 
change of selection conditions. It was observed that after changing 
the media up to 75% of the clones died.
Southern blot analysis of infected cells did not reveal any 
gross rearrangements of the provirus and so suppression of the second 
selectable gene could not be attributed to large deletions or 
rearrangements of the unselected promoter. Emerman and Temein 
reasoned that if the suppression was a permanent mutational event, 
then the rescue of provirus from tk+ cell lines that re-plated poorly 
into G418 media, would, in a subsequent infection give rise to few 
G4l8r colonies but many HAT colonies. If, however, the suppression 
was epigenetic then rescue of the provirus via a helper virus would 
result in a virus population that could transform cells to a tk+ or 
G4l8r phenotype at the same frequency as the parental virus stock. In 
fact, the latter result was obtained and virus rescue was assumed to 
release the provirus from a particular chromatin configuration which 
had previously caused the epigenetic suppression. The approach, of 
rescuing integrated virus in order to prove that an effect is not 
mutational has one fault however, since that any mutations in the left 
hand LTR U3 region will not be passed on to the rescued viral 
transcript. Therefore if suppression was due to point mutations in 
the left hand LTR U3, the resulting virus stock would not carry this.
It is of interest that the internal tk promoter is less 
efficient at suppressing activity of the SNV LTR promoter than vice 
versa. Emerman and Temin suggest that the SNV LTR is a stronger 
promoter in fibroblast cells than the tk promoter and thus can 
suppress expression of the tk promoter to a greater extent. By using 
constructs with various other internal promoters, Emerman and Temin 
(1986) demonstrated that epigenetic suppression at the biological 
level could not be observed of the internal unselected promoter was 
either mouse metallothionein I (MTI) or SV40 early promoter. However,
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analysis of viral transcripts did show a reduction in the steady state 
mRNA from these promoters, concomitant with a reduction in protein. 
The drop in biochemical levels of the unselected proteins must then
still be above a threshold level requred to allow cells survival upon
switching of selective conditions.
The observations by Emmerman and Temin (1984^ ( 1986) have
obvious implications for the construction of retrovirus vectors. It
would be desirable to prevent epigenetic suppression so that 
retrovirus vectors can express a nonselected gene efficiently . It is 
possible that this phenomenon may be restricted to SNV based vectors 
as there are no other reports of epigenetic suppression from other 
groups, although this does not mean it is not occurring but merely 
unobserved under the designs of specific experiments.
Retrovirus Infection and Expression in Haematopoietic Cells
Retrovirus vectors have been used successfully to transfer 
genetic information into cells from many species including human and 
mouse (Gruber et al., 1985; Hogge et al., 1987; Williams et al. f
1984) A distinction must be made however between virus infection and 
virus expression. It is possible to infect 100% of a haematopoietic 
stem cell population (CFU-S) (Lemischka et al., 1986; Dick et al.,
1985) and the mature progeny of stem cells as determined by detection 
of viral sequences by Southern blotting but this reveals nothing about 
the transcriptional activity of the vector.
Semi-solid assays for progenitor cells have been used to
quantitate virus infection as transfer and expression of a dominant 
selectable marker in such assays will permit colony survival under 
selective conditions. An early attempt to transfer a neor gene was
successful in converting 0.3% of the CFU-GM progenitors to neor
(Joyner et al., 1983)* This has subsequently been improved upon to
yield up to almost 100% neor CFU-GM colonies (Magli et al., 1987).
The detection of gene expression in haematopoietic cells will 
depend on several factors. If selection is dependent on achieving a
particular level of an enzyme to overcome a selective drug, then 
different optimal levels of expression may be required for different 
selection systems. Thus the number of methotrexate resistant colonies 
may differ from the number of G418 colonies after infection by virus 
containing the DHFR and neo genes respectively (Hock and Miller, 1986;
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Kwok et al.. 1986). Kwok et al(1986) determined the number of CFU-GM
that could produce infective virus after infecting bone marrow with a 
retrovirus vector in the presence of helper virus. They demonstrated 
that 10 fold more colonies released virus than could form colonies 
under selection for methotrexate. Thus viral expression was sufficient 
to produce viral particles but not sufficient to confer resistance to 
methotrexate. It is clear from the above examples that "expression” 
varies with the method of detection.
It is possible that although cells may be permissive for 
infection, a sub-population may not permit expression, (Anklesaria 
et al. 1987). Viral integration into the host chromosome is 
essentially random but may be associated with regions of open 
chromatin configuration such as the 5f end of active genes (Vijaya et 
al 1986). However, methylation of DNA is generally associated with 
gene inacitvity and provirus have been shown to be hypermethylated and 
transcriptionally inactive in several cells types, such as embryonal 
carcinoma cell lines and mouse embryos(Jahner and Jaenisch 1985, 
Stewart et al 1982). It is likely that these early undifferentiated 
cells preferentially shut off viral transcription by methylating the 
viral genome (Jahner and Jaenisch 1985, Stewart et al 1982) or trans 
acting proteins present in the cells repress the viral promoter 
(Gorman et al 1985). The active repression of virus expression in 
undifferentiated multipotent cells may be an important consideration 
in the infection of haematopoietic stem cells.
It is the viral enhancer/promoter region which is
responsible for provirus transcriptional activity (Weiss et al 1985). 
This level of transcription may then be modulated according to 
chromosomal position effects (Wyke jet al., 1987), tissue (Magli et
al., 1987; Kwok et al., 1986) or differentiation state differences.
Mo-MuLV based vectors have been shown to express dominant selectable 
markers efficiently in progenitor type colonies formed during .in vitro 
assays (Lim et al., 1987; Magli et al., 1987). However, demonstration 
of viral expression in CFU-S colonies derived from infected doner 
marrow has been somewhat elusive. Williams et al. (1986) and Mclvor 
et al. (1987) both transferred retrovirus vectors containing the human 
ada gene into CFU-S but failed to detect expression of the ada. gene at 
the protein level. Williams et al(1986) demonstrated virus specific 
mRNA at extremely low levels in CFU-S colonies. Interestingly an SV40
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virus promoter included in their retroviral construct is not utilised 
and only full length viral RNA from the LTR was detectable. Lim et 
al. (1987) expressed the ada gene from the human phosphoglycerate
kinase (PGK) gene promoter within a MoMLV based vector and did show 
Ada protein activity in mouse CFU-S colonies.
It is becoming clear that the expression of genes within
haematopoietic cells is dependent on the promoter used (Magli et al
1987). Magli et al(1987) have screened a number of vectors
containing different viral enhancer/promoter elements for expression
in haematopoietic cells and shown that although SV40 sequences are 
efficient in fibroblast cells it is a poor promoter in haematopoietic 
cells. However the thymidine kinase promoters from HSV was relatively 
efficient.
The systematic search for promoters which can operate in
extremely specialised cells such as haematopoietic stem cells is
important. Retrovirus particles are capable of infecting stem cells
and integrating into the host genome as discused above, but most
retrovirus vectors rely on MoMLV enhancer/promoter sequences for 
expression (Williams et al. 1986, Mclvor et al. 1987). The MoMLV 
virus quite clearly does not express well in stem cells (Williams et 
al. 1986, Mclvor et al 1987) and so other promoters must be used. To 
this end both the tk (Magli et al 1987) and pgk promoters (Lim et al
1987) and retroviral enhancers related to MoMLV such as the
myeloproliferative sarcoma virus (MPSV) enhancer (Stocking et al
1986), are of interest. Vectors based of MPSV will be discussed in 
the results section. Also of interest is a viral enhancer sequence
related to polyoma virus which is specifically active in haematopoitic 
cells but not in fibroblasts or epithelial cells (Mosthaf et al 1985),
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AIMS OF THIS THESIS
A central aim of this thesis was to study autocrine 
stimulation by GM-CSF on haematopoieitc cells in terms of factor 
independent colony formation. In order to do this, two retrovirus 
vectors containing GM-CSF sequences were used. One of these, 
mos”^neoGM (kindly provided by Dr. W. Ostertag) was used to subclone 
GM-CSF sequences in a second retrovirus vector pVneoGM.
The use of these vectors was designed to allow two approaches 
to the investigation of expression of exogenous sequences in 
haematopoietic cells, in the hope of overcoming technical difficulties 
experienced in previous studies (Williams et al 1986; Mclvor et al.
1987). An added advantage of this approach was the possibility of 
making direct comparisons between two vecors differing both in the 
virus of origin and mode of gene expression.
The question as to how these vectors are expressed of the in 
fibroblast cells lines was also addressed. Both molecular and 
cellular techniques were adopted in order to relate molecular 
expression to growth factor/haematopoietic cell interaction. This 
work was considered to be of particular importance since it is only 
once vector expression is established and repeatable in a predictable 
manner that more complex manipulations, such as infection of primary 
cells, can be carried out with any conviction that the phenotypic 
effects observed are due to vector expression.
Finally, optimal conditions for the efficient infection of 
primary bone marrow cells were examined with specific emphasis of 
modifications which may effect retroviral-mediated expression of 
GM-CSF.
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MATERIALS AND METHODS
1. Bacterial Strains
The bacterial strains used in this study were E.coli HB101 and 
JM83. Strains in current use were maintained on Luria agar plates at 
4%. For long term storage, frozen cultures of each strain were 
prepared in nutrient broth containing 30% v/v glycerol and stored at 
-80%.
2. Media and Antibiotics
L-broth: 1% (w/v) tryptone, 0.5% (w/v) yeast extract, 1% (w/v) 
sodium chloride. Ampicillin was included when required at 100pg/ml. 
L-agar: L-broth containing 1.5% agar.
Top agar/X-gal: L agar containing lOOpg/ml ampicillin and
250)ig/ml X-gal.
3. DNA manipulation. General Techniques
(a) Handling of DNA
When handling DNA disposable gloves were worn, all buffers, 
reagents, glass and plastic ware was sterilised by autoclaving and all 
glassware coming into contact with DNA was siliconised. Many of the 
techniques used are modified versions of those described in Maniatis 
et al. (1982).
(b) Phenol Extraction
DNA solutions were mixed with an equal volume of phenol, 
chloroform, isoamyl alcohol, 8 - hydroxyquinoline (100:100:4:0.4; 
w:v:v:w) saturated with 10mM Tris-HCl, pH7.5, 1mM EDTA. The upper 
aqueous phase containing the DNA was removed and the phenol layer 
re-extracted with an equal volume of 10mM Tris -HC1, pH7.5, 1mM EDTA. 
The phenol was AR grade.
(c) Ethanol precipitation
DNA was precipitated from solution by the addition of 0.1 
volume of 3M sodium acetate, pH6.5 or a 0.5 volume 7.5M ammonium 
acetate and 2.5 volumes of ethanol. The mixture was chilled for 20min 
at -2Q6C before precipated DNA was pelleted either using a Sorvall HB4 
rotor (13,000rpm, 15min, 4°C) or an Eppendorf microfuge for 15min at 
maximum speed. The supernatant was then discarded, the pellet washed 
in 70% ethanol and re-centrifuged. DNA was dried under vacuum and
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redissolved as appropriate for further manipulation.
Preparation of plasmid DNA
For solutions and buffers used see table 2.1.
(a) Rapid plasmid preparation for screening
1.5ml of a culture of bacteria grown overnight in nutrient 
broth plus the appropriate antibiotic(s) was transferred to an 
Eppendorf and centrifuged for 3min in an Eppendorf microfuge. Cells 
were resuspended in 100]il of TEG buffer and incubated at room 
temperature for 10min. 200pl of alkaline SDS solution was added and 
the contents of the tube mixed by several sharp inversions, followed 
by 5min incubation on ice. 150pl of potassium acetate was then added, 
the solution was gently mixed and left for 5min on ice. The 
chromosomal DNA was pelleted by centrifugation for 5min at 4°C and the 
supernatant removed using a Gilson P200 pipette. Plasmid DNA was 
recovered by phenol extraction and ethanol precipitation. The pellet 
was washed in 70% ethanol, dried under vacuum and resuspended in 50]il 
TE buffer. RNA was removed by incubation with Ribonuclease A 
(20pg/ml) for 30min at 37®C.
(b) Large scale plasmid preparation (Clewell and Helinski 1Q70)
A 400ml culture in L-broth containing the appropriate antibiotics was 
grown to stationary phase at 37°c overnight in a shaking incubator. 
Cells were harvested and resuspended in 10ml 50mM Tris pH8/25% sucrose 
and 5ml lysozyme(10mg/ml) added. The mixture was incubated on ice for 
20minutes. 5ml of 0.2M EDTA pH7-5 were added, the solution mixed and 
left for 20 minutes on ice. 0.6ml of 10% NP40 in Tris/sucrose was 
then added and the tube inverted until lysis was complete. The lysate 
was then cleared in a Sorvall GSA bottle using a Sorvall SS34 rotor, 
(15000 rpm, 30mins., 4®C). The supernatant was decanted carefully
into a 50ml Falcon tube, an equal volume of phenol added and then 
mixed for 10 minutes. The solution was then spun at 3000rpm for 20 
minutes at room temperature in a bench centrifuge, and the aqueous 
phase recovered. The aqueous phase was re-extracted with an equal 
volume chloroform. The aqueous phase was recovered by centrifugation 
and RNA removed by ribonuclease A treatment (20]ig/ml, 30minutes, 
37“°C)* Ribonuclease A activity was removed by phenol/chloroform 
extraction, and plasmid DNA precipitated by the addition of two 
volumes ethanol. The pellet was washed in 70% ethanol and resuspended
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in 500]il water.
5. Ligation
Restricted plasmid vector DNA and fragments for ligation were 
mixed in a 1:3 molar proportion. Total DNA concentration was usually 
between 5-50 jig/ml in a 10-20]il total volume. 1/10 volume of 10 times 
concentrated ligation buffer (table 2.2) and 1pl of T4 DNA ligase were 
added and the mixture incubated overnight at 15cC. T4 DNA ligase was 
obtained from New England Biolabs.
6. Alkaline Phosphatase treatment of linear, plasmid vector DNA 
To minimise recircularisation of plasmid DNA, 5’ phosphates
were removed from both ends of linear DNA by treatment with calf 
intestinal phosphatase (Ullrich et al., 1977). Digested vector DNA
was phenol extracted and precipiatated with ethanol before the DNA was 
resuspended in a minimum volume of 10mM Tris-Cl, pH8.0. 1/10 volume
of 10 times concentrated CIP buffer (see table 2.2) and 1jil of calf 
intestinal phosphatase was added. The mixture was incubated at 37^ 0 
for 30min and the reaction stopped by phenol extraction.
7. Transformation of bacteria with plasmid DNA (Cohen et al.
m2i
(a) Preparation of competent cells
Stationary phase cultures of E.coli were diluted in nutrient 
broth to an A450 of less than 0.01 and grown rapidly with good 
aeration to mid-exponential phase (A450 = 0.3-0.5). Cultures were 
immediately placed on ice before 10ml of these cells were harvested by 
centrifugation for 3min at 4,000rpm in an M.S.E. chillspin. Cell 
pellets were resuspended in 5ml of ice cold 100mM MgC^, harvested as 
described above and resuspended in 5ml of ice cold CaC^. The cells 
were kept on ice for 20min before centrifuging as before and 
resuspending in 600]il of ice cold 100mM CaC^. Cells were then kept 
at 4°C for a minimum of 1h before use and were used within two days.
(b) Transformation
200jil of the prepared competent cells were incubated on ice
for 1h with 10-500ng of plasmid DNA. After a 2min heat shock at 42cC 
the bacteria were added to 2ml of prewarmed nutrient broth in a 25ml 
flask without shaking. Undiluted culture and culture diluted to 10“1 
and 10“  ^ were spread on nutrient agar containing the necessary
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antibiotics to select for plasmid transformed cells.
8. Agarose Gel Electrophoresis
Horizontal slab agarose gels (0.5-1% w/v) were prepared using 
BRL analytical agarose in TAE or TBE buffer, (table2.3). Ethidium 
bromide was added to both gel and running buffer to a concentration of 
0.5pg/ml. All samples were mixed with 1/6 volume agarose gel sample 
buffer before loading (see table 2.3). Electrophoresis was carried 
out with the gel completely submerged in electrophoresis buffer at 
25-100V, until the dye front had migrated through 3/4 of the gel. DNA 
was visualised by transillumination with long wave (260nm) UV light. 
A DNA restricted with Hindlll was used to supply molecular weight 
markers and gave sizes of 23kb, 9.4kb, 6.5kb, 4.4kbh, 2.3kb 2.0kb,
0.5kb and 0.1kb respectively.
9. Restriction enzvme digestion of DNA
Digests were performed in sterile 1.5ml Eppendorf 
microcentrifuge tubes according to the enzyme supplier’s
specifications in the recommended buffers.
10. Agarose gels for Southern blot analysis
Restriction enzyme digests of genomic DNA (20pg per lane) were 
electrophoresed in 0.7% (w/v) agarose gels (19*5 x 14.5 x 0.5cm) with 
TAE buffer at 25V overnight.
11. Agarose gels for Northern blot analysis
1.4% (w/v) agarose gels (19.5 x 14.5 x 0.5cm) were prepared by 
dissolving 2.8g of agar in 145ml of water in a microwave oven. When
cooled to 60^ 0, 35.8ml of formaldehyde and 20ml of 10 times MOPS
buffer (table2.3)j were added and the gel poured. RNA samples were
freeze dried, redissolved in 20jil of RNA loading buffer, plus 2pl gel 
sample buffer(table2.3), heated to 65'^ c/10minutes, loaded and 
electrophoresed at 2V/cm for 10-I6h at 4°C in 1 times MOPS buffer.
12. Isolation of DNA fragments from agarose gels
After digestion with the appropriate restriction enzymes, DNA 
was electrophoresed in a 1.0% low melting point agarose gel. Bands 
were visualised under long wave UV light and the required band excised
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from the gel. 2-3 volumes of H20 were added to the gel slice and the 
mixture was heated at 70°C until the agarose melted. After rapid 
cooling on ice, phenol was added, the mixture was vortexed and 
centrifuged (2,500rpm, 5min). The supernatant was removed and phenol 
extracted until the interface was clear before DNA was precipitated by 
the addition of ethanol.
13. Hybridisation analysis of DNA and RNA (Manniatis et al. 1Q82)
Hybridisation analyses were performed essentially as described
in the GeneScreen hybridisation instruction manual (NEN, 
Boston).Solutions used are shown in table 2.4.
(a) Southern blot transfer of DNA
DNA samples were electrophoresed and transferred by the 
Southern (1975) method on to GENEScreen membranes. This involved 
denaturation of the DNA in the gel in 1.5M NaCl/0.5M NaOH, followed by 
neutralisation in 3M NaCl/0.5M Tris-HCl pH7.0, then washing briefly 
with 1 times phosphate buffer. Transfer was performed overnight 
(r14h) in 1 times phosphate buffer. The membrane was then rinsed in 1 
times phosphate buffer and baked at 80cC for 2-4h to fix the DNA.
(b). Northern blot transfer of RNA
RNA samples were size separated as described in section 11. 
The gel was soaked in excess 0.1M Tris pH7.5 for 15 minutes and then 
transfered into excess 0.1M Tris pH7.5 containing 0.5Mg/ml ethidium 
bromide for 15 minutes. The gel was destained for 15 minutes in 1x 
sodium phosphate buffer (pH6.5). The RNA was then visualised using a 
U.V. source and a photograph taken. Transfer was performed overnight 
in 1x phosphate buffer. The membrane was rinsed in 1x phosphate 
buffer briefly and baked at 80°C for 2-4 hours.
14. Hybridisation
Solutions used shown in table 2.4
Membranes were pre-wetted in 1% Triton-X100 then prehybridised 
in sealed polythene bags in a 10ml volume or hybridisation chambers 
with a volume of 30-80ml, containing: 50% (v/v) formamide
(de-ionised), 5X SSC, 5X Denhardts solutions, 1X phosphate buffer, 10% 
(w/v) dextran sulphate, 0.1% (w/v) SDS and 100ug/ml of denatured 
salmon sperm DNA at 42cC overnight with agitation. Radioactive
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probe was added to a concentration of 5ng/ral and hybridised overnight 
at 42®C with agitation. The next day membranes were rinsed in 2X SSC 
0.1% SDS several times at room temperature, washed at 60°C with
agitation in 0.1X SSC/0.1% SDS for 1h including three changes of wash
solution. Membranes dried on Whatman 3MM paper were sealed in thin
polythene bags for autioradiography.
15. Simultanious Extraction of High Molecular Weight DNA
and RNA From Cell Lines (Krieg et al 1Q83).
Cells were lysed by addition of 10ml phenol equilibrated with
0.3M Na Acetate, and 10ml of 0.3M Na acetate, 0.5% SDS, 5mM EDTA.
Adherant cell lines were lysed in situ after removal of the culture 
media from 75cm^ or 175cm^  flasks containing approximately 10^  cells 
or more, and the lysis solution transfered to a 50ml Falcon tube after 
gentle shaking for 5 minutes. Non-adherent cell lines were pelleted 
in 50ml Falcon tubes prior to lysis. After gentle shaking for 5 
minutes, 10ml chloroform were added, and the mixture shaken for 
another 5 minutes. The aqueous and organic phases were then separated 
by centrifugation (3500rpm, 20 minutes, 4^ C).
The aqueous phase was collected and re-extracted with 10ml 
chloroform as descibed above, prior to the addition of 2 volumes of 
ethanol in order to precipitate the nucleic acids, (at least 1 hour at 
-20°C).
The ethanol precipitated nucleic acids were pelleted by 
centrifugation, and resuspended in 2ml autoclaved water. The RNA was 
selectively precipitated by addition of an equal volume of 4M LiCl at 
4^C overnight. The precipitate was pelleted in a Sorval centrifuge 
(SS34 rotor, 15000rpm, 4^ C), and the RNA resuspended in sterile water. 
Contaminating DNA was removed by the addition of MgC^ (5mM final 
concentration), together with 20pg/ml DNAasel, (RNAase free, Boeringer 
Mannheim). After a 20 minute incubation at roan temperature, the 
reaction was terminated by freezing at -20®C or ethanol precipitation. 
The RNA was stored at -20°C. The DNA which was contained in the LiCl 
supernatant, was recovered ethanol precipitation and resuspended in 
sterile water.
16. Preparation of Radioactivelv-Labelled DNA Fragments...
Random Priming Method.
Approximately 50-100ng of the probe DNA insert is added to
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32jil water and boiled for 7 minutes to denature the DNA. Add 10jil 
oligo labelling buffer (0LB-table2.5), 2pl bovine serum albumen (BSA 
10mg/ml), 5lil alpha 32p radioatively labelled dCTP (Amersham code 
PB10205) and 0.5]il Klenow. The above mixture was mixed gently and 
incubated for 2-4hr at room temperature. The reaction was stopped by 
the addition of 100pl 0.5M EDTA.
Unincorporated nucleotides were removed by gel filtration 
through a Sephadex G50 column. The specific activity of the labelled 
probe calculated (usually 1-2x10® cpn/jig) and the appropriate amount 
used in the hybridisation. The probe was always boiled for 5 minutes 
and chilled quickly on ice before use.
Tissue Culture
All solutions used are shown in table 2.6
17. Maintenance of Cell Lines
All cell lines were maintained in SLM (table2.6). During 
passage of the FDCP1 cell line, 10% WEHI conditioned media was 
included. 3T3 fibroblasts (Todaro and Green 1963) and packaging cell 
lines were passaged twice a week by aspirating off the old media 
washing the cells once in PBS and adding 2ml 0.125% trypsin/25cm flask 
(table2.6). Detached cells were diluted 1:3 for passage. The 
non-adherent FDCP1 cell line (Dexter et al. 1980d^ . was also passaged 
twice a week by removing two thirds of the culture media and replacing 
this with fresh media. In any experiment which required the FDCP1 to 
be replated in semi-solid media, the cells were washed twice in PBS to 
remove growth factors prior to replating.
18. Freezing of Cells
Cells to be frozen under liquid nitrogen were resuspended in 
SLM plus 10% glycerol and aliquoted into Nunc cryotubes (0.75ml/tube). 
The tubes were then stored at -70®C for between 12hours and several 
weeks, after which they were stored under liquid nitrogen.
19. Transient Transfection of Virus Packaging Cell Line_(,gompaY.rac.
and Danna 1981)
A 2.5mg/ml solution of DEAE-dextran was made by dissolving 
1.25g DEAE-dextran in 250ml 1M Tris and the pH adjusted to 7*3. 250ml
of sterile water was added to make 500ml of a 2.5rag/ml solution which 
was filter sterilised. Prior to use the stock solution of
DEAE-dextran was diluted 1:9 with SLM, 0% FCS, and sterilised.
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Cells to be transfected were seeded out 24hr previously at 
5x105 cells/25cm flask in SLM/10% FCS. Media was removed from the 
cells and replaced with 5ml DEAE-dextran/SLM/0% FCS and 5-25ug plasmid 
DNA and incubated for 1 hour at 37°C. The cells were then washed 
twice in SLM/0% FCS before incubating the cells in 5ml SLM/10% FCS for 
48 hours. After 48 hours the virus containing culture media was 
removed, filtered through a 0.45U disposable filter and either stored 
at -20°C for up to 1 month or used immediately.
20. Ca Poj| Co-Precipitation Method For Stable Transfection. 
(Wigler et al. 1070: Graham and Van Per Ebb 1Q73)
One day before transfection, the cells were reseeded at a 
density of 5x10-V75cm flask. The precipitate was formed as follows: 
60jil of CaCl2 was added to 540pl water containing 0.5-3pg plasmid DNA 
and 20pg sheared genomic carrier DNA. 600)il of 2xHBS (table2.6) was 
added slowly dropwise while vortexing. A precipitate was allowed to
form at room temperature for 30 minutes. The DNA/CaPo^ precipitate 
was then pipetted onto the cells and left overnight. The next day the 
cells were washed with PBS and incubated in SLM for a further 48 
hours. The cells were then trypsinised and reseeded at 5x10^
cells/10cm tissue culture petri dish.
21. G418 Selection (Colbere-Garapin et al. 1Q8D
Aliquots of sterile stock G418 (Gibco, 80mg/ml in water) were 
frozen at -20°C and was added to cultures at a range of concentrations 
from 0.4mg/ml to 2mg/ml. G418 resistant fibroblast colonies were 
scored after 14 days by the addition of Giemsa stain to a final
concentration of 10% for 2 minutes. The cells were washed gently in 
water and air dried.
22. Virus Infections. (Maeli et al. 1987; Mulligan 1983; Laker et
al. 1Q87)
Virus containing media was harvested from virus producing cell 
lines reseeded 24hr previously at 5x10^  cells/25cm flask, passed 
through a 0.45U filter and either used immediately or stored at -20°C 
for 1 month.
Fibroblasts to be infected were seeded out at 5x10^  cells/25cm 
flask 1 day before infection. Immediately before virus infection the
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culture media was changed. The fibroblasts were exposed to an aliquot 
of virus supernatant, (usually 50pl), for 24hr in the presence of 
6pg/ml polybrene, (Toyoshima and Vogt 1969) after which the cells were 
washed and incubated for a further 48hr, The cells were then 
trypsinised, counted in a Coulter counter and replated at 5x105 
cells/10cm petri dish (10ml media) . A minimum of 4 dishes were used 
per experiment and G418 (see21) was added at a concentration of 
800pg/ml. For each experiment two 10cm petri dishes containing 200 
cells were plated out in non-selective media in order to determine
replating efficiency. Infected cells were incubated for 2 weeks at 
which time well isolated colonies were picked after removal of the 
culture media with a Gilson p200 pipette. Colonies were also counted 
by the addition of Giemsa stain (10% v/v) to the media for 2 minutes, 
followed by a brief wash in water.
Bone marrow cells harvested as described in (23) and FDCP1 
cells were exposed to virus by co-cultivation with virus producing
cells seeded out 24hr previously at 5x10^  cells/25cm flask . Polybrene 
was added at 6jig/ml and WEHI conditioned media to 10% (FDCP1 cells), 
or 2% (bone marrow cells). Co-cultivation was allowed to take place 
for 24hr after which non-adherent cells were recovered. The 
non-adherent cells were washed twice in PBS to remove polybrene and
growth factors prior to replating. Details of individual infections
are described in the results chapter 6.
23. Harvesting of Bone Marrow.
Normal bone marrow was obtained from the femurs of 8-12 week 
old female NIH mice (obtained through 01ac directly, or bred at the 
Beatson). A minimum of two animals were used per experiment. The 
femurs were cleaned of surrounding tissue and both ends of the femur
cut off using scissors. The core of bone marrow in the femur cavity
was flushed out with 1ml SLM by inserting a 21 gauge needle into one
end of the femur. The cells were dispersed into a single cell
suspension with a 10ml pipette and nucleated cells counted using a 
haemocytometer by diluting a sample of cells 1 in 10 with 0.3$ 
methylene blue in 90% ethanol. Approximately 10^  nucleated cells are 
recovered per femur.
24. Conditioned Media (Pragnell et al. 1988)
The WEHI 3B (Metcalf and Nicola 1982; Ihle et al^ 1982), AF1
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(Pragnell et al. 1988) and L-929 (Stanley and Heard 1977) cell lines
were grown in roller bottles with SLM/10% FCS to half confluence. 
Spent media was then removed, replaced with fresh media and the 
cultures allowed to grow for a further 3 days. The conditioned media 
was removed, passed through 0.45 and 0.22p filters and stored at 
-20°C.
25. Clonogenic Assays
1. CFU-S (Till et al 1Q61)
CFU-S were assayed by injecting 0.2ml aliquots containing 
5-8x10^ nucleated bone marrow cells (harvested as described in 23)
into female NIH mice exposed 24 hours previosly to 8.2 Gy
X-irradiation (10 per group). Cells to be injected were resuspended in 
SLM containing 0.2% serum. Spleen colonies were counted 10 days 
later after fixation of the whole spleen in Bouins fixative.
2. CFU-C Progenitor Assay (Pragnell et al 1988)
CFU-C were assayed by culturing ^ #-5x10^  cells per 3cm petri 
dish containing 0.3% agar orO ‘9% methocellulose in supplemented 
alpha-modified MEM containing 25% FCS (Table2.6). Conditioned media 
from the AF1 or WEHI 3B cell lines were used as sources of colony 
stimulating factor. The 1ml cultures were incubated at 37°C in a 
fully humidified atmosphere of 5% CO2 in air and colonies were counted 
on day 7 using an inverted microscope.
3. CFU-A Primitive Progenitors (Pragnell et al 1988)
For the detection of CFU-A, 10^  cells in 4ml supplemented 
alpha-modified MEM (Table 2.6) containing 25% FCS and 0.3% agar o r O ^  
methocellulose were seeded on top of an underlayer of the same medium 
containing 0.6% agar, 10% L929 conditioned media and AF1-19T 
conditioned media in a 6cm petri dish. Cultures were incubated at 
37°C in a fully humidified atmosphere of 10% CO2 , 5% O2, 85% ^  for
11 days. Colonies were stained overnight with INT (2-(4
Iodophenyl)-3-(nitrophenyl)-5-phenyltetrazolium chloride) overnight 
(Boll et al 1977) and those with a diameter of greater than 2mm were 
scored.
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4. FDCP1 Clonoeenic Assay
Details of individual experiments are given in the results. 
FDCP1 cells were washed twice in PBS to remove residual growth factors 
before being added to 0.3% agar or£>9% methocellulose in supplemented 
alpha-modified MEM (Table 2.6) containing 25% FCS at the desired cell 
density.
26. Microwell Assays (Metcalf et al. 1Q86; Lane et al. 1985)
Microwell assays for GM-CSF activity in conditioned media were
performed using Falcon Terasaki 60 well plates containing 500 FDCP1
cells in 10pl SLM/10/5 FCS. Viable cell counts were performed after 
48hr of incubation at 37°C.
27- 5-Fluoruracil Treatment (Pragnell et al 1988)
Groups of 5 NIH mice were given a single dose of
5-Fluorouracil (5FU) at 150mg/kg. Bone marrow cells were obtained at
different times after treatment as described in section 23.
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Table 2.1 Plasmid Preparation.
TEG buffer 50mM glucose 
25mM Tris HC1 pH8 
1OmM EDTA 
4mg/ml lysozyme
Alkaline/SDS 0.2N NaOH 
1 % SDS
Potassium Acetate 5M
Table 2.2 Ligation of DNA
Ligation buffer x
Tris/CL pH7.5
MgClp
ATP ^
BRL nuclease free
Alkaline Phosphot 
Tris/HCL pH9
MgClp 
ZnClp
spermidine
0
500mM 
10OmM 
1mM
BSA w/v
se (CIP) buffer x10
500mM 
1 OmM 
1mM 
10mM
Table 2.^ Agarose Gel Electrophoresis 
TEA buffer pH8
Tris base 40mM
EDTA 2mM
NaCl 20mM
NaAc 2 OmM
TBE buffer pH8
Tris borate 89mM
Boric acid 89mM
EDTA 2.5mM
MOPS buffer x10 dH7
MOPS(Sigma) 0.4M
NaAc 0. 1M
EDTA 0.01M
Gel^ SamDle Buffer
Tris/CL pH7 125mM
Glycerol 20% w/v
EDTA 5mM
Bromophenol blue 0.25% w/v
xylene cyanol 0.25% w/v
RNA loading buffer
MOPS buffer 1 X
Formamide 50% v/v
Formaldehyde 2.2M
Table 2.4 Transfer and hybridisation buffers.
20x SSC sodium chloride 3M
sodium citrate 0.3M
20x Phosphate buffer pH6.5
50x Denhardt's solution 
F icoll-400
polyvinylpyrrolidone 
BSA (Pentax fraction V)
Na HPO. 
NaH^ POjJ
1% w/v 
\% w/v 
'[% w/v
0.5M
0.5M
Table 2.5 Random Priming Labelling Buffer.
OLB-250U1 1M Tris pH7.4 62pl
1M MgClp 6pl
2-mercaptoethanol 1pl 
15mM dATP 2pl
15mM dGTP 2pi
15mM dTTP 2pl
2M Hepes pH6.6 125pl
150 OD units/ml 
calf thymus hexanucleotides 
(Pharmacia) 50pl
Store at -20cC
Table 2.6 Tissue Culture 
Culture Medium (SLM)
Supplemented modified Eagles medium (SLM , Gibco cat. no.
10% foetal calf serum (FCS, Gibco)
2mM Glutamine
Dulbecco's phosphate-buffered saline, solution A (PBS)
Trvpsin dilutant. PBS/EDTA. 
PBS
1mM EDTA 
Trypsin
0.15% trypsin in PBS/EDTA
2x Hepes buffered saline
NaCl 280mM
NapHPOa 1.5mM
Hepes pH7.4 50mM
Adjusted to pH7.12 with HC1
MEM Alpha Stock (Gibco)
Disolve 5 Litre Pack (Gibco) in 1400ml water, add 50ml MEM 
x100 vitamins (Gibco), 10ml Phenol red and 100mg gentamycin 
sulphate. Filter sterilise.
MEM Alpha x2
For 100ml
Alpha stock 21ml
200mM glutamine 1ml 
7.5% NaHCO- 3ml
serum 25ml
043-01136M)
KC1
Na2HP0i|7H20
2.68mM 
1.47mM 
0.137M 
8.06mM
Add equal volumes of MEM Alpha x2 and agar or methocellulose 
at the required viscosity to obtain MEM Alpha x1.
Table 2.7 Sources of Chemicals
Unless otherwise stated, all chemicals were obtained from BDH 
Chemicals, Poole, Dorset, UK, or Sigma Chemical Co, St Louis, 
Missourri, USA.
Sephadex G50
polnucleotide kinase
Pharmacia, Uppsala, Sweden,
ampicillin Vestric, Glasgow, Scotland,
Methocel MC4000 Fluka, Buchs, Switzerland.
Bacto Agar Difco, Detroit, USA.
Agarose BRL, Rockville, Marryland, USA.
low melting point agarose
restriction endonucleases
bacterial alkaline phosphatase
Klenow large fragment
T4 DNA polymerase
Special liquid medium Gibco Ltd, Paisly, Scotland.
Foetal bovine serum
glutamine
G418
CHAPTER THREE
3-1 Subcloning of GM&7 into pV2QQneo
The retroviral vector pV200neo (Episkopou al., 1984) is based
on MoMLV and is a double expression type of vector (Chap.1.7). 
Selection of this vector can be achieved in eukaryotic cells by 
virtue of the neomycin (neo) gene under the control of the herpes 
simplex virus thymidine kinase (HSVtk) promoter (see Fig. 3.1, 3.2A).
The vector pV200neo (pVneo) has a unique BamHI restriction site, 5’ to 
the tkneo selectable marker into which fragments of DNA can be 
subcloned (Fig.3.1). Subcloning of GMA7 into the BamHI site requires 
the 5’ LTR for its expression and so the insert must be orientated 
parallel with the viral LTRs.
Although a full length GM-CSF cDNA has been cloned (Gough et 
al.. 1985), it has been shown that deletion of 5’ non coding sequence
increased growth factor production from cos cells transfected with an 
expresssion vector carrying the deleted GM-CSF cDNA (Gough et al., 
1985). The 5’deleted cDNA was termed GM67 (Fig.3.2B, Gough et al.. 
1985). In order to express GM-CSF in haematopoietic cells, two 
vectors were used. Dr W. Ostertag kindly provided mos“^neoGM which 
relies on viral splice signals for efficient expresion of GM-CSF, 
(Laker et al 1987, Ostertag pers. comm.). However, due to the problems 
associated with splice type vectors discused in chapter 1.7, it was 
decided to subclone GM&7 from mos“^neoGM into the double expression 
vector, pVneo. Thus, both vectors contain identical GM-CSF inserts , 
and can be used in parallel to compare vector mediated gene 
expression. To subclone the approximately 920 base pair GMA7 BamHI 
fragment was removed from mos"”^ neoGM (Fig. 3«2B, 4.1), ligated to
BamHI digested pV200neo (pVneo) and transformed into E.coli strain 
HB101 as described in Materials and Methods. Transformants were 
selected on the basis of ampicillin resistance. DNA from twenty 
clones were examined by restriction analysis with BamHI, ( Fig.
3.3). Clones 3, 11, 14 and 20 appeared to have inserts, (Fig.3.3).
In order to establish the orientation of the inserts within 
the retroviral vector, a diagnostic Pst1 digest was carried out. The 
predicted fragment sizes are shown in Fig 3*4, 3*1, 3*2.
Fig.3.5A shows Pst1 digests of samples 3, 11, 14 and 20 and
reveals that only clone 3 contains the GMA7 fragment in the correct
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FigU—3»1
A pV200neo (pVneo)
Redrawn with modifications from Episkopou et al..
(1984)
LTR - long terminal repeat 
pBR - pBR322 sequences
TK - sequences from herpes simplex virus thymidine 
kinase promoter
NEO - neomycin coding sequences
s.d. - splice donor sequence (viral encoded)
B pVneoGM
Derived from pVneo by subcloning GMA7 into the
BamHI cloning site as described in 3*1*
All sizes are in base pairs.
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A Diagram to show Pst1 sites in the TKNEO region 
of pVneo(pVneo).
B Relationship of GMCSf to GM-CSF 3*2 including 
Pst1 sites.
All sizes are in base pairs.
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Figure 3.3
Construction of pVneoGM
BamHI cut pVneo ligated with GM 7. Miniprep DNA 
from 20 transformants cut with BamHI.
Samples 3, 11, 14 and 20 had inserts released by
BamHI.
M - EcoRI X  markers.

orientation with a fragment of approximately 6215 base pairs similar 
to control cut pV200neo (Fig 3*5B). Samples 11, 14 and 20 contain the
larger 6951 base pair fragment. The correct orientation of GM&7 was 
confirmed by the experiment shown in Fig. 3.5C. In comparison to Pst1 
cut pV200neo, sample 3 contains a 931bp fragment which would not be 
present if the insert was antiparallel to the viral LTRs. Sample 3 
was therefore confirmed to be the desired transformant and was renamed 
pVneoGM.
3.2 Subcloning of probes into Bluescribe Vector
The Bluescribe vector (Vector Cloning Systems) contains a
multiple cloning site identical to that found in pUC19 (Pharmacia) but
flanked by the RNA polymerase promoters T3 and T7. The bluescribe
vector has the advantage of permitting colour selection for inserts 
due to the presence of the beta galactosidase gene in the appropriate 
host/inducer system (see Materials and Methods). Once an insert has 
been cloned into the vector and its orientation deduced, sense or 
antisense RNA probes can be generated using the T3 or T7 promoters 
(Melton e t al 1984). In addition the inserts can be labelled by
random priming (See Materials and Methods).
In order to carry out molecular analysis on RNA and DNA from 
transfected or infected eukaryotic cell lines the following probes 
were subcloned (Fig.3.6):-
i) tk promoter
ii) neo gene
iii) GMA7
iv) promoter containing fragment of MoMLV LTR
The tk promoter and neo gene were subcloned from plasmid p6l 
Cl 24 kindly donated by Dr J Lang (Fig 3.6), Gm(\7 from mos”^neoGM (Fig
4.1 ) and the MoMLV LTR sequences from pV200neo (Fig. 3-1 Episkopou 
et al 1984).
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Figure 3.5
Subcloning of GM&7 into pVneo: determination of
insert orientation.
A All samples were cut with Pst1 and run on a 
TBE agarose gel. Lane 1, pVneo; lane 2, sample 3; 
lane 3» sample 11, lane 4, sample 14, lane 5 
sample 20.
Markers are EcoRI cut X and EcoRI/Hindlll cut X  .
B Lane 1, pVneo; lane 2 sample 3. Both samples 
were cut with PstI and run on a 1? TEA agarose gel. 
Markers are EcoRI/Hindlll cut X and Hindlll cut X •
C Both samples are cut with Pst1 and run on a 4% 
acrylamide gel. Lane 1 pVneo; lane 2 sample 3. 
Markers are Hpall cut pBR322, Haell cut pBR322 and 
EcoRI/Hindlll cut X  •
A
—  21-8
— 5*2459 r
— 1*96
3-38
1 2 3 4 5
,930
880
■590
'450/430
"370
-221
Figure 3.6
Bluescribe vector was cut and ligated to insert DNA as in 
Materials and Methods. The table below sumarises the 
restriction digests used. After ligation, JM83 bacteria were 
transformed and whitfl colonies picked for analysis.
Plasmids containing the correct inserts were mapped for 
insert orientation. In all the figures , orientation of the 
insert within the polylinker is shown by an arrow. For 
simplicity only the polylinker region is shown.
T3 and T7 are the promoter sequences for RNA polymerases T3 
and T7 respectively
Figure Bluescribe digest Insert New
Plasmid 
Name
Bgl11/Sma1 1kb neo BS-NEO
fragment from p6lcl-24
Bam H1/Bgl11 250bp BS-TK
TK promoter fragment 
from p6lcl-24 
BamHI 920bp fragment 
from mos”^neoGM BS-GM
EcoRI/Sma1 1.8kb 
fragment from pV200neo BS-pV200
3.6C BamHI/Hindi
3.6C BamHI
3.6B BamHI
3.6A EcoRI/Sma1
pV200neo 5'LTR
LTR
EcoRI Smal
EcoRI/ Smal 
1800 bp
BS-pV200
T7 T 3
EcoRI Smal Hindin
B
GMA7
T7
BamHI Pstl Bam HII .
T3
SstI Bam Pstl BamHI HindlD 
HI
BS-GM
c.
BamHI
Bglll
Smal
I
BamHI/Bglll 
250bp TK
I
Bglll/Smaf 
lOOObp NEO
B S - T K
T7 T 3
SstI BamHI BamHI HindHI 
Bglll
T7
BS-NEO 
— *
T3
SstI Bglll Smal HindlD
BamHI Hindi
CHAPTER FOUR
GENERATION AND ANALYSIS OF VIRUS PRODUCING CELL LINES 
Introduction
In order to generate virus producing clones, retroviral 
constructs must be introduced into a packaging cell line(Mulligan
1983). This can be achieved in two ways. The vector can either be 
transfected by calcium phosphate co-precipitation into the packaging 
cell line, or a transient transfection of the V  Am (amphotropic) 
packaging cell line can be carried out and rescue virus particles 
rescued 48 hours after transfection (See Materials and Methods, Miller 
et al 1986). The amphotropic virus produced during the transient 
transfection is then used to generate stable virus producing cell 
lines by infecting ecotropic Y2 cells (Miller et al., 1986). In 
either case, stable integrants can be selected by resistance to 
antibiotic. The latter method relies on the availability of two 
packaging cell lines which release virus particles capable of 
recognising different cell receptors (Miller et al., 1986). ^2 cells 
produce ecotropic envelope protein and so will be refractory to 
superinfection by an ecotropic virus (Miller et al., 1986. Weiss et al^ 
1985). However by packaging the vector in a virus particle comprising 
of amphotropic envelope molecules this block can be overcome (Miller 
et al., 1986).
The use of the infective virus to generate virus producing 
cell lines has several advantages over stable transfection. Calcium 
phosphate co-precipitation is relatively inefficient generating only 
about one transfectant per 10^  fibroblast cells (Debenham jet al.
1984). The integrated DNA is often rearranged and is present in 
multiple copies thus the virus produced from such cell lines may be a 
heterogeneous mixture of normal and re-arranged virus, (Mulligan 1983, 
Lebkowski et alv1984)
Virus infection is on the other hand a very efficient 
process, capable of generating up to 10 drug resistant 3T3 cells per 
millilitre of virus supernatant (Miller et al., 1986). Infection of
retrovirus packaging cell lines should generate virus producing cell 
lines which harbour only one or at most a few copies of the retrovirus 
and so virus production should be relatively homogeneous (Miller et 
al., 1986). Rearrangement of provirus within the packaging cell line 
should not be common, as the cell line is generated by a biologically
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active retrovirus which integrates in the defined orintation of 
cellular DNA-LTR-viral sequences-LTR-cellular DNA (Miller et al., 
1986, Bernstein et al 1985). It has also been demonstrated that genes 
introduced into cells by viral infection are more efficiently 
expressed than genes introduced by DNA transfection (Hwang and Gilboa,
1984). Thus it should be possible to generate virus producing cell 
lines with higher virus titres by this approach (Miller et al., 1986).
4.1 Retrovirus vectors used in this study
The four retroviral vectors that have been introduced into the 
¥2 packaging cell line are shown in Fig. 4.1. These are pVneo
(Episkopou et al., 1984) and its GM-CSF derivative pVneoGM,
(Fig.3.1B), pmos "^neo and its GM-CSF derivative, pmos“^neoGM (Laker 
et al, 1987; Oestertag pers. comm.). The GM-CSF insert is GMA7 in
both cases. The pVneo vector of Episkopou is based on MoMLV and
contains the bacterial neomycin gene (neo) which confers resistance to 
the antibiotic G418 (Santerre et alJ984). The neo gene is 
transcriptionally controlled by the herpes simplex virus thymidine 
kinase promoter. pVneoGM relies on a full length message starting 
from the 5’ LTR and terminating in the 3’ LTR for expression of the 
GM-CSF sequences. The predicted transcripts form both pVneo and
pVneoGM are shown in Fig. 4.2.
In vivo. MoMLV is associated with long latency lympoid disease 
(Weiss et al 1985) and the related virus, Moloney murine sarcoma virus 
(MoMSV) which carries the mos oncogene (Weiss et al 1985), will cause 
sarcomas _in vivo and transform fibroblasts in  vitro (Ostertag et .al,. 
1980). The vector pmos'"^ neo is based on myeloproliferative sarcoma 
virus (MPSV) (Ostertag et al. 1980,Laker et al.1987, Ostertag pers. 
comm.). MPSV, like MoMSV carries the mos oncogene (Stocking et _al4
1985) but not only will MPSV transform fibroblasts In vitro and cause 
sarcomas jln vivo but it will also induce proliferation of both early 
myeloid and erythroid progenitor cells and CFU-S (Ostertag et al- 
1980, Klein et al.1981). The LTRs of MPSV have been shown to be 
derived from MoMLV and that the expanded host cell range of MPSV is 
due to point mutations in the U3 region of the LTR (Stocking et al., 
1985,1986).
pmos“ n^eo, like pVneo carries the neomycin gene but it is the 
viral LTR which exerts control over transcription rather than a
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Figure 4.1 
Vectors
The four vectors used in this study are shown in
this figure. Relevant restriction sites are
marked. pVneo (Episkopou et al., 1984) and pVneoGM
are based on MoMLV. pmos'^neo (Laker et al., 1987;
Ostertag, pers. comm.) and pmos“^neoGM ( Ostertag
pers. comm) are based on myeloproliferative sarcoma
virus. All sizes are in base pairs and the vectors
are pBR322 based.
s.d. - viral splice donor site
s.a. - viral splice acceptor site
pBR - pBR322 plasmid sequences.
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Figure 4.2
Probes used in Southern and Northern blotting. The 
figure shows diagramatically the predicted proviral 
structures and transcripts for each of the four 
vectors. Predicted transcript sizes are in 
kilobases.
The positions of the DNA sequences recognised by 
the restriction enzymes SstI and BamHI are sfrown. 
Digestion of genomic DNA with SstI should release a 
DNA fragment containing almost the complete 
provirus which can be used to examine provirus 
integrity. The distance between the SstI sites of 
the viral LTRs is approximately the same as the 
size in kilobases given for the full length viral 
transcripts shown under each provirus. Digestion 
of genomic DNA with BamHI. which cleaves the 
proviral structure internally, when probed with 
neo gives some indication of the number of viral 
copies per genome. The probes used in all blots 
are shown as solid blocks under the region of the 
provirus to which they correspond. The 1kb neo 
fragment used was a Bglll/Smal digest from plasmid 
p61 cl-24 (see Fig.3.6c). The 381 bp GM-CSF 
fragment was a Pstl/EcoRV digest from plasmid 
pGM3.2. All probes were labelled by random priming 
as described in Materials and Methods.
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thymidine kinase promoter. The GMA7 sequences in pmos“3neoGM also 
rely on the viral LTR for their expression as this is a splice type 
vector (see1.7). Efficient expression of GM&7 in pmos“3neoGM relies 
on the viral splice donor and acceptor sites being utilised to 
generate sub-genomic mRNA (Laker et al 1987, Ostertag pers. comm.) 
The predicted mRNAs derived from pmos“^neo and pmos“^neoGM are shown 
in Fig. 4.2.
4.2 Generation of Virus Producing Cell lines and Infection of T^^  
fibroblasts
Two methods were used to generate virus producing^ clones, 
details of which are in Materials and Methods:-
1) Stable transfectants using calcium phosphate co-precipitation: One 
microgram of each plasmid to be transfected was added to sheared 
genomic carrier DNA and precipitated onto ¥2 cells seeded out 24 
hours previously at 5x10^  cells per 75cm^ flask. The transfected 
cells were then left for 24 hours, at which time the medium was 
replaced with 20ml of fresh medium. After a further 48 hours , the 
cells were trypsinised, counted and seeded at a density of 5x10^  
cells per 10cm plate in the presence of 800 pg/ml of G418. All the 
vectors used in these studies carry the neomycin gene which confers 
resistance to G418. The plates were incubated for two weeks and 
distinct G418 resistant colonies were cloned and expanded under 
selective conditions (800 pg/ml). Control plates had no colony growth 
in the presence of 800pg/ml G418.
2) Transient transfection into f'Am (Amphotrophic) packaging cell line, 
followed by virus rescue after 48 hours and infection of f  2 cells 
(Details in Materials and Methods). 'fAm cells had been seeded
out 24 hours previously at a concentration of 5x10^ cells per 75cm^ 
flask and plasmid was transiently transfected using DEAE dextran . 
The media was changed 1 hour after the transfection and virus was 
harvested after a further 48 hours. The media containing virus was 
passed through a 0.45U filter and used immediately to infect f2  cells 
which had been seeded out 24 hours previously at 5x10^ cells per 
25cm^ flask. Media was removed from the ^2 cells and 5ml of virus 
containing media was added to the 25cm^ flask together with polybrene 
(6 pg/ml) to aid virus absorption. The cells were then incubated for 
a further 24 hours then washed with PBS and 5ml of fresh media added.
99
A 48 hour period to allow virus expression then followed, after which 
the cells were trypsinised counted and seeded into 10cm dishes at a 
density of 5x10^ cells per dish in the presence of 800 ug/ml G418. 
After two weeks G418 resistant colonies were cloned and expanded in 
the presence of 800^g/ml G418.
Table 4.3 shows 13 ^ 2 virus producing clones that were isolated either 
by stable transfection (T) or transient transfection followed by 
infection (I). The vector introduced into each clone (and therefore 
the virus released) is also shown.
The virus titre released form each clone was assayed as 
follows:- ^2 clones were plated out at 5x10-* cells per 25cm^ plate 
with 5ml of media without G418. After 24 hours the media was removed 
and used immediately for virus assay. A 50 pi aliquot of virus 
supernatant was added to 3T3 fibroblasts seeded out 24 hours 
previously at 5x10^ in a 25cm^ flask. Virus absorption to the cells 
was aided by the addition of poybrene(6 jig/ml) and left on the 3T3 
cells for 24 hours, before the cells were washed in PBS and 5ml fresh 
media added. After a 48 hour expression period the 3T3 fibroblasts 
were trypsinised, counted and seeded at 5x10^ cells per 10cm dish in 
the presence of 800 pg/ml G418. The plates were incubated for 2 weeks 
before the frequency of G418 resistant colonies was calculated. The 
number of G418 resistant colonies was adjusted for re-plating 
efficiency, the fraction of infected cells plated out and virus volume 
to give a value for the number of G418 resistant 3T3 cells generated 
per millilitre of virus supernatant (G418 colonies per ml). Table
4.3 shows the virus titres of the 13^2 clones on up to three separate 
experiments.
Titre is determined by how efficiently the viral genome is 
encapsidated and the degree of selectable gene expression in any given 
cell type. Although the virus titres vary between clones from about 
2x10-3 cfu/ml to 5x10^ cfu/ml these figures are similar to reported 
titres for the f2 and amphotropic packaging cell lines (Eglitus et 
al.,1985; Chang et al., 1987; Kwok et al., 1986; Dick et al., 1985;
Miller and Buttimore 1986; Mann et al., 1983). There is also
variation between independent titring of the same clone, for example 
in Fig4.3, the virus titre of clone 11 was measured three times and 
showed up to a ten fold difference in virus titre. The reasons for 
such differences within a clone may be a reflection of the degree of,
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Figure 4.3
Generation of virus producing clones and their 
viral titres in 3T3 fibroblasts.
Virus producing cell lines were generated in two 
ways; either by transfection using calcium 
phosphate co-precipitation (T) or alternatively, 
an amphotropic virus packaging cell line C^ Am) was 
transfected by DEAE Dextran and transiently 
released virus was harvested after 48h. The virus 
contaiing media ws then used to infect t 2 cells 
(I).
Transfected (T) or infected (I) i 2 cells were 
placed under G418 (800ug/ml) selection for two 
weeks. Well separated colonies were then expanded. 
In order to titre virus release from ^ 2 clones, 
virus containing media (50pl) was used to infect 
3T3 fibroblasts. The number of 800]ig/ml G418 
resistant colonies was determined after two weeks 
and adjusted for plating efficiency, proportion of 
cells replated and volume of virus used. This 
gives a figure for colony forming units per ml 
virus supernatant (colonies/ml). The titre on 3T3 
fibroblasts was performed on up to three 
independent occassions for each clone.
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VIRUS TITRES OF INDIVIDUALf2 CLONES 
GENERATED BY VECTOR TITRE ON 3T3 CELLS
TRANSFECTION(T) 
OR INFECTION(I)
T
T
T
I
I
I
I
I
I
T
-3mos neo 
-3mos neo 
-3mos neo 
-3mos neo
-•3
mos neoGM
pVneo
pVneo
pVneo
pVneo
pVneo
G418 R 
1
2.3x105
>105
1.6x104
2.5x105
4.1x104
1.4x104
5.8x 105
5x103
7.6x 104
2.3x104
COLONIES/ML
2 3
2x105
3-5x103
1.7x104
5.3x105
5.3x104
2x103
>105
5.9x103
>105
T
T
T
pVneoGM 2.8x104 3.3x105 6.0x104
pVneoGM 1.2x105
pVneoGM 5-3x104 >105
confluence at the time of virus harvest, or it may also reflect 
experimental error in cell counting and incubator variation. From 
these experiments there does not appear to be any gross differences in 
virus titres on 3T3 fibroblasts from virus producer lines generated by 
transfection or infection as suggested by Miller et al. 1986, nor are 
there any apparent differences in titre between the four vectors. It 
is possible that real differences in titre do exist but the 
experimental method used to titre virus here did not show it. By 
taking a range of dilutions of virus rather than any one value then 
comparative differences in virus titre may be observable.
4.3 Molecular analysis of ^2 virus producer clones and 3T3 cell lines 
derived bv infection.
Although the data in table 4.3 demonstrates that virus
producing clones can be made, it is important that the virus released 
is unrearranged and expresses its transcriptional units as predicted 
(Fig.4.2). It is also desirable that infected cells only contain one 
copy of the virus so that any phenotypic effect may be attributed to 
that single provirus copy. If cell lines contain multiple copies of a 
gene then the analysis of its integrity in all copies and their 
transcriptional activity is complex.
Southern Analysis
All four of the retroviral vectors used in this study (fig.
4.1 and 4.2) generate a DNA fragment corresponding to the full length 
of the virus genome when digested with Sst1 (Fig.4.2). Since the 
restriction enzyme BamHI cuts the retrovirus vectors internally, 
gross rearrangements can be detected by SstI digest and vector copy
number can be evaluated by BamHI digest. The neo probe shown in 
Fig. 4.2 was used in the experiments described below. The
fragment sizes detected in the Southern blot in Fig.4.4, lanes 1 to 4 
reflect the integrity of each of the four basic vector types in these 
cell lines and their relative sizes. It can be seen that the viral 
genome sizes are 4.4kb for pVneo (lane 1), 5.75KB for pVneoGM (LANE
2), 6.0kb for mos”^neo (lane 3) and 7.0kb for mos”  ^neoGM (lane 4).
Although these sizes differ from the predicted genome sizes for the
virus shown in Fig. 4.2 and 4.1, the relative sizes are correct. In
separate experiments, DNA from clone 35 cut with Sst.1 results in a neo 
hybridising fragment of 3-3kb (Fig.4.5 lane 1; Fig 4.6 lane 1). Thus
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Figure 4.4
Southern analysis of virus producer clones.
Samples were run on a 0.7% TEA agarose gel and 20pg 
of DNA was loaded per lane. Size markers are 
Hindlll cut X • The blot was probed with neo.
Lane Clone Vector Digest
1 cl-35 pVneo SstI
2 cl-11 pVneoGM S?tl
3 cl-41
_3mos -’neo SstI
4 cl-31 mos”^neoGM SstI
5 cl-35 pVneo BamHI
6 cl-11 pVneoGM BarrjHI
7 cl-41
_3mos -’neo BamHI
8 cl-31 mos“^neoGM BajnHI
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Figure 4.5
Southern analysis of virus producer cell lines and 
infected 3T3 fibroblasts.
The cell lines 3T3 11-5 and 3T3 11-6 were derived 
by infection of 3T3 fibroblasts with virus from 
cl-35. Cell lines 3T3 24-4 and 3T3 24-10 were 
derived by infection of 3T3 fibroblasts by virus 
from cl-1. Infections carried out as described in 
Material and Methods.
Lane Clone Vector Digest
1 cl-35 pVneo SstI
2 3T3 11-5 t it
3 3T3 11-6 tr tt
4 cl-35 it BamHI
5 3T3 11-5 t t
6 3T3 11-6 tr tt
7 cl-1 mos'^neo SstI
8 3T3 24-4 tt tt
9 3T3 24-10 tt tt
10 cl-1 tt BamHI
11 3T3 24-4 it t
12 3T3 24-10 t tt
2 3 4 5 6 7 8 9 10 11 12
differences observed in sizes of hybridising bands for any identical 
DNA sample cut with the same enzyme on different occassions may be due 
to the differances in the running of the markers. However it is clear 
from the relative sizes of the hybridising fragments in Fig4.4 lanes 
1-4 that the vectors are not grossly rearranged in these Y  2 clones.
The three ^2 clones - Cl-35, Cl-41, and Cl-31 were generated 
by infection, where as 61-11 was generated by transfection, (Fig.4.3). 
BamHI digests of genomic DNA from these clones (Fig 4.4 lanes 5-8) 
demonstrate that all four clones probably contain only one copy of 
the vector as only one hybridising fragment is observed in each cell 
line. This is expected for clones generated by viral infection which 
usually only leads to integration of a few copies of the virus per 
genome (Mulligan 1983).
The ^ 2 virus producer clone, Cl-1 was generated by DNA 
transfection. Cleavage of genomic DNA from Cl-1 by BamHI reveals a 
complex pattern of many neo hybridising fragments (Fig.4.5 lane 10) 
indicating multiple copies of the vector. Digestion of this same DNA 
with Sst1 (Fig 4.5 lane 7) also reveals multiple bands hybridising to 
neo which suggests that during transfection the multiple copies of 
the plasmid have become rearranged. Interestingly, two 3T3 cell lines 
(3T3 24-4 and 3T3 24-10) derived by infecting 3T3 fibroblasts with 
virus from Cl-1 contain only one copy of virus each (Fig 4.5 lanes 11 
and 12) which appear to be of the correct size (4.9kb) and 
unrearranged (Fig. 4.5 lanes 8 and 9). Clone 1 was kindly assayed for 
helper virus release by Dr D. Onions and found to be positive. It is 
therefore possible that vector sequences in this clone have undergone 
recombination with one of the endogenous packaging defective helper 
viruses. Although clone-1 contains many copies of the vector, the 
virus it releases is of the predicted size. It cannot be assumed 
however that this is a homogeneous population of viral particles due 
to the multiple vector copies in Cl-1.
One virus producer cell line, Cl-35, which contained only one 
copy of pVneo per genome (Fig 4.4 lane 5; Fig. 4.5 lane 4 and Fig. 4.6 
lane 2) and did not show any gross rearrangements ( Fig4.4 lane 1; 
Fig4.6 lane 1) was used to infect 3T3 fibroblasts which were then 
selected for G418 resistance (G4l8r). Four G418 resistant 3T3 cell 
lines that had been generated from this infection were analysed for 
the integrity of the viral genomes present. In Fig. 4.6 lane 1 an
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SstI digest of the parental virus producing cell line Cl-35 reveals a 
3.3kb neo hybridising fragment. Lanes 3,5,7,9 show DNA from four 
independent 3T3 cell lines generated by infection with virus from 
Cl-35. All four cell lines have genomes of identical size to the 
parental ^ 2 clone and therefore no gross rearrangements have
occurred. Unfortunately the copy number of virus per genome can only
be ascertained in one 3T3 line, 3T3 11-6 (Fig. 4.6 lane 8).
A similar analysis of three independent G4l8r 3T3 cell lines 
derived by infection from virus from clone 11 (Fig.4.7), also 
demonstrated intact proviral sequences identical to that in the
parental virus producing line (Fig.4.7 lanes 1-4). Viral copy number 
per genome was only estimated for the parental virus producing clone, 
Cl—11 (Fig4.7 lane 5) and one 3T3 cell line (Fig.4.7 lane 8) In both 
cases there was only one virus copy per genome.
Northern Analysis
RNA was extracted from the f 2  virus producing cell lines and 
virus containing 3T3 cell lines by phenol extraction and precipitation 
of the RNA with lithium chloride (Details in Materials and Methods). 
Although it was known the vectors used can generate G4l8r clones 
(Fig4.3) and therefore express the neo gene, it was important to 
establish the molecular basis for expression of this and other 
transcripts arising within the vectors. (Fig.4.2). Northern analysis 
was used to study steady state levels of viral encoded mRNA species, 
however, as with all the transcription studies RNase protection 
experiments (Melton et al 1984) with the appropriate probes (Chap.3.2) 
would be required to confirm the predicted transcriptional 
units,(Fig.4.2).
RNA from virus producing cell lines was isolated as described 
in Materials and Methods before separating on a 1.4% denaturing 
formaldehyde agarose gel. The gel stained with ethidium bromide 
prior to blotting is shown in Fig. 4.9C. The 28S and 18S ribosomal 
bands are clearly visible in the ethidium bromide stained gel 
indicating the RNA is not degraded. After blotting the filter was 
hybridised with neo (Fig 4.8A), exposed to film, stripped of neo probe 
and re-probed with GM-CSF (Fig 4.8B).
In cell lines containing the vectors pVneo or pVneoGM, two 
transcripts should be detectable if the neo probe is used (Fig4.2).
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Figure 4.6
Southern analysis of virus producing clone 35 and 
3T3 fibroblast cell lines derived by infection from 
virus released from clone 35.
Lane Clone Vector Digest
1 cl-35 pVneo SstI
2 it i BamHI
3 3T3 11-8 " SstI
4 it t BamHI
5 3T3 11-7 " SstI
6 it it BamHI
7 3T3 11-6 " SstI
8 tt it BamHI
9 3T3 11-5 " SstI
10 it it BamHI
Samples were.run on a 0.7% TEA agarose gel and the
filter was probed with neo. The£4l8 resistant cell
lines were generated by infecting 3T3 cells with
virus from cl-35.
> 2 3 4 5 6  7 8 9 1 0
Figure 4.7
Southern analysis of virus producer clone 11 and 
3T3 fibroblast cell lines derived by infection from 
virus from clone 11.
Lane Clone Vector Digest
1 cl-11 pVneoGM SstI
2 3T3 25-6 " "
3 3T3 25-8 " "
4 3T3 25-9 " ”
5 cl-11 " BamHI
6 3T3 25-6 " 1
7 3T3 25-8 " ,f
8 3T3 25-9 " ”
Samples were run on a 0.7% TEA agarose gel and the 
filter was probed with neo. The G418 resistant 3T3 
fibroblast cell lines 3T3 25-6, 3T3 25-8 and 3T3
25-9 were generated by infecting 3T3 cells with 
virus from cl-11 as described in Materials and 
Methods.
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Figure 4.8
Northern analysis of virus producing clones.
Lane Clone Vector
1 ^2 /
2 cl-35 pVneo
3 cl-35 pVneo
4 cl-11 pVneoGM
5 cl-15 pVneoGM
6 cl-41 mos”^neo
7 cl-41 mos“^neo
8 cl-31 mos”^neoGM
9 it t
10 it it
11 cl-1 mos“^neo
12 AFI* /
Each sample represents an independent isolation of 
RNA. The samples were run on a 1.4% formaldehyde 
denaturing gel. AFI are normal rat kidney cells 
infected with AFI virus (Pragnell et al.1988).
A probed with neo
B The same filter re-probed with GM-CSF.
C The Northern gel stained with ethidiun bromide 
prior to blotting. The markers are 28S ribosomal 
RNA - 4.7kb, 18S ribosomal RNA - 1.8kb.
D Lane Clone Vector
1 cl-35 pVneo
2 4/2pV-4 "
3 cl-11 pVneoGM
4 cl-15 "
The samples were run on a 1.4% denaturing gel and 
the filter was probed with neo.
In some mRNA samples an apparent hybridisation to a 
mRNA species of molecular size similar to the 18S 
ribosomal RNA is observed and is likely to be 
related to the running of the ribosomal RNA.


Figure 4.9
Northern analysis of virus infected 3T3 fibroblasts 
and their respective virus producing cell lines.
A
Lane Clone Vector
1 cl-11 pVneoGM
2 3T3 25-6 »
3 3T3 25-8 "
4 3T3 25-9 11
B
Lane Clone Vector
1 cl-35 pVneo
2 3T3 11-3 n
3 3T3 11-6 "
Samples were run on 1.4% formaldehyde denaturing 
gels and the filters were probed with neo. The 
markers were 28S = 4.7kb; 18S = 1.8kb. The 3T3 
cell lines 3T3 25-6, 25-8 and 25-9 were derived by 
infection of 3T3 fibroblasts by virus from cl-11.; 
The 3T3 cell lines 3T3 11-3 and 11-6 were derived 
by infection of 3T3 fibroblasts by virus from 
cl-35.

Cell lines containing pVneo should have transcripts of sizes 3.2kb and 
2.4kb and pVneoGM containing cells should also have the 2.4kb 
transcript but due to the insertion of G M A 7 the full length 
transcript should increase in size to 4.2kb. Fig 4.8A lane 2 has RNA 
from Cl-35(pVneo) and two RNA species which hybridise to neo can be 
observed. Hybridisation to the smaller species is faint suggesting 
that at the time of cell harvest the tk promoter is not functioning 
efficiently since the smaller 2.4kb neo specific RNA is transcribed 
form the tk promoter (Fig 4.2). However a previous preparation of
mRNA from Cl-35 cells (Fig 4.8 D lane 1) did show equal,
representations of both the 3.2kb and the 2.4kb RNAs * This
observation suggests that cell lines change during passage either to 
unstable gene expression, or selection of cell line varients. If 
expression of a gene has some phenotypic effect then alteration of its 
expression during cell passage may have to be taken into account.
The cell lines Cl-11 and Cl-15 both contain the pVneoGM 
vector(Fig4.3). Fig.4.8A lanes 4 and 5 shows total mRNA form these 
cells hybridised to neo . Two species of mRNA hybridise to the neo 
probe, the larger of which corresponds to the predicted size of the 
full length viral transcript which encodes both GM&7 and neo. and the 
smaller transcript is the tkneo specific transcript. Indeed when
reprobing this filter with a GM-CSF probe (Fig4.8B lanes 2 to 5) only 
the larger message in clones 11 and 15 was detected (lanes 4 and 5), 
suggesting that the predicted transcriptional units drawn 
schematically in Fig 4.2 do exist and are present in fibroblast RNA.
RNAs from virus producer cell lines containing mos”  ^neo and
mos“^neoGM were also included on the filter shown in Fig. 4.8.
Hybridisation with a neo probe should reveal full length viral 
transcripts of 4.9kb and 5.9kb in cells containing the m o s ^ n e o  vector 
and the mos“^neoGM vectors respectively (Fig.4.2). Lanes 6-11 of 
Fig.4.8A contain RNA from mos“^neo and mos”^neoGM contaning 'Y 2 cell 
lines. All these samples show a considerable smear of hybridisation 
without any clear bands despite the integrity of the RNA (Fig 4.8C). 
These RNAs were isolated from three independent cell lines - Cl-1,
Cl-31 and Cl-41 and in the cases of CL -31 and Cl-41, more than one
independent RNA preparations were made from the same cell line (Fig4.8
lanes 6 and 7, 8-10). It is possible that the smear of hybridisation
which originates from the largest predictable transcript size
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(Fig4.2), is perhaps a feature of this vector. Hybridisation to 
GM-CSF only occurs in mRNA from cell lines containing mos“^neoGM 
vector (Fig. 4.8 B lanes 8-10). From the position of the GMA7 insert 
within the vector (Fig.4.2) the GM-CSF probe should hybridise to the 
full length viral genome transcript and a smaller 2.5kb sub-genomic 
transcript generated by splicing out the neo containing part of the 
virus. No distinct bands are observed with GM-CSF in lanes 8-10 Fig. 
4.8B except for the upper size limit of the hybridising RNA. As with 
the neo probe it is difficult to assess the transcriptional units 
within the mos’3 neo based vectors. The observation that a GM-CSF 
probe hybridises to RNA of a size greater that 2.5kb (i.e the size of 
the predicted sub-genomic message in mos“3 neoGM) suggests that 
sub-genomic splicing does not occur efficiently in this vector and 
therefore translation of the GMA7 transcript may be inefficient as 
the second protein of a bicistronic full length mRNA. Laker et al. 
(1987) also report that sub-genomic mRNA was not observed in 
fibroblasts using a similar vector.
Expression of pVneo and pVneo GM in 3T3 fibroblast cell lines 
derived bv Virus infection.
The virus producing cell line Cl-11 contains one copy of the 
pVneoGM vector per genome (Fig.4.4 lane 5; Fig 4.7 lane 5) which has 
not been rearranged (Fig.4.4 lane 2; Fig 4.7 lane 1). The 3T3 cell 
lines 3T3 25-6, 3T3 25-8 and 3T3 25-9 were selected for G4l8r after
infection by virus released from Cl-11 and all three cell lines 
contain intact retroviruses (Fig. 4.7 lanes 2,3,4). Moreover it is 
likely that 3T3 25-9 contains only one provirus copy per genome as 
assessed by Southern analysis (Fig4.7 lane 8). mRNA was extracted 
from the Cl-11 and the three cell lines derived by infection with 
virus from €1-11, in order to examine the expression of pVneoGM in 
several related cell lines. Fig. 4.9 A lanes 3 and 4 shows that when 
the mRNA extracted from Cl-11 and 3T325-9 was hybridised to neo, the 
two characteristic mRNA species associated with pVneoGM expression 
(Fig4.2) were observed. It can be concluded that the viral mRNA 
observed for Cl-11 and 3T3 25-9 are , transcribed form a single
virus within the cell lines. In the case of Cl-11 this is a single 
transfected vector (Fig.4.3), while in 3T325-9 expression is from a 
single provirus.
A similar analysis was carried out on mRNA extracted from
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Cl-35 and infected cell lines 3T311-3, 3T311-6 (Fig 4.9B). Cl-35 and
3T311-6 were generated by viral infection and contain one copy of 
unrearranged provirus each, (Fig 4.4 lanes 1 and 5; Fig. 4.5 lanes 
1,4,3 and 6, Fig4.6 lanes 1, 2, 7 and 8). The parental and 3T3
fibroblast cell lines derived by viral infection all show the 
characteristic hybridisation to two mRNA species (Fig4.9B) which in 
the cases of Cl-35 and 3T311-6 results from transcription of a single 
proviral copy per genome.
4.4 Growth Factor release from ¥ 2 virus producing cells and 
infected 3T3 fibroblasts
The previous sections have dealt with the molecular analysis 
of H* 2 clones which produce virus and 3T3 fibroblast cell lines
derived by virus infection- It is possible that if a particular cell 
line harboured a GM&7 retrovirus and the mRNA was efficiently
translated and the protein transported to the cell membrane, that
GM-CSF activity should be detectable in the culture medium. The level
of GM-CSF activity in the culture medium may then reflect the 
molecular expression of the vectors. In order to investigate this 
possibility the amount of GM-CSF present in culture medium conditioned
by various cell lines was measured (Fig. 4.10 and 4.12). The culture
media from semi-confluent Y 2 or 3T3 fibroblast clones was removed 
after 3 days,(3 day conditioned media) and stored at -20^ C.
Conditioned media from virus producing clones was heated to 56^C prior 
to use ir^ brder to inactivate virus in the media. Growth factor
activity in the conditioned media was tested in the CFU-C progenitor 
assay ( as described in Materials and Methods). Briefly, 100 pi of 
the test media was added to the bottom of a 3cm dish either in the 
presence or absence of antiserum to GM-CSF. Antiserum to GM-CSF 
(Delamarter et al., 1985) was used to define the specificity of the
colony stimulating factor activity. In experiments using antiserum to 
GM-CSF the test media was incubated for 30min at 37^C prior to 
addition to the culture dish. Bone marrow cells from the femurs of 
NIH mice were added as a suspension in 0.3% agar at a cell density of 
7.5x104 cells/ml (1ml per 3cm dish). The dishes were incubated in a 
humidified 5% CO2 incubator for 7 days and colonies counted using a 
dissection microscope.
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CSF activity in Conditioned media from V 2 cells
Conditioned media from H*2 cell lines which release either 
pVneo or mos ^neo virus do not exibit colony stimulating activity 
(Fig. 4.10 expts. 1,5 and 6). The NP2 cell lines which harbour either 
pVneoGM or mos“3 neoGM gave variable results. Clones 11 and 13
release pVneoGM virus and conditioned media from these cells
stimulates a frequency of colony growth from bone marrow progenitors 
(Fig. 4.10 expts 2 and 3) comparable to control stimulation by pure 
recombinant GM-CSF protein (Fig. 4.10 expt 8). The colony stimulating 
activity released form these cell lines is GM-CSF since addition of
antiserum to GM-CSF to the cultures reduces colony stimulation to zero
(Fig. 4.10 expts. 2 and 3).
Clone 15 also releases pVneoGM virus and conditioned media 
from this cell line stimulates colony growth in the progenitor assay 
(Fig. 4.10 expt 4). However this activity was only partially reduced 
by antiserum to GM-CSF. It is possible that the titre of antiserum is 
not high enough to completely neutralise the GM-CSF protein present. 
However the same batch of antisera completely neutralised GM-CSF 
activity form Cl-11 conditioned media (Fig. 4.10 expt 2), which in the 
absence of antisera stimulated 52 colonies per 10^ cells. Therefore it 
is more likely that some of the activity observed in the conditioned 
media from Cl-15 is due to some other growth factor (or factors) other 
than GM-CSF.
The conditioned media from mos“^neoGM virus releasing clone-31 
has no colony stimulating activity (Fig. 4.10 expt. 7). As shown in 
chapter 4.3 and in Fig 4.8B, clone 31 does harbour mos“3 neoM viral 
sequences and expresses both neo and GM&7 at the transcriptional 
level. However as discussed in the previous section it is apparent 
that translation of GM&7 in this cell line is from either in 
inefficiently spliced sub-genomic mRNA or from the second cistron of a 
bicistronic, full length viral mRNA. The virtual absence of any CSF 
activity in the conditioned medium from Cl-31 may be a reflection of 
the inefficient expression of the GM&7 part of the viral genome.
CSF activity in conditioned media from virus infected 3T3 fibroblasts
A variety of 3T3 fibroblast cell lines which had been 
established by virus infection and G418 selection (see Materials and 
Methods) were tested for release of growth factor into the culture
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Figure 4.10
Growth factor release from ^ 2 cells.
The 3 day conditioned media (CM) from f 2 virus 
producer clones (Fig. 4.3) was assayed for growth 
factor activity in the CFU-C progenitor assay. 
100pl of the test CM was added to 3cm petri dishes. 
1ml of 0-3% soft agar containing 7.5x10^ cells was 
then overlayed. For experiments involving 
antiserum to GM-CSF, the test CM was incubated for 
30min at 37®^ with the antiserum prior to addition 
to the culture dish. Colonies were counted 
after 7 days with the aid of an inverted microscope 
and expressed as colony number per 10-* bone marrow 
cells plated . Experiments 1,2,6,8,9 and 10 were 
repeated twice, initially in duplicate plates, then 
triplicate. All other experiments were performed 
once in triplicate. Recombinant GM-CSF (rGM-CSF) at 
875pg/ml was used as a control stimulus.
GROWTH FACTOR RELEASE FROM f 2 CELLS
EXPT. CONDITIONED MEDIA
1 cl-35
2 cl-11
3 cl-13
4 cl-15
5 cl-41
6 cl-1
7 cl-31
8 rGM-CSF
VECTOR ANTISERA TO 
GM-CSF
pVneo
pVneoGM
+
pVneoGM
+
pVneoGM
+
-3roos neo 
-3mos neo 
mos neoGM
COLONIES/105 
CELLS
0
52
0
34
0
66
21
0
0
2
0
34
0
Figure 4.11
Growth factor release by 3T3 fibroblasts infected 
by retrovirus vectors.
13 3T3 fibroblast cell lines established after 
viral infection were analysed for growth factor 
release into the culture medium. The CFU-C 
progenitor assay was used to evaluate stimulatory 
activity in the conditioned media from the 3T3 cell 
lines. 100pl of conditioned media (CM) was added 
to 3cm petri dishes which were overlayed with 1ml 
of 0.3% soft agar containing 7.5x10^ bone marrow 
cells. Colonies were counted 7 days later with the 
aid of an inverted microscope and the number of 
colonies expressed per 10^  input bone marrow cells. 
Controls were CM from uninfected 3T3 cells, special 
liquid medium (SLM), AFI CM (Pragnell et al., 1988
and no added mediun. In each case 100pl were added 
per 3cm dish. Experiments 10 and 11 were repeated 
3 times. Experiments 11, 2, 3, 4, 9, 12, 13, and 
17 were repeated twice. Experiments 5, 6, 7, 8,
14, 15, and 16 once. Duplicate plates were counted 
for each experiment.
GROWTH FACTOR RELEASE BY 3T3 CELLS
EXPT. CONDITIONED MEDIA
1 11-3
2 11-5
3 11-6
4 11-7
5 11-8
6 25-6
7 25-8
8 25-9
9 24-4
10 10-1
11 10-7
12 10-8
13 10-9
14 3T3
15 S.L.M.
16 /
17 AFI
VECTOR COLONIES/105 CELLS
pVneo 118
pVneo 102
pVneo 120
pVneo 110
pVneo 57
pVneoGM 103
pVneoGM 94
pVneoGM 79
-3mos neo 77
mos neoGM 116
mos neoGM 128
mos neoGM 88
mos neoGM 105
Uninfected 0
0
0
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medium. Figure 4.11 summarises the results of 13 3T3 cell lines which
harbour the virus vectors shown. It is immediately obvious that
conditioned media from all of these cell lines have CSF activity 
irrespective of the vector with which they were infected. For
example, although the cell lines in Fig. 4.11 Expts. 6,7,8,10,11,12 
and 13 should be capable of producing GM-CSF activity, as they were 
infected with either pVneoGM or mos”3neoGM. The cell lines in
experiments 1-5 and 9 were derived from infection by pVneo or mos“^neo 
and should not produce CSF activity. However, in comparison to 
uninfected 3T3 fibroblasts (Fig 4.11 expt. 14) the conditioned media 
had a higher titre of CSF activity than unstimulated controls.
This result is not entirely unexpected as Koury and Pragnell 
(1982) have shown that many fibroblast lines including NIH3T3 cells 
can be induced to release granulocyte/macrophage type stimulating 
activity after infection with retrovirus.
Discussion
Virus producing cell lines have been established which release 
virus of the four vectors required in this study (Fig4.3). Analysis 
of S>2 virus producing cell lines by Southern blotting revealed that 
in most instances the vector genome was not grossly rearranged, and 
was often present in only one copy per cell genome (Fig4.4). The 
virus particles released from the cell lines can therefore be assumed 
to be homogeneous. Southern analysis of 3T3 fibroblasts infected with 
virus, confirmed that the same sized virus was present in parental 
virus producing cells and 3T3 cell lines derived by infection with 
virus from the parental line (Figs. 4.6 and 4.7). Of the two methods 
used to generate the virus producing clones (transfection and 
infection) those produced by infection showed fewer abnormalities in 
virus expression. One clone, Cl-1 derived by transfection (Fig. 4.3), 
contained many copies of the viral vector some of which were probably 
rearranged (Fig. 4.5). Although virus of the correct size was 
released from this cell line, (Fig.4.8) it cannot be ruled out that a 
heterogeneous population of virus particles is released. In 
addition, this clone released helper virus (helper virus assay kindly 
performed by Dr D. Onions) and so is unsuitable for some experiments.
Another clone, 'f'2pV4 which was generated by transfection of 
pVneo into ^2 cells , failed to show any detectable virus production
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(data not shown) but the 4*2 clone was resistant to G418. Only one 
mRNA species was detectable by hybridisation to neo ,(Fig. 4.8 D lane 
1), and it corresponded to the 2.4kb tkneo transcript predicted to be 
present in cells containing this construct (Fig4.2). The failure to 
detect hybridisation of a mRNA species corresponding to the full 
length genomic viral mRNA, suggests that full length viral mRNA is not 
being produced. It is therefore possible that the lack of detectable 
virus production form f2pV4 is due to an rearranged vector which is 
still capable of producing neo specific mRNA but which does not 
produce packagable full length mRNA.
In the light of the results obtained with clone 1 and ^  2pV4 
it is perhaps better to generate virus producing cell lines by 
transient transfection followed by infection rather than stable 
transfection. This approach would select for vector molecules that 
can complete one round of virus replication and retain a selectable 
marker. Vectors introduced into packaging cell lines in this way may 
avoid random DNA breaks in the transfected plasmid which may occur 
prior to plasmid integration into the host genome
Once the vector had been introduced into the packaging cell 
lines and these had been tested for virus release, Northern analysis 
of pVneo or pVneoGM containing cells was used to demonstrate that the 
predicted viral transcriptional units (Fig4.2) were utilised (Fig. 4.8 
A, B, D), although RNase protection studies (Melton et al 1984) would 
be required to formally demonstrate this. The efficient use of 
MoMLV LTR promoter in the fibroblast cells (Fig4.9A, B) resulted in 
detectable growth factor release from 4/2 cells harbouring the pVneoGM 
vector which could, in most instances be neutralised by antiserum 
against GM-CSF (Fig. 4.10).
At the molecular level, cells harbouring the vectors mos“3neo 
and mos'^neoGM were more difficult to analyse due to the lack of 
discernable discrete neo or GM-CSF hybridising mRNA species (Fig. 4.8) 
A predicted 2.5kb sub-genomic mRNA that should be generated from cells 
containing the mos""^ neoGM vector and detected by the GM-CSF probe 
(Fig. 4.2) was not observed (Fig. 4.8 B). However the GM-CSF probe 
did hybridise to mRNA of higher molecular weight, suggesting that the 
viral splice donor and acceptor sites were not used. This would 
result in a polycistronic mRNA from which GM-CSF would have to be 
translated as the second protein after the neo product (Fig 4.2) a
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process which is likely to be a rather inefficient. The lack of 
detectable colony stimulatory activity in the conditioned media from 
Cl—31 (Fig 4.10) which harbours a mos”^neoGM vector, suggests that 
translation of the mRNA species that hybridises to GM-CSF in this 
clone (Fig4.8 B) is inefficient as suspected.
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CHAPTER FIVE
Retroviral Infection of FDCP1 Cell Line 
Introduction
One aim of this project was to study the growth
characteristics of haematopoietic cell lines which express murine 
GM-CSF cDNA from a constitutive promoter. If a cell line requires
GM-CSF for its survival and proliferation in culture, autocrine
stimulation of the cell line can be compared to growth response to
exogenously added GM-CSF. In turn, the growth properties of
haematopoietic cells harbouring a GM-CSF retroviral vector should be a 
reflection of the molecular expression of the vector. By studying 
both the cellular behaviour and the molecular expression of the
vector, it should be possible to determine whether retroviral vectors 
can be used to generate predictable and repeatable effects, which is 
important since it is only in the confidence that the phenotypic 
effect observed in cultures is due to retroviral expression, that the 
more complex situation of retroviral mediated gene transfer into
primary haematopoietic cells can be addressed.
Retroviral expression could be studied exclusively in 
fibroblast cell lines, but haematopoietic and fibroblast cells are 
clearly specialised for different purposes and gene expression may 
vary between different cell lineages (Magli et al., 1937; Kwoik et
al.. 1986; Williams et al., 1986; Mclvor et al., 1987). It is also
conceivable that cells at different stages of differentiation within
any lineage may, on infection, permit varying degrees of viral 
expression (Gorman et al.. 1985; Franz et al., 1986; Rubenstein et
al.. 1984; Williams et al.. 1986).
In order to study retroviral expression in haematopoietic
cells, gene transfer can be carried out in both haematopoietic cell 
lines and primary bone marrow derived haematopoietic cells.
The FDCP1 cell line is a non-adherent murine haematopoietic 
cell line derived from a long term marrow culture, which displays 
primitive granulocytic morphology but does not form CFU-S foci in 
spleens of irradiated mice (Dexter et al1980a). It is ideal as a
recipient cell line for GM-CSF vectors as it is dependant for its 
survival in culture on exogenously added GM-CSF (or 11-3) (Dexter et 
al 1980a, Hapel et al 1984). Thus once the GM-CSF vector has been 
transferred into the factor dependent FDCP1 cell line, the phenotypic
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properties should be a result of autocrine stimulation due to 
expression of vector encoded GM-CSF.
Autonomous growth of tissue culture cells and tumours
Malignant cells in tissue culture require fewer exogenously added 
growth factors than normal cells to trigger proliferation to allow 
their survival (Holley et al., 1975). The difference between
"normal" and "malignant" cells could reside in the fact that malignant 
transformed cells produce and respond to growth factors which normally 
have to be supplied (Sporn and Roberts, 1985). Such cells are 
described as being autocrine stimulated (Sporn and Roberts, 1985). 
The reduced requirement for growth factors may also be due to an 
increased sensitivity to low levels of exogenous factor suboptimal for 
normal cell growth (Cory et al., 1987).
In support of the autocrine hypothesis many small cell lung 
cancer (SCLC) cell lines have been shown to secrete the growth 
stimulator bombesin and bombesin like peptides (Cuttitta .et al. T 
1985). These SCLC cell lines will grow clonally In vitro and as 
xenographs in vivo, but their growth can be inhibited by antiserum 
specific to bombesin (Cuttitta et al., 1985. It has also been
observed that murine cells transformed with murine sarcoma virus 
become less dependent on serum growth factors and secrete 
autostimulatory polypeptides referred to as transforming growth 
factors.lt is not clear however, if in all cases of autocrine 
stimulation the growth factor must necessarily be released from the 
cell to elicit a response (Robbins et al. 1985, Betsholtz et al. 1984)
Fibroblasts infected with simian sarcoma virus (SSV) produce a 
virally encoded protein which has extensive homology to the beta chain 
of human platelet derived growth factor (PDGF), (Waterfield et al., 
1983; Doolittle et al., 1983). Fibroblasts which have receptors for 
PDGF and are infected with SSV, proliferate in response to the virally 
encoded p28v~sis(Huang et al., 1984; Johnson et al., 1985). Betsholtz 
et al. (1984) reported expression of PDGF like molecules from a human
osteosarcoma cell line with constitutively activated PDGF receptors, 
however antibodies raised against PDGF failed to inhibit the 
proliferation of the cell line and so in this instance PDGF may not
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effect the phenotype of the cell. Therefore, alternatively the 
growth factor may not have to be released (and so be available for 
antibody neutralisation) in order to activate their receptors and it 
is of interest that Robbins e t al. (1985) report that the majority of 
PDGF in SSV transformed fibroblasts remains associated with the cell 
membrane.
Autocrine stimulation of haematopoietic cells
Two groups have reported retroviral mediated transfer of 
GM-CSF into haematopoietic cells resulting in autocrine stimulation 
of the recipient cell line (Laker et al., 1987; Lang et al., 1985).
However, despite the fact that both groups used the same recipient 
cell line (GM-CSF dependent FDCP1) slightly different results were 
reported. Lang et al. used a MoMLV based vector termed GMV, which 
after infection of the FDCP1 cell line resulted in cell lines which 
grew in the absence of exogenously added GM-CSF and released GM-CSF 
into the culture medium. Although the GM-CSF activity in conditioned 
medium from GMV infected cells could be neutralised by antiserum 
raised against GM-CSF, direct addition of antiserum to microwell 
cultures of factor independent GMV infected FDCP1 cells did not 
inhibit their proliferation. Thus the released GM-CSF may not be 
responsible for the observed factor independence. However, the GM-CSF 
vector appears to be responsible for the factor independent phenotype 
of the infected FDCP1 cells since infection with parental virus does 
not result in factor independence , although high affinity growth 
factor/receptor interaction may occur very quickly at the cell 
surface, or even internally, so excluding antiserum interference. 
Indeed, the possibility of a membrane bound form of GM-CSF has been 
proposed by Gough et al (1985). Such GM-CSF could possibly interact 
with its cognate receptor without being released from the cell 
surface. A similar situation may occur in the osteosarcoma cell 
line described above which releases PDGF (Betsholtz et al., 1984).
Laker et al. (1987) have infected the FDCP1 cell line with
GM-CSF retroviruses based on MPSV and MoMLV based Z-GMV. In contrast 
to the above observations by Lang et al. (1985), cell lines derived
from GM-CSF virus infections apparently still required release of 
endogenously produced GM-CSF as part of the autocrine stimulation 
pathway. However, after repeated cell passage the requirement for
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released growth factor reduced and the factor independent cell lines 
became more similar in phenotype to those described by Lang et al. 
(1985). Laker et al. (1987) propose that during cell passage further 
mutations may occur which result in the eventual loss of requirement 
for external stimulation by growth factor. It is possible therefore 
that the phenotype of the cell lines described by Lang et al. is 
either due to prolonged passage of factor independent clones in tissue 
culture or a reflection of initial cell cloning conditions such as 
cell density during selection for factor independence (Metcalf et al.. 
19810.
5.1 Retroviral infection of the FDCP1 cell line
The FDCP1 cell line has been infected with a variety of 
neomycin containing retrovirus resulting in up to 20% of the 
clonogenic population becoming resistant to G418 (Lang et al., 1985;
Cory et al., 1987; Metcalf et al., 19810. Laker et al. (1987)
directly compared the ability of MPSV vectors to generate either G418 
resistant fibroblast or FDCP1 haematopoietic colonies, and established 
that both fibroblasts and haematopoietic cells were infected with 
equal efficiency. This is in contrast to the low efficiency of 
infection of haematopoietic cells observed by Lang et al. (1985) using 
MoMLV based vectors.
In this study, infection of FDCP1 cells was carried out by 
co-cultivating up to 2 x 10^  cells for 24h with the H* 2 virus 
producer clones seeded out 24h previously at 5 x 103 cells per 25cm 
flask. Co-cultivation of the virus producing cell line with the target 
cell population has been demonstrated to be more efficient than virus 
supernatant for infection of haematopoietic cells, (Lang et al. (1985; 
Eglitis et al., 1985). The FDCP1 cell line is normally passaged 
using 10% WEHI 3B CM as a source of growth factor (Dexter et al 198Cd(, 
therefore conditioned media (CM) from the WEHI 3B cell line was added 
to a final concentration of 10%. Polybrene at 6 jig/ml was added to 
aid virus absorption. After 24h non-adherent cells were removed, 
washed twice in PBS to remove growth factors and resuspended in medium 
which contained no added growth factor. The FDCP1 cells were counted 
using a Coulter counter and left on ice. The cells were then 
mixed with semi-solid media (0.3% agar orD0% methocellulose) as a 
single cell suspension at the appropriate cell density and dispensed
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into 3cm dishes in 1ml aliquots. The 3cm dishes were prepared by 
adding the required growth or antibiotic supplements prior to the 
addition of cells. Thus the appropriate concentration of G418 or 
growth factor could be varied between plates.
After each infection the cells were plated out in semi-solid 
medium under the following conditions (Fig 5.1)
i) normal growth conditions + 10% WEHI 3B CM, - G418. This gives 
the replating efficiency of the cells.
ii) Selection for neo expression 10% WEHI 3B CM + 1mg/ml G418.
iii) Selection for GM-CSF expression, -WEHI 3B CM, - G418.
The cells were grown under selective conditions for one week
and colonies counted using an inverted microscope. If infected 
parental FDCP1 (FD cells ) were incubated without added growth factor, 
no colony formation occured (Fig 5.7). Similarly in the presence of 
10% WEHI 3B CM and 1mg/ml G418, no colony formation occured (Fig. 
5.7). The relative plating efficiency is the ratio of colony 
formation under selective conditions to colony formation under 
non-selective conditions (+ 10% WEHI 3B CM, no G418) expressed as a 
percentage.
Prior to the addition of FD cells to the virus producer cells,
a O
the 24h old virus medium was removed and stored at-20 C for up to one 
month. This medium could then be assayed for the presence of virus 
on 3T3 fibroblast cells, thus giving as indication of the viral titre 
of the cell line immediately prior to the addition of FDCP1 cells.
The virus titre on 3T3 fibroblasts is also shown in Fig. 5.1.
G418 resistance in FDCP1 cells
All four of the viruses used in this study (Fig 4.2) can be 
selected for G418 resistance (neomycin selection). Following 
infection of the FD cell line and selection for neo expression (G418,
+ WEHI 3B in Fig. 5.1), varying numbers of G418 resistant colonies 
grew in each experiment, demonstrating that viral infection and 
expression could be achieved using all four vectors. There is a 
slight indication that mos”^neo virus may be more efficient than pVneo 
in confering G418 resistance to FD cells (Fig. 5.1 experiments A and
B) however, in one other paired experiment using clones which release 
pVneo or mos'^neo virus, the mos”  ^ neo producer clone was very 
inefficient in conferring G418 resistance to FD cells (Fig 5.1 expt*
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Figure 5.1 
Retrovial infection of FDCP1 cell line 
Infection of FDCP1 (FD) cells was carried out by 
co-cultivation of up to 2x 10 FD cells with virus 
producing cells seeded out 24h previously at 5 x 
10^  cells per 25cm^ flask. After 24h, non-adherent 
cells were removed. 3cm petri dishes were 
prepared by addition of growth supplement (10% 
WEHI) and antibiotic (1mg/ml G418) and overlayed 
with 0 *9% methylcellulose (1ml per 3cm dish)
p
containing a range of cell densities from 10 to 
105 cells/ml. At least 3 cell densities wre used 
in each experiment, with 3 or 5 plates per point. 
The infected cells were plated out under these 
conditions:-
i) 10% WEHI CM, this us the replating efficincy of 
the cells under normal growth conditions.
ii) + 1mg/ml G418, + 10% WEHI CM selection for neo
expression.
iii) -G418, -WEHI CM, this selects for growth 
factor independent growth.
The relative plating efficiency is the ratio of
colonies which develop under the selective
conditions to colony formation under normal 
conditions expressed as a percentage.
If no colony formation occurred, the frequency of 
one 11 imaginary" colony out of the total number of 
cells plated was calculated and the frequency of 
colony formation expressed as less than this.
Also included is the virus titre on 3T3 fibroblasts
of the clones immediately prior to the addition of 
FD cells. Colony formation is expressed as G418 
colony forming units per ml on 3T3 fibroblasts.
RETROVIRAL INFECTION OF FDCP1 CELL LINE
EXPT.
A
B
C
D
E
CLONE VECTOR TITRE 
ON 3T3’S
37 pVneo >10
41 mos- n^eo 5-3x10'
REPLATING 
EFFICIENCY 
+WEHI %
RELATIVE PLATING 
EFFICIENCY % 
+G418 -G418
+WEHI -WEHI
32
39
8 <3-6x10'
60
-2
<2.6x10-2
34 pVneo 
7 mos neo
2x10-
1.7x10
36 pVneo 
2 mos neo
5.9x10*
3-5x10:
35 pVneo 
11 pVneoGM
>10'
2.8x10
11 pVneoGM 
15 pVneoGM
6.9x10
5.BX101
1 mos neo 2x10
31 mos” n^eoGM 5-3x10^
44
40
1 <2.3x10'
6 <2.5x10
-2
-2
127
156
3 <7-9x10
0.9 <6.6x10
-3
-3
4
10
4 <3x10
2.5 1-8
-2
26
16
3 1.6  
6.5 2.4
20
33
49 <5.6x10
5 0.1
-3
C). The percentage of clonogenic FD cells which can be infected and 
express the neomycin gene ranges from 0.9% to 60% and is therefore as 
efficient as previously published infections of FD cells (Lang et al.. 
1985; Cory et al., 1987; Metcalf et al., 198£).
Virus expression of GM-CSF in the FDCP1 cell line
By plating out virus infected FD cells in methocell without 
WEHI 3B CM or G418, it should be possible to generate factor 
independent (FI) colonies, if the retrovirus used in the infection
contains and expresses GM-CSF sequences (Lang et al., 1985; Laker et
al., 1987). Fig 5.1 shows that all infections with either pVneoGM or 
mos”^neoGM generated growth factor independent colonies. In the case 
of pVneoGM infected FD cells between 1.6% and 2.4% of the clonogenic 
cells infected developed into factor independent colonies whereas only 
0.1% of the clonogenic cells infected by mos“^neoGM resulted in factor 
independent colony growth. The lower conversion of mos“^neoGM
infected cells to factor in dependence could be due to a lower 
percentage of infected cells than observed in the experiments using 
pVneoGM, but mos”^neoGM virus converts 5% of FD clonogenic cells to 
neomycin resistance which is comparable to pVneoGM virus (Fig 5.1). 
It can therefore be concluded that mos“^neoGM virus from clone 31
efficiently infects FD cells but when the GM-CSF unit of the vector is 
assayed for expression, it is less efficient in converting FD cells to 
factor independence by a factor of ten, than the pVneoGM vector. In 
viral infections using either pVneo or mos“ n^eo, if no factor 
independent colonies were observed, a frequency for one imaginary 
factor independent colony out of the total number of cells plated out 
can be calculated, and the conversion to factor independence 
expressed as less than this. Therefore although the conversion of FD 
cells to factor independence is lower using mos~3neoGM virus producer 
cells, than 2 clones releasing pVneoGM, the number of factor 
independent colonies is at least 100 fold greater than any spontaneous 
background of factor independent colonies (Fig 5.1). Only in one 
infection with a mos”^neo virus were sufficient numbers of FDCP1 cells 
plated out (5.55x10^cells) which demonstrated spontaneous colony 
formation at a frequency of 1 in 7.9 x 10^cells plated out (1.26 x 
10~3 %) (data not shown).
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5.2 Establishment of virally infected FDCP1 cell lines
A number of cell lines were established from the virally 
infected FD cells to enable further studies on vector expression to be 
carried out. In order to generate cell lines, infected FD cells were 
selected for either resistance to G418 or for growth factor 
independent colony formation. These colonies were picked in a volume 
of 50 pi using a Pippetteman and transferred into liquid medium which 
maintained the initial selection. Fig 5.2 shows the number of 
successfully established cell lines, the viruses they contain and the 
conditions under which they were selected. All colonies selected in 
+WEHI, +G418 conditions, could be immediately transferred into 5ml of 
growth media in 25cm flasks. However colonies which were selected 
for growth factor independence (-WEHI, - G418) had to be transferred 
initially in 100 pi of medium in 96 well dishes, and allowed to reach 
a high cell density, before transfer into 1ml of culture medium in 6 
well dishes (Costar). Again, these cells were left until a high cell 
density was reached, and then transferred to 5ml of medium in 25cm^ 
flasks. Selection pressure was maintained at all times. The factor 
independent cell lines (-G418, -WEHI) were maintained and passaged at 
high cell density as it was observed that cell growth did not occur if 
the cells were seeded out too sparsely. It should be noted that of 89 
pVneoGM factor independent colonies transfered only 18 generated cell 
* lines (Fig. 5.2). In comparison relatively few colonies had to be 
picked in order to establish all the other cells lines (Fig 5.4).
Once the cell lines were established, experiments were 
designed to examine expression of the retroviral vectors in the FD 
cells under different selective conditions. Thus the expression of 
both selected and non-selected genes could be related to cell line 
phenotype. For example cells grown in +G418, +WEHI conditions are 
dependent only on expression of neo for their survival. However if the 
cell line harbours a GM-CSF retrovirus and the GM-CSF unit is 
transcriptionally active then these cells should replate under factor 
independent growth conditions (-G418, -WEHI). It is possible that the 
previously discussed phenomenon of epigenetic suppression (Emmerman 
and Temin 1984, Chap.1.7) may act on these vectors to silence 
non-selected genes which would result in their inability to replate 
into previously nonselected conditions.
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Figure 5.2
Establishment of cell lines from virus infected 
FDCP1 cells.
A number of cell lines were established after 
infection of the FD line by the four retroviruses 
used in this study (Fig. 4.1). Varying nunbers of 
well isolated colonies were picked after one week 
of culture and maintained under the same growth 
conditions in which they were originally selected. 
All clones which were selected in +G418, +WEHI were 
transferred directly from methylcellulose into 
25cm^ flasks containing 5ml media including the 
appropriate growth factor and antibiotic 
supplements necessary for the maintainance of 
selction.
All factor independent colonies (-1mg/ml G418 -10% 
WEHI were transferred from methylcellulose to 96 
well dishes (100pl) then to 6 well dishes (1ml 
medium) and to 25cm^ flasks (5ml). Selection was 
maintained at all times and the cells were allowed 
to attain a high density before transfer into 
increasing volumes of media.
ESTABLISHMENT OF CELL LINES FROM VIRUS INFECTED FDCP1 CELLS
VIRUS
pVneo
pVneoGM
pVneoGM
-3mos neo
mos neoGM
SELECTION NO. OF COLONIES NO. OF CELL
PICKED LINES ESTABLISHED
+G418 24 11
+WEHI
+G418 24 11
+WEHI
-G418 89 18
-WEHI
+G418 24 24
+WEHI
+G418 24 24
+WEHI
mos*"^ neoGM -G418 12 7
-WEHI
5*3 Replating of individual FDCP1 cell lines harbouring either 
pVneo or pVneoGM initially selected in +G418. +WEHI.
The twelve clones shown in Fig. 5*3 contain either pVneo or 
pVneoGM and were selected and maintained in media selective for neo 
expression. The cell lines which contain pVneoGM can be used to study
the expression of the non-selected GM-CSF gene by replating into
factor independent conditions in methocell. Fig. 5.3 shows the 
clones, the virus they contain, their replating efficiency in 
methocell under normal conditions for the parental FD cell line (+10% 
WEHI CM) and their relative plating efficiencies under selective 
conditions for either neo expression (+ G418, +WEHI), GM-CSF
expression, (-G418, -WEHI) or double selection for neo and GM-CSF 
(+G418, -WEHI). Cells were plated out in triplicate at 10^ , 10^ , 10-*
cells per ml but only plates at 10^  cells per ml were informative.
All twelve clones replate with varying but high (greater than 
70%) efficiency into methocell containing +G418, +WEHI. This 
efficiency is to be expected as all these cell lines were maintained
in liquid culture in +G418, +WEHI. Also as expected the six clones
B4, B5, A3, B8, A9, and A11 which harbour pVneo do not generate factor 
independent colonies when replated under the appropriate conditions 
(-G418, - WEHI) at 10^ , 1o\ and 10^  cells per millilitre (10^  cells
only shown in table 5.3)*
The clones E8, E5, D5, D4, E4 and E11 contain pVneoGM and were 
selected for neo expression (Fig. 5.3) • These six clones can 
therefore be used to investigate GM-CSF expression from the 
non-selected transcriptional unit of pVneoGM by replating the cells 
under conditions which select for factor independent colony growth 
(-G418, -WEHI). When this was carried out the six clones showed 
variable plating efficiency in -G418 -WEHI conditions in relation to 
+WEHI, ranging from 0 to 60% (Fig. 5.3). The low plating efficiency 
of five of these clones (E5, D5, D4, E4, E11) in the absence of added
growth factor in comparison to colony growth stimulated by WEHI CM 
implies that autocrine stimulation of these clones by GM-CSF is not so 
efficient as exogenous stimulation by WEHI CM. This may be due to 
differences in efficiency of stimulation by GM-CSF and WEHI CM, 
however addition of recombinant GM-CSF to parental FDCP1 cells results 
in a replating efficiency almost as high as WEHI CM (Fig. 5.10). The 
lower plating efficiency of the clones in the absence of growth factor
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Figure 5.3
Replating of individual FDCP1 clones selected for 
G418 resistance (+G418, +WEHI).
12 clones selected for G418 resistance (+1mg/ml 
G418, +10% WEHI) were plated out under several
growth conditions. This figure shows these clones 
and the virus they harbour. The cells were plated 
out at 103, 10^  and 10^  cells per ml (3cm plates,
1ml per plate in triplicate) and colonies counted 7 
days later. Only the data for cells plated out at 
10^  cells/ml is shown. The relative plating 
efficiency is the ratio of colony formation under 
selective conditions to colony formation under 
non-selective conditions (+ 10%WEHI) expressed as a 
percentage. 
n.d. = not done
REPLATING OF INDIVIDUAL FDCP1 CLONES SELECTED +0418 +WEHI
CLONE VIRUS REPLATING 
EFFICIENCY % 
+WEHI
RELATIVE
+G418
+WEHI
PLATING
%
-G418
-WEHI
EFFICIE]
+G41I
-weh:
B4 pVneo 25 124 0 n.d.
B5 pVneo 10 50 0 n.d.
A3 pVneo 5 114 0 n.d.
B8 pVneo 15 98 0 n.d.
A9 pVneo 4 200 0 0
A11 pVneo 2 160 0 0
E8 pVneoGM 33 77 60 n.d.
E5 pVneoGM 15 20 7.5 n.d.
D5 pVneoGM 17 72 15 n.d.
D4 pVneoGM 7 107 10 28
E4 pVneoGM 22 58 4 4
E11 pVneoGM 7 70 0 n.d.
is perhaps due to inefficient production of retrovirally encoded 
GM-CSF by the FDCP1 cells themselves. The clones E8, E5, D5, D4, E4
and E11 were initially selected for neo expression and therefore if 
epigenetic suppression was ocurring (Emmerman and Temin, 1984) then 
selection for G418 resistance may have resulted in the inability of 
the integrated vectors to express the second transcriptional unit (the 
GM-CSF sequences) efficiently. Only one clone, E11, did not form any 
colonies under selection for factor independence (Fig 5.3) and so in 
five out of six clones if epigenetic suppression of viral sequences is 
occurring then it is not absolute and some GM-CSF is produced to which 
the cells can respond in an autocrine fashion. Two clones, D4 and E4 
which were replated under double selection for neo and GM-CSF 
expression (Fig 5.3) were capable of colony formation. Thus even if 
initial selection for neo does cause suppression of GM-CSF expression 
both genes are still capable of expression to a level which allows 
colony growth during double selection.
5.4 Molecular Analysis of Clone E11
One FDCP1 derived clone, El 1, which contains pVneoGM and was 
selected initially for neo expression was unable to replate into 
methocell without added growth factor (Fig 5.3). It was decided to 
analyse this clone in more detail at the molecular level in order to 
determine why clone E11 showed this phenotype. Northern ananlysis of 
total RNA extracted from FD clones derived from infections with pVneo 
or pVneoGM probed with neo (Fig 5.4) confirms that the two predicted 
mRNA species (Fig 4.2) observed in fibroblasts are present. The one 
exception to this is clone E11. Hybridisation of mRNA from El 1 to neo 
should detect two RNA species of identical molecular weight to those 
detected in Fig. 5.4A lanes 5,6 and 8. However the larger full length 
viral mRNA which encodes the GM-CSF protein (Fig 4.2) is not detected 
(Fig 5.4 lane 7). The smaller 2.4kb mRNA which may be directed from 
the tk promoter adjacent to the neo gene (Fig. 4.2) is present (Fig 
5.4A lane 7). The possibility therefore exists that selection for neo 
expression from the .tk promoter has resulted in epigenetic suppression 
of the MoMLV promoter sequences responsible for expression of full 
length viral transcripts. An alternative explanation to the 
unexpected transcriptional pattern in clone El 1 is that the vector has 
become mutated or rearranged such that tkneo transcription is still
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possible, but full length message production has become disrupted. In 
an attempt to visualise gross rearrangements of the virus, genomic DNA 
from several FD cell lines was digested with Sst1 which cleaves once 
within each of the viral LTRs (Fig. 4.2). On probing a Southern 
filter which contained DNA from six FD clones including E11 with neo, 
five of the six clones contained viral fragments of the predicted
sizes (Fig. 5.5, Fig. 4.2, Fig. 4.1). The genomic DNA from clone E11
cut with Sst1 hybridised to a 15kb fragment on probing with neo. If 
the virus was totally intact in clone El 1, a predicted 4.2kb 
hybridising fragment should be present (Fig 5.5 lanes 5 and 6) 
therefore the provirus has undergone some rearrangement in this cell 
line which is most probably the reason for the lack of full length 
viral transcript encoding the GM-CSF sequences. It can be concluded 
from this that the inability of clone E11 to replate under selective
conditions for factor independent growth is probably due to viral
rearragement and not epigenetic suppression.
5.5 Growth factor independent colony formation bv FD clones 
containing pVneoGM
The possibility exists that FD cells containing pVneoGM do not 
produce high enough levels of GM-CSF to support maximal colony growth 
in an autocrine fashion (section 5.3). The reason for this is not 
clear. The clones studied in section 5.3 were initially selected in 
the presence of added growth factor and therefore it was decided to 
examine the replating characteristics of pVneoGM containing FD cells 
which were initially selected for growth factor independent colony 
growth in an attempt to obtain further insight into the expression of 
GM-CSF.
All the FD clones in Fig. 5.6 contain pVneoGM and were 
selected for growth factor independent colony growth (-G418, -WEHI). 
Although the initial selection procedure did not require expression of 
the neo gene when these clones were replated into G418 (Fig 5.6) 
(+G418, +WEHI) all replated with high but variable efficiency. 
Therefore the neo gene is not adversely affected in terms of 
expression in the eight clones initially selected for viral GM-CSF 
expression.
As expected the three factor independent clones R5, R6 and R9
generated factor independent colonies when plated in methocell without
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Figure 5.4
Northern blot analysis of FDCP1 clones infected 
with retroviruses.
A autoradiograph of Northern blot
Lane Clone Virus Selection
1 FDCP1 / /
2 A3 pVneo +G418, +WEHI
3 B4 t! it t
4 B5 It t t
5 E5 pVneoGM it t
6 E8 t rr t
7 E11 t t t
8 T11 t -G418, -WEHI
B Ethidium bromide stained gel prior to blotting 
Total RNA was extracted from FD cell lines as 
described in Materials and Methods. Approximately 
20pg of total RNA was loaded per lane fractionated 
on a denaturing gel and analysed by Northern 
Blotting using a neo probe (Fig. 4.2)
Size markers were 28S - 4.7kb, 18S 1.8kb.
A1
B
1 2 3 45678
Figure 5.5
Southern analysis of virus infected FDCP1 clones.
Lane Clone Virus
1 FDCP1 /
2 A3 pVneo
3 B4 t
4 B5 it
5 E5 pVneoGM
6 E8 t
7 E11 ji
All genomic DNA was digested with SstI and probed 
with neo to assess viral integrity (Fig4.2). The 
clones A3, B4, B5, E5, E8 and E11 were all
initially selected for neomycin expression. Cells 
were always maintained in selctive media during 
cell culture. Markers are Hindlll digested X . 
Sizes are in kilobases.
15 —  
9-5— '
6-7 — •
4-2 —  
3-2 —
2-3 —  
1-9 —
mm*
i
mm
i
1 2  3 4 5 6 7
growth factor (-G418, -WEHI) at a cell density of 5 x 10^ cells/ml, 
however this cell density resulted in colony numbers per plate which 
were too high to count accurately (Fig 5.6). In order to obtain 
quantitative replating data for the factor independent clones, 8 
clones including R5, R6 and R9 were plated out at low cell density 
CIO* cells /ml). The results shown in Fig 5.6 demonstrate that only 
one factor independent clone (S2) generated colonies at this cell 
density. This is surprising as these clones were selected for factor 
independent growth and are capable of colony formation at higher cell 
density (5 x 10^  cells/ml). In addition at low cell density (10^  
celIs/ml) they are capable of forming colonies in the presence of WEHI 
or G418 (Fig. 5.6). It is therefore possible that these apparently 
factor independent colonies did not produce sufficient growth factor 
to allow efficient colony growth at low cell density (10^  cells/ml) 
despite their initial selection. If this is the case, the previous 
data regarding FD (pVneoGM) clones selected for neo expression which 
display a poor cloning efficiency in factor independent growth 
conditions (-G418, -WEHI) in comparison to exogenous stimulation by 
WEHI or selection in +WEHI, +G418 (Fig. 5.3) may be interpreted as 
inherently poor expression of viral encoded GM-CSF in FD cells rather 
than epigenetic suppression. Thus, although the colonies selected in 
-G418, -WEHI may appear to be completely factor independent during 
cloning their replating characteristics indicate a requirement for 
high cell density which presumably maintains the overall concentration 
of autocrine growth factor at a level compatible with colony 
formation.
If the factor independent pneoGM FD cells are producing low 
levels of GM-CSF and this determines these cell lines requirement for 
high cell density in order to form factor independent colonies, then 
it should be possible to replace the high density dependent colony 
growth by the addition of exogenous growth factor. Thus levels of 
growth factor sub-optimal for the proliferation of parental FDCP1 
cells could supplement the low level of autocrine produced GM-CSF from 
factor independent clones resulting in colony growth.
The experiment shown in Fig. 5.7 was designed to examine any 
differential response of the parental FDCP1 cell line and two factor 
independent cell lines, R5 and R6, to exogenously added recombinant 
GM-CSF, (rGM-CSF) which was added to a final concentration of 0.1%
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(9pg/ml). Fig 5.7 shows that the parental FD line was not stimulated 
to form colonies by 0.1% rGM-CSF (-G418, + 0.1% rGM) and as expected
no colonies formed when growth factor was omitted (-G418, -WEHI). In 
contrast clone R5 had a relative plating efficiency of 13% in the 
absence of growth factor (-G418, -WEHI) which increased to 46% with 
the addition of 0.1% rGM-CSF. Similarly, the factor independent clone 
R6 showed the relative replating efficiencies of 17% and 75% in the 
absence of growth factor and with the addition of 0.1% rGM-CSF 
respectively. The above data indicates that the cell lines containing 
the pVneoGM vector have a proliferative advantage over the parental FD 
cell line which may be due to a low level of virally encoded GM-CSF. 
This conclusion was confirmed by the data shown in Fig. 5.8 which 
relates colony formation to growth factor titration for clones R5, R6 
and the parental FD cell line, as it clearly shows that the two factor 
independent cell lines R5 and R6 do have a growth advantage over the 
parental FD cell line over a range of rGM-CSF concentrations from 0 to 
27pg/ml and confirms the two factor independent cell lines R5 and R6 
respond to exogenous growth factor by increasing their efficiency of 
colony formation under conditions sub-optimal for parental FD colony 
development (Figs. 5.7 and 5.8).
The data discussed above suggests that pVneoGM containing FD 
cell lines produce levels of virally encoded GM-CSF which at lew cell 
density is insufficient for maximal autocrine stimulated colony 
development. In an attempt to prove finally that GM-CSF is released 
from pVneoGM containing factor independent cell lines, growth media 
from three lines R6, R5 and R9 was removed after three days ( 3 day 
conditioned medium, CM) passed through a 0.2ji filter and then tested 
for growth factor activity. The CM was added to 500 parental FDCP1 
cells in a final volume of 10]il in Terasaki dishes, as 10% of the 
total volume, either in the presence or absence of antisera raised 
against rGM-CSF (DeLamarter et al., 1985). As the FDCP1 cell line
responds to GM-CSF, if sufficient levels of growth factor are present 
in the test CM, then the FD cells should proliferate in the absence of 
antiserum against GM-CSF, but not in its presence. The use of 
Terasaki dishes and FDCP1 indicator cells is a very sensitive method 
for detecting growth factor activity and will detect down to 
approximately 1-2 pg/ml GM-CSF (Metcalf .et al., 1986a). Duplicate
wells are scored after 48h for evidence of proliferation of the
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Figure 5.6
Replating of individual factor independent (FI) 
clones infected by pVneoGM.
Factor independent cell lines which were derived by 
infection with pVneoGM and initially selected under 
-G418, -WEHI growth conditions were analysed for 
colony formation under various growth conditions 
and at two cell densities (10^  cells /ml and 5 x10^ 
cells/ml). Triplicate 3cm dishes were used 
containing 1ml of methylcellulose per dish. WEHI 
CM was added to a final concentration of 1mg/ml and 
G418 was added to a concentration of 10% if 
required. The relative plating efficiency is the 
ratio of colony formation under selective 
conditions to colony formation under non-selective 
conditions (+10% WEHI) expressed as a percentage, 
n.d. not done
TNTC colony numbers too numerous to count.
REPLATING OF INDIVIDUAL F.I CLONES INFECTED BY 
pVneoGM IN -G418, -WEHI
CLONE CELL DENSITY REPLATING
(ml) EFFICIENCY %
+WEHI
R5 5X104 >1
R6 5x104 >1
R9 5x104 >1
R5 103 5
R6 103 0.5
R9 103 1
R12 103 7
51 103 1
52 103 3
S9 103 1.4
T11 103 2
RELATIVE PLATING EFFICIENCY 
%
+G418 -G418 +G418
+WEHI -WEHI -WEHI
T.N.T.C. T.N.T.C. n.d.
T.N.T.C. T.N.T.C. n.d.
T.N.T.C. T.N.T.C. n.d.
42 0 0
40 0 0
146 0 0
76 0 0
66 0 0
93 10 30
237 0 0
57 0 0
Figure 5.7
Response of factor independent (FI) clones to 
exogenous growth factor.
Clones R5 and R6 which were initially identified as 
colonies which grew in the absence of added growth 
factor after infection with pVneoGM. The relative 
plating efficiencies of these two clones in 
response to low levels of exogenously added growth 
factor 0.1% recombinant GM-CSF (9pg/ml) was 
compared to the response of the parental FDCP1 (FD) 
line. Triplicate 3cm dishes containing 1ml 
methocell were used per point. G418 was used at 
1mg/ml. WEHI CM was included to a final 
concentration of 10% when required. The relative 
plating efficiency is the ratio of colony formation 
under selective conditions to colony formation 
under non-selective conditions expressed as a 
percentage. Colonies of more than 20 cells were 
counted on day 7.
RESPONSE OF F. I. CLONES TO EXOGENOUS GROWTH FACTOR
CLONE CELL DENSITY 
(ml)
REPLATING
EFFICIENCY
+WEHI
RELATIVE REPLATING
+G418
+WEHI
-G418
-WEHI
FD
R5
R6
5 x 10 
5 x 10:
5 x 10-
>1
4.5
0.5
0
130
158
0
13
17
EFFICIENCY
-G418
+0.1%rGM
0
46
75
Figure 5.8
Titration of recombinant GM-CSF (rGM-CSF) against 
colony formation.
Colony formation of factor independent cell lines 
R5 (o) and R6 (x) and the parental FDCP1 cell line 
(®) in response to a titration of rGM-CSF. The 
rGM-CSF was diluted in PBS and added to the petri 
dishes in a volume of 100pl. All points were 
scored in triplicate using 3cm dishes containing 5 
x 103 cells in 1ml methocellulose. Colonies of 
more than 20 cells were counted after 7 days 
incubation. Colony numbers are expressed as a 
ratio of the number of colonies formed at any 
concentration of rGM-CSF to the colony numbers 
formed on stimulation of the parental FDCP1 cell 
line with 875pg/ml rGM-CSF.
Co C?
NT- O
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indicator FDCP1 cell line by comparing the area of the well bottom 
covered by cells in comparison to exogenously added rGM-CSF (875 
pg/ml), fresh WEHI CM and spent WEHI CM. Spent WEHI CM was obtained 
by removing the growth medium from parental FD cells after 5 days of 
culture.
The results of this experiment are shown in Fig. 5.9. As 
expected the FD cells proliferate in response to rGM-CSF and WEHI CM, 
but antiserum against rGM-CSF only inhibits FD proliferation when 
rGM-CSF is added but not WEHI CM (the active factor in WEHI CM is
likely to be 11-3 to which the FDCP1 cell line also responds). The
conditioned medium from the FDCP1 cell lines do not stimulate 
proliferation of the FD cells when added at a final concentration 
of 10%. This is perhaps not unexpected as these cell lines must be 
passaged at high cell density in liquid cultures and as described 
above probably only release low levels of GM-CSF. The autocrine 
produced GM-CSF is probably consumed by the factor independent cell 
lines almost instantly> due to its rather sub-optimal production. The 
observation that the conditioned medium from the parental FDCP1 stock 
which is maintained in 10% WEHI CM was also incapable of stimulating 
FDCP1 proliferation suggests that the requirement of FD cells for 
growth factor for their survival depletes growth factor from the 
culture medium, reducing it to a level below that which is detected by 
this assay.
5.6 Replatine efficiency of FD clones containing mos~3 neo and
mos~^neoGM
The generation of FD clones containing mos“^neo and mos“^neoGM 
is described in section 5.1. As with pVneo/pVneoGM FD clones,
mos"^neo/mos“^neoGM clones were plated under different selection 
conditions in order to assess the expression of the viral constructs 
they harbour. All the mos“^neo clones shown in Fig. 5.11 were 
initially selected for resistance to G418 and as expected replated 
efficiently into methocell under similar conditions to those in which 
they were selected in, (+G418, +WEHI). Also as expected all clones 
which only contain the mos"3neo vector do not form colonies under 
selection for factor indepedent growth (Fig. 5.11, clones I 12, 111,
12 and 110). The three clones L1, L11 and L12 all contain mos"3neoGM 
and should therefore have the potential to express GM-CSF. However no
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Figure .5
Assay for growth factor release by factor 
independent (FI) clones.
Three FI clones R5, R6 and R9 were tested for 
production of growth factor. Conditioned medium 
from the cell lines was prepared as in Materials 
and Methods and added to 500 FDCP1 cells as 10% of 
the final volume using Terasaki dishes (60 wells 
per dish). Each well contained a final volume of 
10jjl1. Antiserum to GM-CSF was added at 10% final 
volume, when required. As controls fresh WEHI CM 
was added to 10% final volume, recombinant GM-CSF 
(rGM-CSF) was added to 875pg/ml). The conditioned 
medium from the parental FDCP1 cell line 5 days 
after removal of growth medium (which contains 10% 
WEHI CM) was also included (spent WEHI). Duplicate 
wells were scored after 48h for proliferation of 
the indicator FDCP1 cells in comparison to control 
conditioned medium .
CONDITIONED MEDIA FROM F.I. CLONES
CONDITIONED MEDIA ANTISERA TO GM-CSF CELL PROLIFERATION
Fresh WEHI - +
+ +
rGM-CSF - +
R5
R6
R9
Spent WEHI
Figure 5.10
Stimulation of FDCP1 colonies by recombinant GM-CSF 
(rGM-CSF) and WEHI conditioned medium (WEHI CM). 
Triplicate 3cm plates containing 5 x 10^  FDCP1 
cells per ml of methocellulose (1ml per plate) were 
stimulated to form colonies by either the addition 
of 10% WEHI CM or 875pg/ml rGM-CSRF. Colonies were 
scored after 7 days of incubation and the ratio of 
the number of colonies formed to number of cells 
plated out expressed as a percentage. This is 
defined as the replating efficiency.
STIMULATION OF FDCPI COLONY FORMATION BY 
WEHI 3B CONDITIONED MEDIUM AND rGM-CSF
SOURCE OF REPLATING
STIMULATION EFFICIENCY
10% WEHI CM 
875 pg/ml rGM-CSF
20
16
Figure 5.11
This figure shows 7 individual FDCP1 clones which 
contain either mos“^neo or mos“^neoGM and were 
initially selected for G418 resistance (+1mg/ml 
G418, +10% WEHI CM). These clones were replated at 
the appropriate cell density into 3cm petri dishes 
under the appropriate selective growth conditions. 
All points were scored in triplicate. Colonies 
were counted after 7 days and the relative plating 
efficiency expressed as the ratio of colony 
formation under selective conditions to colony 
formation under non-selective conditions (+10% WEHI 
expressed as a percentage.
TNTC - Colony number per plate was too numerous to 
count.
n.d. not done
REPLATING OF INDIVIDUAL FDCP1 CLONES SELECTED -*0418 +WEHI
CLONE VIRUS CELL REPLATING RELATIVE REPLATING
DENSITY(ml) EFFICIENCY % EFFICIENCY
+WEHI %
+G418 -G418 +G418
+WEHI -WEHI -WEHI
112 mos neo 10^ 44 100 0 n.d.
111 -3mos neo 210^ 7 250 0 n.d.
12 -3mos neo
ono
5 180 0 0
110 -3mos neo 103 11 100 0 0
112 -3mos neo 104 44 T.N.T.C. 0 n.d.
111 -3mos neo 104 7 T.N.T.C. 0 n.d.
L12 mos neoGM
CMo
41 100 0 n.d.
L11 -3mos neoGM
CMO
6 51 0 n.d.
L1 -3mos neoGM 103 5 93 0 0
L12 -3mos neoGM 104 41 T.N.T.C. 0 n.d.
L11 -3mos neoGM 104 6 T.N.T.C. 0 n.d.
Figure 5.12
Replating of factor independent clones generated by 
infection with mos“^neoGM virus.
This figure shows the replating in methocellulose 
of four cell lines derived from colonies which 
displayed factor independence after co-cultivation 
with a mos"-3neoGM producing cell line. The 
relative replating efficiency is the ratio of 
colony formation under selective conditions to 
colony formation under non-selective conditions 
(+10% WEHI) expressed as a percentage. The 
appropriate density of cells in methocellulose were 
added to 3cm petri dishes (1ml per dish) under to 
appropriate selective conditions. All points were 
performed in triplicate, 
n.d. - not done.
REPLATING OF INDIVIDUAL F.I. CLONES INFECTED BY mos"3neoGM
AND SELECTED IN -G418, -WEHI
CLONE CELL DENSITY REPLATING 
(ml) EFFICIENCY
+WEHI
RELATIVE REPLATING EFFICIENCY
+G418
+WEHI
-G418.
-WEHI
+G418
-WEHI
N11
N12
N1
N2
10
10
10-
10-
0.43
2.4
6
3
230
158
0
0
5
36
0
0
n.d.
n.d.
0
0
factor independent colonies (-G418, -WEHI) were observed even when 
clones L12 and L11 were plated out at 10^cells/ml (Fig. 5.11).
Four cell lines N11, N12, N1 and N2 (Fig. 5.12) were initially 
selected for their growth factor independent phenotype (-G418, -WEHI) 
after infection with mos”3neoGM. Both N11 and N12 still express the 
neomycin gene as demonstrated by replating the clones in +G418, +WEHI 
when both clones formed colonies in methocell under selection for 
factor independent growth (-G418, -WEHI). As with pVneoGM containing 
clones (see sections 5*3, 5.5) autocrine stimulation by mos“^neoGM
encoded GM-CSF is less efficient than exogenous stimulation by WEHI 
relative replating efficiency (Fig. 5.12). The lack of colony 
formation observed by mos”^neoGM containing clones under factor 
independent growth conditions (-WEHI, -G418) in Fig. 5.11 is probably 
a reflection of the poor expression of virally encoded GM-CSF in three 
clones. The mos^neoGM clones in Fig. 5.11 were initially selected 
for neo expression which is an extremely efficient method for the 
generation of virus containing clones (Fig. 5.1). Therefore if 
virally encoded GM-CSF expression is low but variable, many clones may 
have to be screened before rare clones which can produce enough viral 
GM-CSF to replate under factor independant conditions to be observed. 
It is possible that the two clones N11 and N12 which were initially 
selected for factor independence and do generate colonies in factor 
independent semi-solid growth medium (Fig. 5.12) are examples of such 
a sub-population of clones theoretically present within the neo 
selected population of clones. Clones N1 and N2 do not form colonies 
when replated into G418 (Fig. 5.12). The four clones N11, N12 N1 and
N2 were derived from an infection in which the number of factor 
independent clones generated by infection was approximately only twice 
the spontaneous background (data not shown) and so the inability of N1 
and N2 to replate into G418 may mean that these are spontaneous 
factor independent mutants.
Discussion
A number of virus containing FDCP1 cell lines have been 
generated in an attempt to investigate retroviral expression in 
haematopoietic cell lines. Specifically, it was of interest to 
analyse viral expression of GM-CSF in relation to autocrine stimulated 
proliferation of the FD cell line. In view of the results presented
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in section 4 which documents growth factor release from virally 
infected fibroblasts, irrespective of the genes carried by the vector 
(Koury and Pragnell, 1982) it was important to establish whether viral 
infection of the factor independent FDCP1 cell line with either pVneo 
or mos“^neo resulted in the generation of the growth factor 
independent colonies. As can be seen from Fig. 5.1, factor 
independent colonies were not observed in any virus infection 
involving pVneo or mos~^neo. It can therefore be assumed that the 
colony growth observed after infection of the FD line with pVneoGM 
(Fig. 5.1) or mos“ 3neo (Fig. 5.1) is due to retrovirally expressed 
GM-CSF.
The frequency with which factor independent colonies are 
generated by both viruses (pVneoGM and mos”^neoGM) is not however the 
same. The virus pVneoGM appears to be capable of producing 
approximately 10 fold more factor independent colonies than mos^neoGM 
virus, ( Fig. 5.1). This latter observation may be related to earlier 
observations on virally directed expression in fibroblast cells 
(section 4). In section 4 it was noted that ' f  2 cells which produced 
pVneoGM virus could be shown to have GM-CSF activity in their culture 
medium, whereas mos neoGM did not. The lack of detectable growth 
factor from Cl-31 cannot be ascribed to the clone containing a deleted 
virus which no longer includes the GM-CSF sequences as viral 
transcripts which hybridise to a GM-CSF probe can be detected. Also 
virus from Cl-31 does generate factor independent FD clones after 
infection at a frequency of at least 20 fold greater than background. 
Possibly, the reduced abililty of mos”^neoGM virus to generate factor 
independent colonies in comparison to pVneoGM virus is due to poor 
processing of the full legth genomic mRNA to generate the GM-CSF 
specific sub-genomic message. FD cells containing pVneo or pVneoGM do 
show the two predicted neo hybridising mRNA species (Fig. 5.4) 
predicted from the vector design (Fig. 4.2) however mRNA from FD cells 
containing mos'^neoGM virus was not analysed and so the above 
explanation is based on the viral transcripts observed in fibroblast 
cells. Both Laker et al. (1987) and Lang et al. (1985) discuss
vectors which rely on viral splice signals for expression of 
sub-genomic message with the conclusion that splicing may not be 
efficient. It may be that the poor expression of GM-CSF from mos 
neoGM containing cells is related to this problem.
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FD cell lines which contain pVneoGM generally display poor 
cloning efficiencies at low cell densities (10^ cells/ml) in the 
absence of added growth factor (Figs. 5.3, 5.6) despite having been
cloned due to their factor independent phenotype. However at high 
cell density it was observed that colony formation did occur (Fig 
5.6). The possibility that these cell lines produced lew levels of 
GM-CSF which required them to be maintained at high cell density in 
order to raise the level of GM-CSF above a threshold level for 
survival and proliferation was tested. The addition of low levels of 
exogenous rGM-CSF increased the cloning efficiency of two factor 
independent cell lines R5 and R6, without stimulating the parental 
cell line (Fig. 5.7, 5.8). Thus, it can be assumed that the low level 
of GM-CSF produced by the factor independent cells is "optimised" by 
the addition of exogenous growth factor and cloning efficiency in 
methocell rises accordingly.
Although the mos“^neo and mos“^neoGM containing clones were 
not studied in so much detail, the mos”^neoGM clones showed a poor 
cloning efficiency in factor independent conditions similar to pVneoGM 
containing clones (Figs. 5.11 and 5.12). Therefore it is possible 
that such clones also produce very low levels of growth factor which 
is insufficient to promote efficient colony formation in semi-solid 
medium.
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CHAPTER SIX
Retroviral Infection of Murine Bone Marrow Cells 
Introduction
The results in chapter five which examined the efficiency of 
retroviral gene expression in FDCP1 derived cell lines, were very 
encouraging. The cell lines displayed variation in plating 
efficiencies in WEHI CM and relative plating efficiencies in +G418, 
+WEHI or -G418, -WEHI, but expression of the neomycin gene was 
apparently efficient, whereas expression of GM-CSF was sub-optimal for 
efficient clonal development at low cell density. With the assurance 
that these vectors could infect a GM-CSF dependent haematopoietic cell 
line and alter its phenotype by expression of virally encoded GM-CSF, 
bone marrow infections were attempted.
The success of earlier attempts to infect bone marrow stem and 
progenitor cells was disscussed in chapter 1.7* These experiments 
used a number of related protocols to infect bone marrow cells and 
these will now be discussed.
Optimal conditions for infection of bone marrow progenitor 
and stem cells appear to be attained by the co-cultivation of the 
target cell population for 24h with the virus producing cell line. 
This is prefered to the addition of viral supernatants removed form 
the ^  2 cells to the target cells ( Hogge et al., 1987; Eglitus et
al.T 1985), since presumably, bone marrow cells are constantly exposed 
to fresh virus particles throughout the 24h incubation period. 
Moreover the efficiency of infection is greatest when high titre virus 
producer clones are used as a source of virus (Hogge et al., 1987;
Eglitus et al., 1985). One problem which may be encountered during
co-culivation of virus producer cell lines and bone marrow is the 
contamination of bone marrow cells with'^2 fibroblasts which might 
lead to fibroblast colonies forming in the semi-solid medium. This 
problem can however be circumvented by irradiating the f2 cells prior 
to co-cultivation, a procedure which does not appear to affect their 
ability to produce virus (Hogge et al., 1987; Magli et al., 1987; Dick 
et al., 1985; Keller et al., 1985).
The reliance of progenitor and stem cells on a source of 
growth factor for their short term survival in tissue culture has led 
to a source of 11-3 being included during the 24h co-cultivation of 
bone marrow (Lemischka et .al., 1986; Magli et al., 1987 Keller et sd.,
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1985; Dick et al., 1985). The use of growth factor during viral
infection may also trigger quiescent stem cells into cell cycle. An 
important characteristic, since cell replication may be required for 
efficient viral integration (Weiss et al., 1982). Both Eglitus et al. 
(1985) and Lemischka et al. (1986) have observed increased proviral 
integration into CFU-S if a source of 11-3 is included during the 
exposure of bone marrow to virus. However Eglitus et al. (1985) state 
that this increase is in fact very slight, and the average number of 
virally infected CFU-S per spleen rises only from 8.4 to 9-6.
In an attempt to increase the proportion of multipotential 
cells and so enrich the target cell population for virus infection, 
bone marrow from 5-fluorouracil (5FU) treated mice is often used 
(Bradley and Hodgson 1979). These workers observed that after a 
single intravenous dose of 5FU, a primitive cell population, with a 
high proliferative capacity (HPP-CFC), demonstrated a characteristic 
recovery pattern over a period of days. Thus bone marrow recovered 
at the appropriate time point post 5FU treatment is enriched for 
HPP-CFCs. Several investigators have used bone marrow recovered 
either 2 or 5 days post 5FU treatment (Keller et al., 1985; Dick et
al.T 1985; Williams et al., 1986; Lemischka et al., 1986) in infection 
procedures. However there is little direct evidence to substantiate 
the use of 5FU treated bone marrow in viral infections. Lemischka et 
al. (1985) compared infection efficiency between 1 and 2 day post 5FU 
bone marrow but did not include normal bone marrow in this study, 
therefore although it appeared that CFU-S in 2 day post 5FU marrow
could be infected more efficiently than CFU-S in 1 day post 5FU
marrow, no proper control was included. Treatment of bone marrow with 
5FU may therefore not necessarily be advantageous (Magli .et al.f
1987).
A more systematic approach which has experimentally been shown 
to increase the frequency of infection of colony forming cells, is to 
include after co-cultivation, and prior to selection in semisolid 
media, a 48h liquid culture pre-selection step in the presence of 
2mg/ml G418. Keller et al. (1985) demonstrated that pre-selection 
in G418 for 48h reduced the colony forming cells (CFC) to 15-50% of
the input number but a high percentage of these were infected
(60-90%). In comparison, 50-95% of CFC survived the 24h 
co-cultivation period but without 48h pre-selection in 2mg/ml G418
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only 10-20% were infected. Magli et al. (1987) also show that 
pre-selection in high levels of G418 leads to a 3 to 5 fold increase 
in infected CFU-GM.
The tentative identification of steps which may be altered to 
improve efficiency of retroviral infection of haematopoietic stem and 
progenitor cells, so far achieved, demonstrates that conditions for 
efficient infection frequencies are not yet fully established. While 
some paramenters such as virus titre and pre-selection do appear to 
have some significant effect on increasing the efficiency of 
infection, others, such as the inclusion of 11-3 during the infection 
step, or the use of 5FU marrow, have less proven effects. Since some 
of these alternatives are labourious, it was considered important to 
more fully examine the effects of pre-selection, or 5FU marrow.
6.1 Preliminary experiments on bone marrow cells prior to viral 
infections
To infect bone marrow cells, cells must be removed from the 
femur of mice and co-cultivated with the virus producing cell line for 
24h (Eglitus et al., 1985). After this period, non-adherent cells are 
removed and added to semi-solid media as a single cell suspension. 
Obviously the number of clonogenic cells per millilitre of semi-solid 
medium will determine colony density after incubation. Therefore if 
different assays such as the CFU-A stem cell assay (Pragnell et al.T
1988) and the CFU-GM progenitor assay require different cell 
densities, any effective loss or gain of clonogneic cells during 
co-cultivation may affect the assay conditions. Also, if too many 
cells are plated out in any dish, cross-feeding between cells of 
autScrine produced factors may occur. In either case it is difficult 
to draw meaningful conclusions.
It was therefore of interest to investigate any effective 
deviations from the normal frequency of colony forming units per 10^  
bone marrow cells after a 24h incubation period. Bone marrow from the 
femurs of NIH Beatson mice was added to 25cm2 tissue culture flasks at 
a density of 1-2 x 10^  nucleated cells per flask (10mls media), in 
the presence of 2% WEHI CM, in order to maintain primitive cells 
(Koike et al., 1986). Polybrene was also added to the culture medium
at 6 ug/ml, a substance normally added during virus infections to 
enhance viral absorption to the cell membrane. The final volume of
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the medium was 10ml per flask. Mo virus, or virus producing cells 
were present during this experiment., After a 24b. incubation period, 
non-adherent cells were removed by gently standing the flasks upright 
and allowing the medium to drain to the bottom. The medium was then 
removed using a 10ml pipette , and the media used to wash the adherent 
cells once, after which it was spun at 1.5K for 10min in a bench top 
centrifuge and resuspended in fresh medium ( approximately 
10 cells/ml). The cells were kept on ice until used. At this point 
the nucleated cells were counted and used in three assays as described 
in Materials and Methods:-
i) The CFU-S _in vivo stem cell assay.
ii) The CFU-A _in vitro stem cell assay.
iii) The CFU-C progenitor assay.
The numbers of progenitors and stem cells present per 10^  cells after 
the 24h incubation period were compared to their frequency in fresh 
unincubated bone marrow which had been used directly in all three 
assays. The results are shown in Fig, 6.1. Fig. 6.1 shows that there 
is an effective drop in the frequency of progenitor CFU-C of 
approximately one third. However, if stem cell frequency is assayed 
in vitro (CFU-A), or in vivo (CFU-S), then almost two thirds of the 
assayable stem cells are lost,
The rather large loss of non-adherent stem cells considerably
reduces the target cell population for virus infection, therefore it
was considered important to establish the reasons for this loss.
It was observed that over the 24h incubation period, bone 
marrow derived cells adhered to the bottom of the tissue culture dish. 
This is presumably one event which occurs during the initial stages of 
long term marrow culture. Two groups, Mauch et al. (1980) and
Schofield and Dexter (1985) have documented the presence of CFU-S in 
the adherent layer of the long term marrow cultures (LTMC). 
Interestingly, the latter have greater self-renewal properties than 
the non-adherent CFU-S , and may be more primitive. Although this 
data refers to LTMC, it is possible that some of the stem cell losses 
observed in Fig. 6.1 may be due to CFU-A and CFU-S adhering to the 
tissue culture flask directly, or through other adherent cells. The 
observations by Schofield and Dexter (1985) and Mauch et al. (1980) on 
the qualitative differences between adherent and non-adherent stem 
cells may be of importance if the same discrimination is present
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during short term culture. In the short term culture the only bone 
marrcw derived cells recovered after co-cultivation with virus 
producers are non-adherent cells. Also of interest is the report by 
McCulloch and Till (1971) which documents quantitative and qualitative 
changes in suspension bone marrow and progenitor stem cells cultivated 
with or without a source of growth factor over a period of two days.
In order to assess the proportion of stem cells partitioned 
between the non-adherent and adherent fraction of cells after a period 
of culture, bone marrow was incubated for either 24h or 48h after 
which both fractions were assayed for stem cells using the _in vitro 
assay of Pragnell et al. (1988). In total, twelve 25cm2 (10ml
volume) tissue culture flasks were inoculated with 10^  freshly 
isolated nucleated bone marrow cells. Pairs of flasks were 
supplemented with either 0, 1, 2, 3} 4, or 5% WEHI CM and one member
of each pair was harvested after 24h of incubation, the other after 
48h. By varying the concentration of WEHI CM present during the 
incubation, any gross effects on stem cells numbers should be 
observed. Non-adherent cells were harvested as described above and 
the remaining adherent cells were scraped from the flask bottom in 1ml 
of medium using a rubber policeman. The adherent cells were then 
passed through a 19 gauge needle in order to disperse them into 
single cells. The cells from both fractions were spun at 1.5K for 
5min, washed once in medium, respun, and the pellet resuspended in 
fresh medium. The nucleated cells were then counted and assayed in 
the CFU-A assay to determine the number of _in vitro stem cells 
present. Figure 6.2 shows the number of CFU-A type colonies present 
in the adherent (hatched columns) and non-adherent (open columns) 
fractions, after 24h (6.2A) and 48h (6.2B) in the presence of
increasing amounts of WEHI CM. The number on the vertical axis is the 
ratio, expressed as a percentage, of the CFU-A colonies per 10-* cells 
in any given experimental condition, to the number of CFU-A type 
colonies per 10^  cells found in the starting bone marrow material 
prior to incubation. It can be seen from Fig. 6.2 that a varying 
percentage of the total recoverable CFU-A type colonies under any 
experimental condition are found on the adherent layer of the tissue 
culture flask. For example, after a 24h incubation in the presence of 
5% WEHI CM, almost 50% of the total recoverable CFU-A from both the 
adherent and non-adherent layers are in the adherent layer. Therefore
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Figure 6.1
24 hour incubation of bone marrow.
Freshly isolated bone marrow cells were incubated 
for 24h at a density of 1-2 x 10^  nucleated cells 
per 25cm2 flask (10ml) in the presence of 2% WEHI 
CM. The non-adherent cells were then gently 
harvested and assayed in vitro for CFU-C progenitor 
cells and CFU-A stem cells and in vivo for CFU-S 
stem cells. The number of colonies per 10^  cells 
in each assay was compared to the frequency of 
CFU-C, CFU-A and CFU-S in the starting material 
before incubation.
CFU-C assay Five 3cm petri dishes containing 1ml of 
methocellulose and 7.5 x 10^  bone marrow cells were 
used per plate.
CFU-A assay Five 6cm petri dishes containing 4ml of 
methocellulose and 5 x 10^  cells for control 
incubated marrcw and 2 x10^ cells for 24h incubated 
marrow were used per point.
Both the CFU-C and CFU-A assays were performed in 5 
separate o cessions. The values shown represent 
the average colony number per 10^  cells for the 5 
experiments. The standard deviation is shown in 
brackets.
CFU-S assay CFU-S were assayed by injecting 0.2ml 
aliquots of 5 x 10^  unincubated fresh marrow or 10^  
24h incubated marrow into 8.2 Gy X- irradiated 
mice. Spleen foci from 4 mice were counted for the 
injection of normal marrow, 7 mice for incubated 
marrow. The average number of foci per 10^  cells 
injected is shown. The standard deviation is in 
brackets.
24 HOUR INCUBATION OF BONE MARROW CELLS
ASSAY COLONIES/105 CELLS %
BEFORE AFTER LOSS
CFU-C 72 (35) 45 (17) 37
CFU-A 93 (25) 23 (10) 75
CFU-S 34.5 (7) 10.6 (3.4) 70
Figure 6.2
Presence of CFU-A stem cells in adherent versus 
non-adherent bone marrow cells.
1-2 x 107 nucleated bone marrow cells were 
incubated for either 24 or 48h in the presence of 0
p
5 % WEHI. All incubations were in 25cm tissue 
culture flasks in a final volume of 10ml medium. 
After either 24 of 48h the non-adherent cells were 
removed by gentle pippetting and the cells which 
had adhered to the tissue culture flask wet^ . removed 
by scraping with a rubber policeman, followed by 
cell disaggregation through a 19 gauge syringe 
needle. The nucleated cells were counted and 
assayed for CFU-A stem cells. The frequency of 
adherent (hatched columns) and non-adherent (open 
columns) is expressed as a percentage of the 
frequency of CFU-A present in the starting 
material. 3x6cm petri dishes were used per point, 
containing 4 x 10^  cells per ml (4ml soft agar per 
plate).
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it is possible that much of the loss of stem cells observed when only 
the non-adherent cells are assayed, as described previously, (Fig. 
6.1) is due to stem cells adhering to the bottom of the tissue culture 
flask.
Fig. 6.3 documents the results of an experiment designed to 
investigate the presence of CFU-S within developing _in vitro CFU-A 
colonies. Although bone marrow incubated for 24h does contain CFU-S 
(Figs. 6.1 and 6.3) it was thought of some importance to demonstrate 
that the in vitro colonies which developed in the _in vitro CFU-A assay 
using 24h incubated bone marrow, do contain CFU-S. CFU-S can be 
detected in 24h incubated bone marrow but the cells which form CFU-A 
colonies may be a distinct population in the manipulated bone marrow, 
however the ability to detect low numbers of CFU-S within developing 
CFU-A colonies as shown in Fig.6.3, suggests that the developing 
colonies do still originate from a primitive cell population with stem 
cell characteristics.
6.2 Retroviral infection of bone marrow progenitor and stem cells.
Fig 6.4 shows the frequency with which bone marrow progenitors 
(CFU-C) and stem cells (CFU-A), present within normal and
5-fluorouracil (5FU) treated bone marrow, are infected with pVneo 
virus from the V2 producing clone 38 (Fig.4.3). Bone marrow from NIH 
mice (obtained from 01ac) were co-cultivated for 24h with clone 38 as 
described in Materials and Methods, after which non-adherent cells 
were removed and assayed In vitro for progenitor cells (CFU-C) or stem
cells (CFU-A). Bone marrow from mice treated 10 or 14 days previously
with 5FU was used since bone marrow stem cells (CFU-A and CFU-S) show 
an increase in frequency around this time after 5FU treatment
(Pragnell e£ al., 1988). The frequency of infection was assessed by
adding G418 at 1mg/ml to the semi-solid medium. Thus colonies which 
develop in the presence of 1mg/ml G418 express the retrovirally 
encoded neo (Fig. 6.8). Fig 6.4 shows that CFU-C progenitor cells can 
be infected with a high efficiency irrespective of the marrow used. 
However the frequency of G418 resistant CFU-A stem cells colonies was 
variable. It might be expected from the data of Pragnell et al. that 
bone marrow 14 days after 5FU treatment would contain an increased 
frequency of CFU-A stem cells and therefore represent an increased 
cell population for viral infection in comparison to normal bone
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Figure 6.3
Presence of CFU-S in manipulated bone marrow.
Bone marrow which had been incubated for 24h on 
25cm^ flasks (5 flasks) at a density of 1-2 x10^
nucleated cells per flask (10ml) in the presence of 
WEHI was assayed for the presence of CFU-S stem 
cells immediately after the incubation period and 
after a period of CFU-A colony formation in 
methocellulose. Incubated bone marrow was assayed 
in vitro for CFU-A and developing colonies picked 
using a dissection microscope after 5, 6, 7 or 8
days after commencement of growth in semi-solid 
medium. Developing colonies from 5*6cm plates (2 x 
10^  cells per ml, 4ml per plate) were picked and 
pooled for each time point in 10ml ice cold SLM 
growth medium. The cells were then spun at 1.5K 
for 5min and resuspended in SLM. The numbers of 
cells injected per mouse is shown in the figure.
PRESENCE OF CFU-S IN MANIPULATED BONE MARROW
EXPERIMENTAL NO. OF CELLS COLONIES/SPLEEN MEAN PO£I/
COLONIE 
SPLEEN
CONDITION INJECTED/MOUSE S/ 10b CELLS
Non 0 0,0,0,0,0,1 0.17
Transplanted
Normal marrow 5 x 10^  19*12,19,19 17 34
24hr Liquid 1 x 105 5,10,13,10,15,8,13 10.5 10.5
Culture
5 Days in 2.8 x 10^  1,0,4,6 2.7 9.8
Methocel
6 Days 4 x 104 0,0,4,3,1 1.6 4
7 Days 5 x lO4 \ 3,0,0,0 0.7 1.4
8 Days 1.2 x 104 8,0,2,3,1 2.8 23
Figure 6.4
Virus infection of bone marrow progenitor cells and 
stem cells by pVneo.
1-2 x 10^  nucleated bone marrow cells were 
incubated for 24h with the virus producing cell 
line cl-38 which releases pVneo virus. After 24h 
the non-adherant cells were harvested and assayed 
for CFU-A stem cell colony and CFU-C progenitor 
cell, colonies resistant to 1mg/ml G418.
The source of bone marrow was from normal mice (0 
5FU treated) or bone marrow treated 10 or 14 days 
previously with a single dose of 5 flurouracil 
(5FU).
CFU-A assay 10 x10 cm petri dishes per point were 
used for selection for G418 resistance. 5 x10 cm 
petri dishes per point were used for unselective 
conditions. All plates were overlayed with 10ml of 
0 .3% agar conytaining 8 x 10^  nucleated cells per 
ml.
CFU-C assay 5 x 3 cm petri dishes were used per 
point containing 7.5 x 10^  cells per ml (1ml per 
plate). Control unincubated bone marrcw was plated 
out in the CFU-A assay at 5 x 10^  cells per ml in 
triplicate 6cm plates (4ml per plate) +/- 1mg/ml 
G418 and at 5 x 10^  cells per ml for the CFU-C 
assay in triplicate 3cm plates (1ml per plate).
VIRUS INFECTION OF OLAC NIH MICE BY 
cl-38 (pVneo)
5-FU 
BONE MARROW
0
10
14
CONTROL
ASSAY
G418 CFU-C CFU-A
COLONIES/ % COLONIES/ %
105 CELLS INFECTION 10 CELLS INFECTION
61 34
+ 45 74 11 33
140 55
89 64 11 21
149 56
145 97 4 8
249 215
0 0
marrow. The low frequency of infection of 14 day post 5FU bone marrow 
suggests that perhaps the timing of bone marrow recovery after 5FU may 
be critical. It is also possible that insufficient cells were plated 
to obtain accurate estimations on infection frequency. Alternatively, 
it may be that any advantage theoretically present in using 5FU, 
treated marrow is lost upon co-cultivation with the virus producing 
cells.
One problem encountered during the scoring of the G418 
resistant CFU-A colonies in this experiment was their apparent
reduction in size. In the original protocol described by Pragnell .et 
al. (1988) CFU-A colonies are those which attain a diameter of greater 
than 2mm after 11 days in culture. Although there were many small 
colonies ranging from the microscopic upwards on plates containing 
1mg/ml G418, very few were greater than 2mm. Thus there was sane 
difficulty in scoring CFU-A colonies as the smaller colonies (less 
than 2mm), may have been G418 resistant CFU-A colonies whose 
development had been impaired due perhaps, to poor expression of
viral neo. Alternatively, the small colonies may represent G418 
resistant progenitor colonies. Returning these plates to the incubator 
for a further 7 days did not improve resolution.
Fig. 6.5 shows the use of a liquid culture pre-selaction step 
in 2mg/ml G418 after a 24h co-cultivation period prior to plating the 
non adherent cells in the CFU-C and CFU-A assays. The virus producing 
cell line used in this experiment was clone 41, which releases
mos“^neo virus. Pre-selection in 2mg/ml G418 reduces the number of 
CFU-A colonies per 10^  cells from 80 to 55 in the bone marrow used in 
the co-cultivation with Cl-41 (Fig. 6.5) and from 80 to 30 CFU-A per 
105 cells in the uninfected control bone marrow. On selection with 
1.5mg/ml G418 during colony developnent, although the actual number of 
G418 resistant colonies did not differ greatly between pre-selected 
and non-selected mos"^neo infected marrow, the reduction in total 
CFU-A colonies observed with pre-selection, effectively increased the 
frequency of infected CFU-A colonies. Therefore although this 
experiment was only carried out once, there may be some value in 
including a pre-selection step for the infection of CFU-A stem cells. 
A similar effect of preselection was not obvious using the CFU-C 
progenitor assay, although infection of progenitor type cells was 
achieved.
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The infection shown in Fig 6.5 differs from that in Fig 6.4
since bone marrow used for the pre-selection experiments (Fig. 6.5)
was from NIH mice bred at the Beatson Institute, whereas the previous 
experiment (Fig. 6.4) used marrow from NIH mice obtained directly from 
the suppliers Olac. Also in the pre-selection experiment the marrow 
was infected with mos”^neo virus in comparison to pVneo. Fig 6.6 
shows infected or uninfected pre-selected bone marrow which has been
assayed for CFU-A in the presence of G418. It can be seen that there 
are no obvious size differences between the G418 resistant colonies 
and the control colonies. This is a repeatable observation using bone 
marrow infected with mos~^neo and thus the difficulties encountered 
with scoring CFU-A colonies in the experiment described in Fig. 6.4 
and discussed previously are not encountered.
Fig 6.7 documents an attempt to infect bone marrow stem and 
progenitor cells with a GM-CSF virus, pVneoGM. Previous results on 
the viral expression of GM-CSF in the FDCP1 cell line (chapter 5) 
suggested that both pVneoGM and mos"^neoGM could generate what 
appeared to be factor independent FD colonies after infection, but on 
further analysis, cell lines expressed sub-optimal levels of GM-CSF 
for maximal proliferation . It was therefore decided that any 
effects of virally expressed GM-CSF on colony formation, in terms of 
factor independent proliferation, may only be observed if low levels 
of growth factor were supplied at a suboptimal level for stimulation 
of normal progenitor, and stem cells. Bone marrow cells were 
co-cultivated for 24h with either clone 41 (mos~^neo) or clone 15 
(pVneoGM) followed by 48h pre-selection in 2mg/ml G418. The 
non-adherent cells were then added to semi-solid medium and assayed 
for either CFU-C or CFU-A. The source of stimulation in the CFU-C 
assay was recombinant GM-CSF (rGM-CSF), which was added at 10% 
(875pg/ml), 0.25%. 0.1% and 0%. Using bone marrow co-cultivated with
Cl-41 (mos“3neo) G418 resistant colonies were obtained as before in
the presence of 10% rGM-CSF. Snail clusters of cells also 
proliferated on plates supplemented with 0.25% rGM-CSF but no colonies 
formed in the absence of rGM-CSF or in 0.1% rGM-CSF. No G418 
resistant colonies were formed in co-cultivation with Cl-15 (pVneoGM) 
and thererfore it was impossible to prove that viral infection had 
occurred. Also there were no factor independent colonies, and so even 
if viral infection had occurred the viral genes are not expressed at
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Figure 6.5
Pre-selection in liquid culture during virus 
infection.
1-2 x 10^  nucleated bone marrow cells were 
incubated for 24h either with or without virus 
producing cells, Cl-41 in 25cm flasks. 
Non-adherent cells were then removed, split into 
two new 25cm^ flasks +/- 2mg/ml G418, +WEHI CM and 
incubated for a further 48h. The non-adherent 
cells were again removed and assayed for CFU-C 
progenitor and CFU-A stem cells resistant to 
1.5mg/ml G418 in methocellulose. Cells to be 
assayed for CFU-A content were plated out in 5 x 
6cm petri dishes per point at 5 x 10^  cells/ml. 
Cells to be assayed for CFU-C content were plated 
out in 5 x 3cm petri dishes per point at 7.5 x 10^  
cells /ml (1ml per plate).
INFECTION OF (BEATSON NIH MICE) BONE MARROW CELLS BY mos 3neo
VIRUS. USE OF PRESELECTION STEP
ASSAY
CLONE VIRUS PRESELECTION SELECTION CFU-C CFU-A
2mg/ml G418 1.5mg/ml COLONIES/ % COLONIES/ %
G418 1(T CELLS INF. 1CT CELLS INF.
cl-41 mos” n^eo - - 26 80
+ 12 46 10 12
+ - 20 55
+ + 8 40 15 27
CONTROL UNINFECTED - - 74 85
+ 0 - 0
+ 48 30
+ + 0 - 0
Figure 6.5
G418 resistant CFU-As.
1-2 x 107 nucleated bone marrow cells were
incubated for 24h either with or without virus
p
producing cells, cl-41 in 25cm flasks. 
Non-adherent cells were then removed, transfered to 
a 25cm^ flasks +2mg/ml G418, +2% WEHI CM and
incubated for a further 48h. The non-adherent 
cells were again removed and assayed for CFU-A 
stem cells resistant to 1.5mg/ml G418 in
methocellulose. Cells to be assayed for CFU-A 
content were plated out in 5 x 6cm petri dishes per 
point at 5 x 10^  cells/ml.
A) No virus, -G418
B) No virus, +G418
C) Plus virus, -G418
D) Plus virus, +G418
J »
Figure. .6.t I,
Co-cultivation of bone marrow with a GM-CSF virus 
producer cell line.
1-2 x 107 nucleated bone marrow cells were 
co-cultivated with either Cl-41 or Cl-15 virus 
producer cell lines ot in the absence of a virus 
producer line (control). After 24h co-cultivation 
the non-adherent cells were removed and cultured 
for a further 48h in 25cm^ flasks (10ml) in the 
presence of 2% WEHI CM and 2mg/ml G418. 
Non-adherent cells were again removed and CFU-A and 
CFU-C present in this population was assayed for 
resistance to 1.5mg/ml G418 and response to 
sub-optimal growth factor stimulation. Cells 
assayed for CFU-A frequency were plated at 1.5 x 
10^  cells/ml in 3 x 6 cm plates per point. Cells 
assayed for CFU content were plated at 10-* cells/ml 
in 5 x 3cm plates (1ml per plate). Dilutions of 
recombinant GM-CSF (rGM-CSF) were added to some 
plates in the CFU-C assay. Conditioned media from 
the AFI and the L929 cell lines were used as a 
source of stimulation in the CFU-A assay (Pragnell 
et al., 1988.
>2,3,4 _ microscopic clusters or colonies of
cells .
INFECTION OF BEATSON NIH MICE BY cl-41 AND cl-15
USE OF rGM-CSF TITRATION
A. INFECTION OF CFU-C
CLONE VIRUS
CL-41 -3mos neo
G418 % rGM-CSF
10
10
0.25
0.1
0
COLONIES/ 
10 CELLS
82
23
*
0
0
%
INFECTION
28
cl-15 pVneoGM 10
10
0.25
0.1
0
74
0
0
0
CONTROL 10
10
96
0
B. INFECTION OF CFU-A 
CLONE VIRUS G418
cl-41 -3mos neo
L929 AF1 COLONIES/ 
10^  CELLS
32
18
*3
0
%
INFECTION
56
cl-15 pVneoGM 45
0
0
CONTROL 53
Figure 6.8
Titration of G418 on bone marrow stem cells.
The graph shows frequency of CFU-A colony formation 
with increasing concentrations of the antitx>tic 
G418. Colony size became reduced at concentrations 
of 400]ig/ml and over until at 1 mg/ml only clusters 
of under 50 cells were observed with the aid of a 
dissection microscope. 2 x 6cm plates were used 
per point at a density of 4 x 10^  cells/ml (4ml per 
plate). A similar sensitivity to G418 was observed 
for progenitor CFU-C cells and at 1mg/ml G418 no 
microscopic colonies of greater than 50 cells were 
observed (data not shown).
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detectable levels.
A similar result was observed in the CFU-A assay described in 
Fig. 6.7. The CFU-A assay relies on stimulation by a cocktail of 
growth factors supplied by the conditioned medium from the L929 and 
AF1 cell lines. The conditioned medium from the AF1 cell line can be 
replaced by rGM-CSF (Pragnell et al., 1988) and so the effect of 
expressing a GM-CSF containing vector in CFU-A stem cells should 
theoretically be possible by adding L929 conditioned medium only. 
However as in the progenitor assay, viral infection with the GM-CSF 
virus could not be proven as no G418 resistant colonies were observed.
The bone marrow cells could be infected however by Cl-41 (Fig 
6.7) and therefore the cells themselves are not refractory to 
infection by virus packaged by ^ 2 cells.
Discussion
The data shown in Figs. 6.4, 6.5 and 6.7 shows that normal 
bone marrcw and 5FU treated marrow can be infected with retroviral 
vectors to yield G418 resistant colonies. No obvious advantage to 
using 5FU marrow can be concluded from Fig. 6.4 but these experiments 
would have to be repeated to confirm this. Infection of bone marrow 
with MoMLV based pVneo (clone 38) resulted in small colonies which 
were often difficult to distinguish from progenitor colonies on size 
basis. The above experiment was performed using NIH mice obtained 
through 01ac.
The addition of a pre-selection step in liquid culture for 2 
days in high G418 after co-cultivation, and before plating out in 
semi-solid medium, may have an effect on increasing the relative 
frequency of infection of CFU-A stem cells, but again this should be 
repeated. The preselection step did not appear to have any adverse 
affects on the assay other than lengthening it and so it is perhaps 
worth retaining.
In an attempt to observe virally directed GM-CSF expression, 
bone marrow which had been exposed to virus (either mos“^neo or 
pVneoGM) was plated out under conditions which should detect GM-CSF 
expression (Fig. 6.7). Thus a titration of rGM-CSF was used in the 
CFU-C progenitor assay and the conditioned medium from AF1 cells 
ommitted from the CFU-A assay. However, no viral infection was 
observed using clone 15 which releases pVneoGM virus particles. It is
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possible that expression of a GM-CSF virus in primary haematopoietic 
cells is "toxic" to the cells and so colony development does not 
occur. In this situation one might expect a reduction in plating 
efficiency of bone marrow exposed to pVneoGM in comparison to mos“^neo 
virus. Fig 6.7 indicates that infection with a GM-CSF virus is 
probably not toxic to colony development. Unless clone 15 has stopped 
producing virus, (virus titre was not checked immediately prior to the 
bone marrow infection), the most likely explanation for the lack of 
infection with the MoMLV based pVneoGM is perhaps a poorer expression 
in haematopoietic cells, in comparison to the MPSV based m o s ^ n e o  
virus. This may result in a low frequency of infection with pVneoGM, 
undetected under the assay conditions, which might be observed if a 
greater number of bone marrow cells were plated out after the 
co-cultivation with the virus producer clone. The results in Fig 6.4 
demonstrate that MoMLV vector pVneo can infect and express in primary 
haematopoietic cells but the experiment in Fig 6.7 differed in using 
NIH mice bred at the Beatson Institute and a higher level of G418 
(1.5mg/ml) to select for resistant colonies. Thus the initial success 
in infecting bone marrow cells with a MoMLV based vector may have been 
due to slightly different experimental conditions. The inability of 
MoMLV based vectors to infect bone marrow progenitor and stem cells 
was observed several times using NIH Beatson mice and 1.5mg/ml G418 
selection conditions (data not shown), whereas infection of bone 
marrow cells by clone 41, which releases the MPSV derived mos“^neo was 
observed on both occassions it was used (Figs. 6.5 and 6.7). It is 
therefore possible that the slight advantage that MPSV vectors may 
shew over MoMLV vectors in expressing neo in FDCP1 cells (chapter 5) 
may be magnified in primary haematopoietic cells. Theoretically, MPSV 
based vectors should be capable of expressing efficiently in 
haematopoietic cells (Ostertag et _al 1980) and therefore it should not 
be surprising that at least mos“^neo infected stem and progenitor 
cells express G418 resistance as judged by frequency and size of 
resistant colonies. It must be remembered that all the viruses used 
in this study are packaged in the ¥ 2 cell line and so have the same 
envelope proteins. Thus, frequency of infection is probably not a 
function of the efficiecy with which virus particles interact with 
target cell membrane, but is probably related to the efficiency with 
which the selected gene is expressed once the virus has entered the
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and integrated into the genome.
CHAPTER SEVEN 
Conclusions
Autocrine stimulation of haematopoietic cells has been the 
subject of considerable research in recent years and a complex picture 
of regulation by both GM-CSF and other factors is beginning to emerge 
(Chapter 1.6, 5). This study has concentrated in particular on
retroviral mediated gene expression in cell lines (Chapters 4 and 5) 
and primary bone marrow cells (Chapter 6).
Retroviral mediated expression of GM-CSF described in this 
thesis and elsewhere (Laker et al., 1987; Lang, 1985) demonstrates the 
possibility of altering the growth characteristics of a haematopoietic 
cell line. However the growth observed is dependent on the retroviral 
vector used, an imoprtant consideration for interpretation of any 
results concerning the interaction of autocrine produced GM-CSF with 
the cell line ( Chapter 5). The final interpretation may also be 
dependent on the exact time point at which cells are taken for 
analysis (Laker et al., 1987). The importance of the choice of vector 
is demonstrated by the results described in Chapter 5 which reveal a 
higher conversion of FDCP1 cells to factor independence using the 
pVneoGM vector in comparison to the mos~3neoGM vector.
The observed frequency with which the retroviral constructs 
used in this study convert FDCP1 cells to factor independence may be 
related to the observations in Chapter 4 that growth factor release 
from virus producing cells lines, is greater from cells harbouring 
pVneoGM than mos"^neoGM, possibly via the efficiency of retroviral 
mediated expression of GM-CSF.
Although as indicated above knowledge of the growth 
characteristics of haematopoietic cells immediately after retroviral 
infection does reveal information on the autocrine stimulation of 
FDCP1 cells, the analysis of cell lines derived from infection 
uncovers a complexity hitherto unobserved.
FDCP1 cell lines which contain the pVneoGM virus and which 
were initially selected for resistance to G418 demonstrate a variable 
relative replating efficiency under conditions which select for 
factor independent growth (Fig. 5.3) and maximal colony growth is not 
observed in comparison to stimulation with WEHI conditioned medium 
(Fig. 5.3). The low replating efficiency in factor independent 
conditions may be due to epigenetic suppression of growth factor
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sequences in the vector (Emmerman and Temin, 1984) after selection for 
G418 resistance. However, FDCP1 cells lines containing pVneoGM which 
are selected for factor independence show an even poorer replating 
efficiency in factor independent conditions at low cell density
(1C)3/ml in Fig. 5.6) but it is unlikely that epigenetic suppression of
growth factor sequences is the cause, as the cells were initially
selected for expression of growth factor sequences. The low replating 
efficiency of pVneoGM containing cells is therefore unlikely to be
caused by epigenetic suppression. The inability of the factor
independent cell lines to replate into factor independent conditions 
at low densities can in part be attributed to their low replating 
efficiency even in the presence of WEHI CM (Fig. 5.6).
It was of interest that pVneoGM containing factor independent
cell lines did form colonies at a high cell density and therefore 
efficient colony formation may require cross feeding between colonies. 
The hypothesis that the factor independent cell lines produced levels 
of growth factor sub-optimal for efficient colony stimulation at low 
cell density was tested by examining the cloning efficiency of these
cell lines in response to exogenous growth factor (Figs. 5.7 and 5.8).
From the experiments shown in these figures it can be concluded that 
factor independent clones respond to exogenous growth factor by 
increasing their cloning efficiency in semi-solid medium, thus giving 
them a proliferative advantage over the parental FDCP1 cell line in 
sub-optimal growth conditions. Therefore, although the virus pVneoGM 
is expressed in the FDCP1 cells it is presunably not at a high enough 
level to totally relieve the cells reliance on exogenous growth 
factor, a characteristic which is manifestd in a poor cloning 
efficiency at low cell density.
Initial results using FDCP1 clones derived by infection with 
mos”^neoGM also suggest that expression of viral GM-CSF sequences is 
poor in these cell lines (Chapter 5). These results suggest that 
growth factor must be released from the growth factor independent 
cells and attain a critical concentration before efficient colony 
formation can occur, an event which can be substituted by the addition 
to the culture of low levels of exogenous growth factor. The results 
in this study therefore differ from those of Lang et al. (1985) on the
expression of GM-CSF in FDCP1 cells but are similar to those of Laker
et al. (1987) published during the course of this thesis.
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Returning to the central question of autocrine stimulation of 
primary bone marrow progenitor and stem cells as discussed in Chapters 
1.6 and 1.7, the lessons learned on retroviral gene expression in cell 
lines (Chapter 5) were used to design experiments to address the above 
question.
Conditions were established in which retroviral gene transfer 
could be achieved by the manipulation of existing _in vitro colony 
assays (Chapter 6). However, despite success in expressing the 
neomycin gene in primary haematopoietic cells and considerable effort 
to optimise cell density and growth factor levels, which the results 
in Chapter 5 indicate may be critical in order to observe retroviral 
mediated GM-CSF expression, the autocrine stimulation of primary 
haematopoietic cells was not observed. However, failure to detect 
factor independent colonies in the experiments shown in Fig.6.7 is 
most likely due to poor viral infection and/or expression.
The retroviral expression of genes in short term in vitro 
assays may give some indication as to the multiple steps involved in 
leukaemogenesis, which can then be examined in long term marrow 
cultures or In vivo. Therefore, the use of short term In vitro assays 
to assess the efficiency of new vectors, in terms of gene expression 
in bone marrow cells is important. Over the past few years our 
knowledge of mechanisms by which retrovirus vectors are expressed in 
highly specialised cell types has increased considerably. By the 
application of fundamental observations in both retroviral expression 
and the manipulation of bone marrow _in vitro, the optimal system could 
be generated to study autocrine stimulation in haematopoietic cells. 
This study and others (Laker et al., 1986; Lang et al., 1985) have
gone some way to addressing whether autocrine stimulation results in a 
proliferative advantage over non autocrine stimulated cells and to the 
necessity or otherwise for growth factor release as part of autocrine 
stimulation.
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